syndrome	score	normalized_score
DRAVET SYNDROME	2.6655187000000002	100.0
OCULOFACIOCARDIODENTAL SYNDROME	2.0	75.03230046744747
CHILDHOOD ABSENCE EPILEPSY	1.52074085	57.05234219516073
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	1.2909091	48.429939733681096
MYOCLONIC-ASTASTIC EPILEPSY	1.2186896	45.72054212187669
BEHR SYNDROME	1.20235462	45.10771655813181
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	44.782803437094614
260150 PALANT CLEFT PALATE SYNDROME	1.166667	43.768854444727765
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.1528726900000001	43.25134503839722
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.00342466	37.64463029278316
COLOBOMA OF MACULA AND SKELETAL ANOMALIES	1.00120482	37.56135044184833
DUPLICATION OF THE PITUITARY GLAND	1.00075643	37.54452857524503
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	1.00075643	37.54452857524503
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	1.000541419	37.53646219026713
ANAPLASTIC THYROID CARCINOMA	1.0	37.516150233723735
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	37.516150233723735
MYOCLONIC EPILEPSY OF LAFORA	0.93444076	35.056619936674984
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.833333	31.263446022719705
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.825714109	30.977614563349338
%187370 ARTHROGRYPOSIS, DISTAL, TYPE 10; DA10;;CONGENITAL PLANTAR CONTRACTURES;;TENDO CALCANEUS, SHORT	0.79684233	29.89445656487047
LAFORA DISEASE	0.7715289599999999	28.94479637302863
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	28.91058689627651
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.74803341	28.063333789404666
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.70997286	26.63544847762651
EARLY MYOCLONIC ENCEPHALOPATHY	0.7081833599999999	26.56831332678326
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.6969696	26.147616221938335
15Q OVERGROWTH SYNDROME	0.6672074189999999	25.03105376825906
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.59274141	22.237375787309237
ROLANDIC EPILEPSY	0.5906213	22.15783742203722
MUCOPOLYSACCHARIDOSIS TYPE 2	0.5872993790000001	22.033211734736657
ARTHROGRYPOSIS, DISTAL, TYPE 2E	0.5640871700000001	21.162379014636066
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.5555556	20.84230735278653
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5333330000000001	20.008600952602585
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	19.77202410922872
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.52312228	19.6255340470881
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.51630151	19.369645015058417
WIEACKER-WOLFF SYNDROME	0.515634949	19.344638212442476
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.51341463	19.261340391271688
ARTHROGRYPOSIS-LIKE HAND ANOMALY AND SENSORINEURAL DEAFNESS	0.50719424	19.027975305519334
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.50714286	19.026047725720325
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	19.02227322584531
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.50704225	19.02227322584531
INHALATIONAL ANTHRAX	0.5035461	18.891111137205677
PAROXYSMAL HEMICRANIA	0.50342466	18.88655517592129
NON-DISTAL MONOSOMY 20Q	0.501297849	18.806765414926556
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.500541419	18.778387073405263
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.758075116861868
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.5	18.758075116861868
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.5	18.758075116861868
BICD2-RELATED AUTOSOMAL DOMINANT CHILDHOOD-ONSET PROXIMAL SPINAL MUSCULAR ATROPHY	0.5	18.758075116861868
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.5	18.758075116861868
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.5	18.758075116861868
CREST SYNDROME	0.5	18.758075116861868
BENIGN SCHWANNOMA	0.5	18.758075116861868
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.5	18.758075116861868
MYOPATHIC EHLERS-DANLOS SYNDROME	0.47007909999999997	17.635558137333643
ULNAR HEMIMELIA	0.4455281	16.71449913294549
ANOCTAMIN-5-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R12	0.4383321	16.444532915863615
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.42149728000000003	15.81295527958592
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.41534218000000006	15.582039623282329
SPINOCEREBELLAR ATAXIA TYPE 10	0.4088913	15.340027440062604
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.39780377	14.924065998861682
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.377126619	14.148338895540292
CALPAIN-3-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R1	0.37166509999999997	13.943443728231955
MYOSCLEROSIS, AUTOSOMAL RECESSIVE	0.36781579999999997	13.799032811137282
PERIORAL MYOCLONIA WITH ABSENCES	0.36455991	13.676884352752804
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.412686243769361
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.412686243769361
CENTRALOPATHIC EPILEPSY	0.35470090000000004	13.307012252437023
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.34973511999999995	13.120715303929398
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.34825196	13.06507285054875
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.34603212	12.98179299961392
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.3448273	12.936592791489327
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.3444743799999999	12.923352591748834
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.34406480899999997	12.90798706458146
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.769569014841275
EMERY-NELSON SYNDROME	0.33814068999999997	12.685736926175004
COG4-CDG	0.33529425	12.578949455503727
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.333333	12.505370905857834
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	12.505370905857834
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	12.505370905857834
FRASER-LIKE SYNDROME	0.333333	12.505370905857834
OROFACIODIGITAL SYNDROME TYPE 3	0.333333	12.505370905857834
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.31762715999999996	11.916148252871004
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.30073585999999997	11.282451704428107
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.2934783	11.010175993137846
PALLISTER-HALL SYNDROME	0.2934783	11.010175993137846
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.2924201	10.97047640296052
SCHWARTZ-JAMPEL SYNDROME	0.28771257	10.793868000250757
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.28538658	10.706605809968618
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.266667	10.004319234376407
STUVE-WIEDEMANN SYNDROME	0.26294890000000004	9.8648304361924
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.25508440000000004	9.569784672679281
SCLERODERMA	0.254087519	9.532385535318134
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.251297849	9.427727856495622
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 46	0.25120482	9.42423776655553
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.25119335000000004	9.42380745631235
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.25075643	9.407415899952229
EXTRAORAL HALITOSIS DUE TO METHANETHIOL OXIDASE DEFICIENCY; EHMTO	0.25	9.379037558430934
WILD TYPE ABETA2M AMYLOIDOSIS	0.25	9.379037558430934
MUCOPOLYSACCHARIDOSIS TYPE 1	0.25	9.379037558430934
DYSTONIA 6, TORSION	0.25	9.379037558430934
PRIMARY CILIARY DYSKINESIA	0.25	9.379037558430934
HYPERPARATHYROIDISM 2	0.25	9.379037558430934
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	9.379037558430934
IDIOPATHIC BRONCHIECTASIS	0.25	9.379037558430934
HYPEREKPLEXIA 1; HKPX1	0.25	9.379037558430934
MICROPHTHALMIA WITH LIMB ANOMALIES	0.25	9.379037558430934
METHIONINE ADENOSYLTRANSFERASE I/III DEFICIENCY	0.25	9.379037558430934
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	9.379037558430934
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.2426566	9.103541460804607
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.24249960000000004	9.097651425217915
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.23749391	8.909857207154465
ARTHROGRYPOSIS, DISTAL, TYPE 1B	0.2371406	8.896602376115387
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.23544956	8.833161065424152
LENNOX-GASTAUT SYNDROME	0.23257130999999998	8.725180206013935
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915000000002	8.475991933577506
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.22510605000000003	8.445112390320128
JUVENILE MYOCLONIC EPILEPSY	0.2214368	8.307456256075035
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.21705794	8.143178286462593
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.21234543	7.966383053324668
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 43	0.20962820000000001	7.864443044425087
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.20873440000000001	7.830911109346185
KUFOR-RAKEB SYNDROME	0.20475092	7.68146627521315
BETHLEM MYOPATHY 2; BTHLM2	0.20409836	7.656984736216632
SARCOIDOSIS	0.2035461	7.636266067088555
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.20342466	7.6317101058041725
FAMILIAL CERVICAL ARTERY DISSECTION	0.20342466	7.6317101058041725
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.20342466	7.6317101058041725
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.20308968	7.619142945798879
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.20196125	7.576808596390638
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.200541419	7.52354200328814
WHIM SYNDROME	0.200541419	7.52354200328814
SALIVARY DUCT CALCULI	0.2	7.503230046744748
RADIATION PROCTITIS	0.2	7.503230046744748
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.2	7.503230046744748
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.2	7.503230046744748
MYOFIBROMATOSIS, INFANTILE, 1; IMF1	0.2	7.503230046744748
HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS	0.2	7.503230046744748
MELIOIDOSIS	0.2	7.503230046744748
SECONDARY NON-TRAUMATIC AVASCULAR NECROSIS	0.2	7.503230046744748
RAT-BITE FEVER	0.2	7.503230046744748
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.2	7.503230046744748
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	7.503230046744748
RIGID SPINE SYNDROME	0.19969540000000002	7.4918026273835565
TRANSIENT NEONATAL DIABETES MELLITUS	0.19016275	7.134174297858048
PERMANENT NEONATAL DIABETES MELLITUS	0.19016275	7.134174297858048
AUTOSOMAL RECESSIVE EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.18953489999999998	7.110619782933804
EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1	0.18953489999999998	7.110619782933804
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.18953489999999998	7.110619782933804
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.18953489999999998	7.110619782933804
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.18953489999999998	7.110619782933804
ROBERTS SYNDROME	0.18823045	7.061681840761425
ZUNICH NEUROECTODERMAL SYNDROME	0.187009479	7.015875709294404
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.18074025999999999	6.7806787474422885
MYOCLONIC EPILEPSY OF INFANCY	0.18074025999999999	6.7806787474422885
LIMITED CUTANEOUS SYSTEMIC SCLEROSIS	0.17932520000000002	6.727591143892557
DUPUYTREN CONTRACTUREDUPUYTREN CONTRACTURE 1, INCLUDED	0.17932520000000002	6.727591143892557
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.1773398	6.6531065792185204
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.174351279	6.540988776405883
PORPHYRIA	0.17417917900000002	6.5345322469506595
GRANULOMATOSIS WITH POLYANGIITIS	0.17417917900000002	6.5345322469506595
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.17198444899999998	6.452194426548198
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.17076536	6.4064589004759185
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.17064042999999998	6.401772007827218
PFAPA SYNDROME	0.1702131	6.3857402313478415
UNILATERAL POLYMICROGYRIA	0.16875813	6.331155358242281
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.167964849	6.3013945090687224
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.16742343	6.28108255252533
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.16742343	6.28108255252533
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.166667	6.252704211004034
CUTANEOUS SMALL VESSEL VASCULITIS	0.166667	6.252704211004034
SYNPOLYDACTYLY 1	0.166667	6.252704211004034
GRAFT VERSUS HOST DISEASE	0.166667	6.252704211004034
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 10	0.166667	6.252704211004034
CRANIOACROFACIAL SYNDROME	0.166667	6.252704211004034
PEYRONIE DISEASE	0.166667	6.252704211004034
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.166667	6.252704211004034
PITYRIASIS RUBRA PILARIS	0.166667	6.252704211004034
PEMPHIGUS VULGARIS	0.166667	6.252704211004034
FASCIAL DYSTROPHY, CONGENITAL	0.166667	6.252704211004034
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.16361056	6.138038348783671
CAMPTODACTYLY-ARTHROPATHY-COXA VARA-PERICARDITIS SYNDROME	0.1625	6.096374412980107
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.1595057	5.984039804335269
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.1595057	5.984039804335269
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.15699616	5.889891524677729
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15621461999999997	5.860571152624064
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.15510772999999997	5.819044901091857
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.1515915	5.687129488155532
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.15147173	5.682636178842039
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.15010410000000002	5.631327966297891
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.14880960000000001	5.582763309820336
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.148123149	5.5570103109762465
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.14771178999999998	5.541577704932251
AMISH NEMALINE MYOPATHY	0.1458333	5.471103991879703
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.14481824999999998	5.433023223584962
COMBINED SAPOSIN DEFICIENCY	0.14285699999999998	5.3594446739390715
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.3594446739390715
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.14089111	5.285692049356097
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.13702114999999998	5.140506048597595
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.13699983000000002	5.139706204274613
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.135780649	5.093967226716511
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.13490821899999997	5.061237011768102
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.134346419	5.040160438566796
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.13349208899999998	5.00810926593762
BLAU SYNDROME	0.13323235	4.998364858592063
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.1324787	4.970090811968417
INSULIN-RESISTANCE SYNDROME TYPE B	0.1285461	4.822554799559275
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.126297849	4.738209077280155
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.126297849	4.738209077280155
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.125541419	4.709830735758859
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.125541419	4.709830735758859
VAN DER WOUDE SYNDROME	0.125	4.689518779215467
KIMURA DISEASE	0.125	4.689518779215467
CHEILITIS GLANDULARIS	0.125	4.689518779215467
SEVERE HEMOPHILIA A	0.125	4.689518779215467
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.125	4.689518779215467
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.125	4.689518779215467
HEARING LOSS-FAMILIAL SALIVARY GLAND INSENSITIVITY TO ALDOSTERONE SYNDROME	0.125	4.689518779215467
OXOGLUTARIC ACIDURIA	0.125	4.689518779215467
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.12425806	4.661684046711058
FRONTOMETAPHYSEAL DYSPLASIA	0.12246399000000001	4.594377447061242
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.12157512000000001	4.5610304666029915
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.1208448	4.533631671764298
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.12080790899999999	4.532247663466025
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.12037025999999999	4.515828757832387
ROBERTS SYNDROME; RBS	0.11841273000000001	4.442389768265366
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	4.4326550776027185
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.11808175999999998	4.429973048022509
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.11438980000000001	4.291464922005612
SCHINZEL-GIEDION SYNDROME	0.11428576000000001	4.287561741735296
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.11231581999999998	4.213657176743872
FG SYNDROME TYPE 1	0.11165241899999999	4.1887689251626705
TERMINAL OSSEOUS DYSPLASIA; TOD	0.11139679000000002	4.1791787091945745
BILATERAL POLYMICROGYRIA	0.11130945	4.17590204863316
HYALINE FIBROMATOSIS SYNDROME; HFS	0.11111099999999999	4.168456968619277
JUVENILE HYALINE FIBROMATOSIS	0.11111099999999999	4.168456968619277
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.10815050000000001	4.057390405852339
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.10621331	3.984714494781072
AICARDI SYNDROME; AIC	0.10564795	3.963504364084934
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.104843949	3.9333413417808694
SYNOSTOSIS, CARPAL, WITH DYSPLASTIC ELBOW JOINTS AND BRACHYDACTYLY	0.10310420000000001	3.868072656927899
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.10170259999999999	3.8154900207603113
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.10056594000000002	3.772846913435648
CAMPTOBRACHYDACTYLY	0.1	3.751615023372374
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.1	3.751615023372374
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.09940118900000001	3.729149939934768
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.09860473	3.699269864435766
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.09860473	3.699269864435766
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.09860473	3.699269864435766
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09840755	3.6918724299326797
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185000000001	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185000000001	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185000000001	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185000000001	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185000000001	3.681154065810906
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.09674793000000001	3.629609876681788
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.09653291900000002	3.621543491703885
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.09599150000000001	3.601231535160492
ECTODERMAL DYSPLASIA-SENSORINEURAL DEAFNESS SYNDROME	0.09571679000000001	3.590925473529786
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.09397259000000001	3.5254898042921248
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.093155839	3.4948484510725812
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.0925926	3.4737178921310883
MARDEN-WALKER SYNDROME	0.09252750900000001	3.471275928396225
TRICHOTHIODYSTROPHY	0.09252131	3.4710433657809263
OCULODENTODIGITAL DYSPLASIA; ODDD	0.09220694900000001	3.4592497512773033
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.091771079	3.4428975868749294
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.09166553000000001	3.438937794733911
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.09166553000000001	3.438937794733911
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.0909091	3.4105594532126147
WT LIMB-BLOOD SYNDROME	0.0909091	3.4105594532126147
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.0902778	3.386875507570065
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.08943883900000002	3.3554009206538304
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.08913404000000001	3.3439660355787417
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.08897280900000001	3.3379172691604078
CAMPTODACTYLY-TAURINURIA SYNDROME	0.08814099000000002	3.3067106225891423
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.08583596900000001	3.2202351084612535
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.08583596900000001	3.2202351084612535
3Q29 MICRODUPLICATION SYNDROME	0.08463114900000002	3.1750349003366587
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.08463114900000002	3.1750349003366587
MONOSOMY 22	0.08408973000000002	3.1547229437932667
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.08387471900000001	3.146656558815363
8P INVERTED DUPLICATION/DELETION SYNDROME	0.08387471900000001	3.146656558815363
MANDIBULOACRAL DYSPLASIA	0.08333330000000001	3.126344602271971
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.08333330000000001	3.126344602271971
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.07904281	2.965381934855681
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN	0.07862284000000001	2.9496262772420243
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.07845034000000001	2.943154741326707
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.07812792	2.9310587841683495
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.07759372	2.9110176567134944
WHITE-SUTTON SYNDROME; WHSUS	0.07714533000000001	2.894195790110195
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.07692310000000001	2.8858585760437547
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.07692310000000001	2.8858585760437547
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.07692310000000001	2.8858585760437547
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.0763091	2.8628236598002483
BLAU SYNDROME	0.07623629000000001	2.860092108901731
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.07623629000000001	2.860092108901731
URBAN-ROGERS-MEYER SYNDROME	0.07623629000000001	2.860092108901731
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.07610066	2.8550037934455306
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.07598959999999999	2.850837249800573
LETHAL CONGENITAL CONTRACTURE SYNDROME 5	0.07552696	2.8334807780564435
TUBEROUS SCLEROSIS COMPLEX	0.07495486	2.8120177885077298
JUVENILE ABSENCE EPILEPSY	0.07412774999999999	2.7809878054879147
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.07409842999999999	2.7798878319630616
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	0.0737813	2.767990335239441
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.07272644900000001	2.728416386649248
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.07272644900000001	2.728416386649248
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.07268190000000001	2.7267450796724857
17Q23.1Q23.2 MICRODELETION SYNDROME	0.07218503000000001	2.7081044301058554
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.07197001900000001	2.700038045127952
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.07197001900000001	2.700038045127952
LOCALIZED SCLERODERMA	0.07142860000000001	2.6797260885845593
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.07142860000000001	2.6797260885845593
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.07142860000000001	2.6797260885845593
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07142860000000001	2.6797260885845593
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.07142860000000001	2.6797260885845593
LETHAL CONGENITAL CONTRACTURE SYNDROME 6; LCCS6	0.07142860000000001	2.6797260885845593
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.07142860000000001	2.6797260885845593
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.07142860000000001	2.6797260885845593
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.07142860000000001	2.6797260885845593
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.07129617999999999	2.674758199970609
%300158 ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX;;ARTHROGRYPOSIS, X-LINKED, TYPE V, FORMERLY; AMCX5, FORMERLY	0.07098874	2.6632242347427537
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.07077939999999999	2.6553706038528255
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.07021279999999999	2.6341139531303974
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.06960179	2.61119121017609
MICROHYDRANENCEPHALY; MHAC	0.06898579	2.5880812616321167
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.0688549	2.5831707727280246
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.0686937	2.5771231693103482
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.068667009	2.57612182574446
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.067964549	2.5497682308512784
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.06787151999999999	2.546278140911185
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.06787151999999999	2.546278140911185
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.06787151999999999	2.546278140911185
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.06776525	2.5422912996258473
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.06742313	2.529456274307886
LETHAL CONGENITAL CONTRACTURE SYNDROME 4; LCCS4	0.0667341	2.5036065213123435
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.0666667	2.50107793278659
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.50107793278659
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.50107793278659
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.50107793278659
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	2.50107793278659
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0666667	2.50107793278659
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0666667	2.50107793278659
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.06535621900000001	2.4519137307121497
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0648148	2.4316017741687577
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0648148	2.4316017741687577
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.06470255	2.427390586305022
OTOONYCHOPERONEAL SYNDROME	0.0637945	2.393324046085289
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.06348501	2.3817131727494534
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.06259785000000001	2.348430344908104
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.06255615	2.3468659214433574
SLC39A8-CDG	0.06231383900000001	2.337775345564074
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.061775079999999996	2.317563181980302
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.060792330000000006	2.2806941853381106
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.06078013	2.2802364883052593
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.060516769000000005	2.2703561974635558
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.0593361	2.226062041883255
CONGENITAL ISOLATED ACTH DEFICIENCY	0.05910170000000001	2.2172682562684702
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.05910170000000001	2.2172682562684702
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.059050269	2.2153387631458
BETHLEM MYOPATHY	0.05836648999999999	2.189686007455134
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.057777909999999995	2.1676047517505688
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.05734132000000001	2.151225575720028
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0573294	2.150778383209242
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.056760420000000006	2.129432444049258
AMISH INFANTILE EPILEPSY SYNDROME	0.0562121	2.1088615885531024
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	2.0842322359246626
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.0842322359246626
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.0842322359246626
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	2.0842322359246626
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.0842322359246626
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	2.0842322359246626
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.0842322359246626
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.0842322359246626
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	2.0842322359246626
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	2.0842322359246626
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.055555600000000004	2.0842322359246626
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	2.0842322359246626
GITELMAN SYNDROME	0.055555600000000004	2.0842322359246626
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.05548023	2.0814046436815463
208080 ARTHROGRYPOSIS, DISTAL, WITH HYPOPITUITARISM, MENTAL RETARDATION,AND FACIAL ANOMALIES	0.05548023	2.0814046436815463
DISTAL MONOSOMY 12Q	0.05461823	2.0490657221800768
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.054351269	2.039050373197532
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.05281559	1.9814376091227572
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.051850299	1.9452236069474957
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.05149209	1.9317849842884236
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.051401908999999996	1.9284017403441962
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.9201185495340927
HYPEREKPLEXIA 4; HKPX4	0.05116257900000001	1.9194230001087595
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.05067254	1.9010386233643755
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.04976443	1.8669698321756283
ERYTHERMALGIA, PRIMARY	0.0494995	1.857030678494208
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.0485313	1.8207075418379168
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.048189269	1.807875855457326
CHROMOSOME 17Q12 DELETION SYNDROME	0.047860299999999995	1.795534205031088
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.04757886	1.7849756597093087
BETHLEM MYOPATHY 1	0.04730579	1.774731124564986
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.04680156	1.7558143561326356
MYOPATHY, MYOFIBRILLAR, 7; MFM7	0.0466779	1.7511751089947334
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.04633119	1.7381678845471988
CHRISTIANSON SYNDROME	0.04619249	1.7329643945097815
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.685432182486658
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.04423473000000001	1.6595167762282066
3P25.3 MICRODELETION SYNDROME	0.04388511	1.6464003797834919
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.0437524	1.641421611485974
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.043664970000000004	1.6381415744710401
GABRIELE-DE VRIES SYNDROME	0.043478300000000004	1.631138434706911
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.043466879	1.6307099627550912
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.04305686	1.6153276283524105
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.0429612	1.611738833421052
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.042756550000000004	1.604061153275721
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.042756550000000004	1.604061153275721
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.042756550000000004	1.604061153275721
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.042721209999999996	1.6027353325264608
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.0427032	1.6020596666607514
16P13.11 MICRODELETION SYNDROME	0.042601120000000006	1.5982300180448932
GENITOPATELLAR SYNDROME	0.041983588999999995	1.5750626322749113
PSEUDOXANTHOMA ELASTICUM; PXE	0.041886160000000006	1.5714074712737902
COG2-CDG	0.041666699999999994	1.5631741769434964
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.041482029999999996	1.556246069479835
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.041110509	1.542308031828852
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.041110509	1.542308031828852
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.041110509	1.542308031828852
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.04097907	1.5373769465582814
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.04073417	1.5281892413660423
PEHO SYNDROME	0.04020877	1.5084782560332437
CHROMOSOME 1P36 DELETION SYNDROME	0.039568459	1.484456252360938
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.03930035	1.4743978348379245
AUTOSOMAL RECESSIVE AXONAL NEUROPATHY WITH NEUROMYOTONIA	0.03929049	1.47402792559662
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.039272100000000004	1.4733380035938222
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.03899825	1.4630642058523167
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.445170877998342
BAZEX SYNDROME; BZX	0.0384615	1.4429274122143656
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0384615	1.4429274122143656
LIP, MEDIAN NODULE OF UPPER	0.0384615	1.4429274122143656
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0384615	1.4429274122143656
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.0384615	1.4429274122143656
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.0384615	1.4429274122143656
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.0384615	1.4429274122143656
ACROCEPHALOPOLYDACTYLY	0.0384615	1.4429274122143656
BLEPHAROCHALASIS AND DOUBLE LIP	0.0384615	1.4429274122143656
MAL DE MELEDA	0.0384615	1.4429274122143656
ABLEPHARON-MACROSTOMIA SYNDROME	0.0384615	1.4429274122143656
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.0384615	1.4429274122143656
SHPRINTZEN OMPHALOCELE SYNDROME	0.0384615	1.4429274122143656
CYCLIC NEUTROPENIA	0.0384615	1.4429274122143656
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.0384615	1.4429274122143656
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.0384615	1.4429274122143656
LIP, HAMARTOMATOUS	0.0384615	1.4429274122143656
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.0384615	1.4429274122143656
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.038416580000000006	1.441242186745867
CANAVAN DISEASE	0.03824182	1.4346858643310212
ZELLWEGER SYNDROME	0.038216969	1.4337535504815628
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.038216969	1.4337535504815628
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.421234073503217
SLC35A2-CDG	0.037822220000000004	1.4189440876929507
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.03779343	1.4178639977277216
LISSENCEPHALY 2; LIS2	0.03779343	1.4178639977277216
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.03771083	1.4147651637184162
OLIVER SYNDROME	0.03745967	1.405342607425714
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.037037	1.389485656206426
MCLEOD SYNDROME; MCLDS	0.037037	1.389485656206426
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.037037	1.389485656206426
MYOCLONUS AND ATAXIA	0.037037	1.389485656206426
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.037037	1.389485656206426
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.037037	1.389485656206426
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.037012149	1.3885533423569678
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.037012149	1.3885533423569678
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.037012149	1.3885533423569678
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.0369544	1.3863868221971203
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.03647073000000001	1.3682413858135756
YOU-HOOVER-FONG SYNDROME; YHFS	0.03647073000000001	1.3682413858135756
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.036255719000000006	1.3601750008356723
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.036255719000000006	1.3601750008356723
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.036255719000000006	1.3601750008356723
LISSENCEPHALY, X-LINKED, 2	0.036255719000000006	1.3601750008356723
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.036255719000000006	1.3601750008356723
MENTAL RETARDATION, X-LINKED 98; MRX98	0.036220379	1.3588491800864122
THUMBS, CONGENITAL CLASPED	0.0361093	1.3546819236346004
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.035804199999999994	1.3432357461982913
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.035780649	1.342352203344137
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.03572847	1.3403946481410915
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.035714300000000004	1.3398630442922796
ROWLEY-ROSENBERG SYNDROME	0.03568276	1.338679784913908
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.03568276	1.338679784913908
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.338060393273549
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.338060393273549
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.03566625	1.338060393273549
ALPERS-HUTTENLOCHER SYNDROME	0.03557648	1.3346925684670679
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.0354509	1.3299812903207169
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.03527407	1.3233473094748875
FETAL AKINESIA DEFORMATION SEQUENCE	0.03525773	1.3227342955800685
RESTRICTIVE DERMOPATHY	0.03525773	1.3227342955800685
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.03523923	1.3220402468007446
DOORS SYNDROME	0.03482568	1.306525442871588
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.3063142269457724
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.034820050000000005	1.3063142269457724
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.03469632	1.3016723536773536
ALPHA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R3	0.0344828	1.293661905279449
GAMMA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R5	0.0344828	1.293661905279449
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.0344828	1.293661905279449
MYOPATHY, SCAPULOHUMEROPERONEAL	0.0344828	1.293661905279449
COSTELLO SYNDROME; CSTLO	0.0344828	1.293661905279449
MUSCULAR DYSTROPHY, CONGENITAL, 1B	0.0344828	1.293661905279449
MYOTILINOPATHY	0.0344828	1.293661905279449
MYOPATHY AND DIABETES MELLITUS	0.0344828	1.293661905279449
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5	0.0344828	1.293661905279449
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.03424793	1.2848504870740542
GENITOPATELLAR SYNDROME; GTPTS	0.03424793	1.2848504870740542
AICARDI SYNDROME	0.034219349999999996	1.2837782755003742
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.034069249999999995	1.278147101350292
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.034069249999999995	1.278147101350292
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.0334915	1.2564721455527585
CAMURATI-ENGELMANN DISEASE, TYPE 2	0.0334915	1.2564721455527585
CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANTCHONDRODYSPLASIA PUNCTATA DUE TO VITAMIN K DEFICIENCY, INCLUDED	0.0334915	1.2564721455527585
PRIMROSE SYNDROME; PRIMS	0.0334915	1.2564721455527585
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.03346292	1.2553999339790787
ALG13-CDG	0.03346292	1.2553999339790787
SPINOCEREBELLAR ATAXIA TYPE 34	0.03346292	1.2553999339790787
DYSSEGMENTAL DYSPLASIA WITH GLAUCOMA	0.0330284	1.2390984163795211
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.03301453	1.2385780673757794
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.03301453	1.2385780673757794
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.032799519	1.2305116823978761
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.032799519	1.2305116823978761
TUBEROUS SCLEROSIS-1	0.032799519	1.2305116823978761
PROGRESSIVE HEMIFACIAL ATROPHY	0.032799519	1.2305116823978761
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.2305116823978761
HYDROXYKYNURENINURIA	0.0322581	1.2101997258544837
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.0322581	1.2101997258544837
DESMOID TUMOR	0.0322581	1.2101997258544837
CRAMPS, FAMILIAL ADOLESCENT	0.0322581	1.2101997258544837
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.0322581	1.2101997258544837
NETHERTON SYNDROME; NETH	0.0322581	1.2101997258544837
HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	0.0322581	1.2101997258544837
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.0322581	1.2101997258544837
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.0322581	1.2101997258544837
THROMBOCYTOPENIA 1	0.0322581	1.2101997258544837
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 2	0.0322581	1.2101997258544837
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.0322581	1.2101997258544837
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0322581	1.2101997258544837
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0322581	1.2101997258544837
APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZEDPOLYNEUROPATHY	0.0322581	1.2101997258544837
WEST SYNDROME	0.0322581	1.2101997258544837
MYALGIA-EOSINOPHILIA SYNDROME ASSOCIATED WITH TRYPTOPHAN	0.0322581	1.2101997258544837
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.0322581	1.2101997258544837
INFANTILE MYOFIBROMATOSIS	0.0322581	1.2101997258544837
PERONEUS TERTIUS MUSCLE, ABSENCE OF	0.0322581	1.2101997258544837
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.17151344689497
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.031125359999999998	1.1677036818387354
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.031114519	1.1672969692540516
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.030844418999999998	1.1571638570759228
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.030844418999999998	1.1571638570759228
LETHAL CONGENITAL CONTRACTURE SYNDROME 3; LCCS3	0.03045004	1.1423682752628972
ALPHA-DYSTROGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R16	0.030302999999999997	1.1368519005325304
KLHL9-RELATED EARLY-ONSET DISTAL MYOPATHY	0.030302999999999997	1.1368519005325304
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.030302999999999997	1.1368519005325304
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Y; LGMD2Y	0.030302999999999997	1.1368519005325304
DISTAL NEBULIN MYOPATHY	0.030302999999999997	1.1368519005325304
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.030302999999999997	1.1368519005325304
AYMÉ-GRIPP SYNDROME	0.030275419999999997	1.1358172051090842
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.030267259999999997	1.135511073323177
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029921848999999997	1.1225525823547962
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.029739050000000003	1.115694667608222
STÜVE-WIEDEMANN SYNDROME	0.02966099	1.1127661569209775
MENKES DISEASE	0.029075649000000002	1.0908064160270192
15Q13.3 MICRODELETION SYNDROME	0.029075649000000002	1.0908064160270192
BRUCK SYNDROME 2	0.02895166	1.0861548260756904
LETHAL INTRAUTERINE GROWTH RESTRICTION-CORTICAL MALFORMATION-CONGENITAL CONTRACTURES SYNDROME	0.02881992	1.0812124484438994
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0738622842901082
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0738622842901082
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.02853423	1.070494459483627
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.02853423	1.070494459483627
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.02853423	1.070494459483627
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.02853423	1.070494459483627
15Q24 RECURRENT MICRODELETION SYNDROME	0.02853423	1.070494459483627
AASE-SMITH SYNDROME	0.02806349	1.052834106922604
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.02797616	1.0495578215226926
EPILEPSY, PYRIDOXINE-DEPENDENT	0.027795809999999997	1.0427917838280405
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.027795809999999997	1.0427917838280405
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.027777800000000002	1.0421161179623313
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.027777800000000002	1.0421161179623313
EDINBURGH MALFORMATION SYNDROME	0.027777800000000002	1.0421161179623313
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	1.0421161179623313
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	1.0421161179623313
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	1.0421161179623313
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	1.0421161179623313
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	1.0421161179623313
OROFACIAL CLEFT 3	0.027777800000000002	1.0421161179623313
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	1.0421161179623313
DWARFISM, LEVI TYPE	0.027777800000000002	1.0421161179623313
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	1.0421161179623313
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.027777800000000002	1.0421161179623313
GANGLIOCYTOMA	0.027777800000000002	1.0421161179623313
WAARDENBURG SYNDROME, TYPE IIB	0.027777800000000002	1.0421161179623313
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	1.0421161179623313
NASAL BONES, ABSENCE OF	0.027777800000000002	1.0421161179623313
MENINGIOMA	0.027777800000000002	1.0421161179623313
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	1.0421161179623313
CYANIDE, INABILITY TO SMELL	0.027777800000000002	1.0421161179623313
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	1.0421161179623313
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	1.0421161179623313
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	1.0421161179623313
CLEFT CHIN	0.027777800000000002	1.0421161179623313
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	1.0421161179623313
DIMPLES, FACIAL	0.027777800000000002	1.0421161179623313
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.027777800000000002	1.0421161179623313
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.027751730000000002	1.0411380719257382
LOWE OCULOCEREBRORENAL SYNDROME	0.027441269	1.029490770408026
GAUCHER DISEASE	0.027041850000000003	1.0145061071978223
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	1.0139489923668514
APNEA, OBSTRUCTIVE SLEEP	0.027027	1.0139489923668514
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027027	1.0139489923668514
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	1.0139489923668514
BENIGN OCCIPITAL EPILEPSY	0.027027	1.0139489923668514
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.02668046	1.0009481456648568
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.026532200000000002	0.9953860012312051
XQ21 MICRODELETION SYNDROME	0.026004199	0.9755774363916485
AICARDI-GOUTIÈRES SYNDROME	0.025758469	0.9663585927947156
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.025609730000000004	0.960778478125102
SAY-BARBER-MILLER SYNDROME	0.025609730000000004	0.960778478125102
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.025394719000000003	0.9527120931471988
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.02521705	0.9460466362513232
CHROMOSOME 17P13.1 DELETION SYNDROME	0.024853300000000002	0.9324001366038063
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.024853300000000002	0.9324001366038063
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.024853300000000002	0.9324001366038063
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.024853300000000002	0.9324001366038063
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.024853300000000002	0.9324001366038063
TRISOMY 8P	0.024553649	0.9211583846701207
EMANUEL SYNDROME	0.024553649	0.9211583846701207
SPASTIC PARAPLEGIA-OPTIC ATROPHY-NEUROPATHY SYNDROME	0.02446062	0.9176682947300275
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.02443564	0.9167311412971892
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.024184659999999997	0.907315337911529
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.02401223	0.9008464281267281
HOLOPROSENCEPHALY WITH FETAL AKINESIA/HYPOKINESIA SEQUENCE	0.02401223	0.9008464281267281
ANE SYNDROME	0.02401223	0.9008464281267281
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.02401223	0.9008464281267281
PMM2-CDG	0.023797219	0.892780043148825
CLASSIC MULTIMINICORE MYOPATHY	0.0232558	0.8724680866054324
DISTAL MYOTILINOPATHY	0.0232558	0.8724680866054324
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.0232558	0.8724680866054324
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.0232558	0.8724680866054324
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.0232558	0.8724680866054324
BATHING SUIT ICHTHYOSIS	0.0232558	0.8724680866054324
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.0232558	0.8724680866054324
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.0232558	0.8724680866054324
CENTRAL CORE DISEASE	0.0232558	0.8724680866054324
MYASTHENIC SYNDROME, CONGENITAL, 15; CMS15	0.0232558	0.8724680866054324
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.0232558	0.8724680866054324
HUNTER-MACDONALD SYNDROME	0.023225720000000002	0.8713396008064022
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.023172469999999997	0.8693418658064562
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.02279455	0.8551637623101275
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.022579539	0.8470973773322242
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.022303729	0.8367500479362608
THROMBOCYTHEMIA, ESSENTIAL	0.02229256	0.8363310300543004
DISTAL TRISOMY 17Q	0.022131149	0.8302755107289249
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.022131149	0.8302755107289249
MOSAIC TRISOMY 15	0.02204909	0.8271969729568958
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.02196765	0.8241416576818612
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02196765	0.8241416576818612
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.02196765	0.8241416576818612
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.02196765	0.8241416576818612
MELAS	0.02196368	0.8239927185654333
OCULOSKELETODENTAL SYNDROME; OCSKD	0.02162906	0.8114390643742246
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.02162906	0.8114390643742246
ISOTRETINOIN-LIKE SYNDROME	0.021589729999999998	0.8099635541855323
ROIFMAN SYNDROME	0.021589729999999998	0.8099635541855323
ROIFMAN SYNDROME; RFMN	0.021589729999999998	0.8099635541855323
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.021589729999999998	0.8099635541855323
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.021589729999999998	0.8099635541855323
ACITRETIN/ETRETINATE EMBRYOPATHY	0.021589729999999998	0.8099635541855323
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.02150999	0.8069720163658952
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.021374719	0.8018971692076292
JERVELL AND LANGE-NIELSEN SYNDROME	0.021374719	0.8018971692076292
DILATED CARDIOMYOPATHY WITH ATAXIA	0.021374719	0.8018971692076292
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.021374719	0.8018971692076292
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.021374719	0.8018971692076292
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.021374719	0.8018971692076292
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.021374719	0.8018971692076292
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.021374719	0.8018971692076292
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.021150289000000003	0.7934774196106748
RENPENNING SYNDROME 1; RENS1	0.021098909000000002	0.7915498398116659
MICROPHTHALMIA, SYNDROMIC 1	0.021098909000000002	0.7915498398116659
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.02100588	0.7880597498715728
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.0208333	0.7815852126642366
DEAFNESS, AUTOSOMAL DOMINANT 39, WITH DENTINOGENESIS IMPERFECTA 1	0.0208333	0.7815852126642366
DEAFNESS, AUTOSOMAL RECESSIVE 101; DFNB101	0.0208333	0.7815852126642366
DEAFNESS, AUTOSOMAL DOMINANT 20	0.0208333	0.7815852126642366
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.0208333	0.7815852126642366
DE BARSY SYNDROME	0.0208333	0.7815852126642366
SPASTIC PARAPLEGIA, SENSORINEURAL DEAFNESS, MENTAL RETARDATION, AND	0.0208333	0.7815852126642366
MEDULLOBLASTOMA	0.0208333	0.7815852126642366
PROTRUSIO ACETABULI	0.0208333	0.7815852126642366
DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY	0.0208333	0.7815852126642366
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.0208333	0.7815852126642366
DEAFNESS, AUTOSOMAL RECESSIVE 94; DFNB94	0.0208333	0.7815852126642366
AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY	0.0208333	0.7815852126642366
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.0208333	0.7815852126642366
DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE	0.0208333	0.7815852126642366
RAMOS-ARROYO SYNDROME	0.0208333	0.7815852126642366
TIETZ SYNDROME	0.0208333	0.7815852126642366
JUVENILE-ONSET DIABETES MELLITUS-CENTRAL AND PERIPHERAL NEURODEGENERATION SYNDROME	0.0208333	0.7815852126642366
DEAFNESS, AUTOSOMAL RECESSIVE 37; DFNB37	0.0208333	0.7815852126642366
DEAFNESS, AUTOSOMAL RECESSIVE 77; DFNB77	0.0208333	0.7815852126642366
N SYNDROME	0.0208333	0.7815852126642366
MYOPATHY, CENTRONUCLEAR, 5	0.0208333	0.7815852126642366
MYOCLONUS-CEREBELLAR ATAXIA-DEAFNESS SYNDROME	0.0208333	0.7815852126642366
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.0208333	0.7815852126642366
WOODHOUSE-SAKATI SYNDROME	0.0208333	0.7815852126642366
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 11	0.0208333	0.7815852126642366
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0207875	0.7798669729835321
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7781168445751289
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7781168445751289
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.020740849999999998	0.7781168445751289
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.020669359999999998	0.77543481499492
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.020614139	0.7733631356628636
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.02055749	0.7712378832682734
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.02055749	0.7712378832682734
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.02055749	0.7712378832682734
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.02055749	0.7712378832682734
MEIER-GORLIN SYNDROME 1; MGORS1	0.02055749	0.7712378832682734
RECOMBINANT CHROMOSOME 8 SYNDROME	0.020342479	0.7631714982903702
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.020342479	0.7631714982903702
611961 STEVENSON-CAREY SYNDROME	0.020342479	0.7631714982903702
FRYNS SYNDROME; FRNS	0.020342479	0.7631714982903702
311450 PALLISTER W SYNDROME;;W SYNDROME	0.020342479	0.7631714982903702
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.020342479	0.7631714982903702
WEAVER SYNDROME	0.020342479	0.7631714982903702
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.020165749	0.7565412690595642
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.01989336	0.7463222824135504
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.019879379	0.7457977691171327
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.019852440000000002	0.7447871215459865
BRACHYDACTYLY, TYPE B1	0.019801060000000002	0.7428595417469778
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	0.019801060000000002	0.7428595417469778
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.019801060000000002	0.7428595417469778
201020 ACROCEPHALOPOLYSYNDACTYLY TYPE IV;;ACPS IV;;GOODMAN SYNDROME	0.019801060000000002	0.7428595417469778
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.019801060000000002	0.7428595417469778
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.019801060000000002	0.7428595417469778
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY;;URBAN-ROGERS-MEYER SYNDROME	0.019801060000000002	0.7428595417469778
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.019801060000000002	0.7428595417469778
601016 MIDLINE MALFORMATIONS, MULTIPLE, WITH LIMB ABNORMALITIES AND HYPOPITUITARISM;;DINCSOY SYNDROME	0.019801060000000002	0.7428595417469778
FIBROCHONDROGENESIS 1; FBCG1	0.019801060000000002	0.7428595417469778
DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	0.019801060000000002	0.7428595417469778
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.019801060000000002	0.7428595417469778
FRONTONASAL DYSPLASIA 1; FND1	0.019801060000000002	0.7428595417469778
MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT	0.019801060000000002	0.7428595417469778
ECTODERMAL DYSPLASIA, ECTRODACTYLY, AND MACULAR DYSTROPHY SYNDROME	0.019801060000000002	0.7428595417469778
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.01974137	0.7406202027395268
HHHH SYNDROME	0.019409319	0.7281629275382686
BAND HETEROTOPIA; BH	0.019409319	0.7281629275382686
COPPER DEFICIENCY, FAMILIAL BENIGN	0.019409319	0.7281629275382686
ATELOSTEOGENESIS TYPE II	0.01933796	0.7254858125737403
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.01933796	0.7254858125737403
SALT-AND-PEPPER SYNDROME	0.01929298	0.7237983361362275
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.01929298	0.7237983361362275
SCHAAF-YANG SYNDROME; SHFYNG	0.018976879000000002	0.7119394435311972
VESICOURETERAL REFLUX 1	0.0188679	0.707850970994876
PRIMARY HYPEROXALURIA TYPE 1	0.0188679	0.707850970994876
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	0.707850970994876
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	0.707850970994876
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.707850970994876
VAN DEN BOSCH SYNDROME	0.0188679	0.707850970994876
DERMOCHONDROCORNEAL DYSTROPHY	0.0188679	0.707850970994876
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.707850970994876
TOE, MISSHAPEN	0.0188679	0.707850970994876
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.707850970994876
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.707850970994876
NEPHROSIALIDOSIS	0.0188679	0.707850970994876
PUBIC BONE DYSPLASIA	0.0188679	0.707850970994876
SPINAL ARACHNOIDITIS	0.0188679	0.707850970994876
MEGAEPIPHYSEAL DWARFISM	0.0188679	0.707850970994876
248100 MACROSOMIA ADIPOSA CONGENITA	0.0188679	0.707850970994876
RAYNAUD DISEASE	0.0188679	0.707850970994876
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.707850970994876
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.707850970994876
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.707850970994876
TRACHEOBRONCHOMEGALY	0.0188679	0.707850970994876
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.707850970994876
LETTERER-SIWE DISEASE	0.0188679	0.707850970994876
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.707850970994876
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0188679	0.707850970994876
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0188679	0.707850970994876
MONOPHALANGY OF GREAT TOE	0.0188679	0.707850970994876
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	0.707850970994876
CIRCUMVALLATE PLACENTA SYNDROME	0.0188679	0.707850970994876
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	0.707850970994876
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.707850970994876
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0188679	0.707850970994876
BEEMER LETHAL MALFORMATION SYNDROME	0.0188679	0.707850970994876
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	0.707850970994876
KNUCKLE PADS	0.0188679	0.707850970994876
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	0.707850970994876
THROMBOCYTOPENIA 3	0.0188679	0.707850970994876
CARPAL DISPLACEMENT	0.0188679	0.707850970994876
THALIDOMIDE SUSCEPTIBILITY	0.0188679	0.707850970994876
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.707850970994876
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0188679	0.707850970994876
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.01855339	0.6960517665848676
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.01853655	0.6954199946149318
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6954199946149318
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.0184715	0.6929795690422279
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.01826276	0.6851484478424404
KAPUR-TORIELLO SYNDROME	0.018007309	0.6755649097490856
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.01755391	0.6585551247492655
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.01746589	0.6552529532056931
SYNDACTYLY, TYPE V	0.01746589	0.6552529532056931
FIBROSCLEROSIS, MULTIFOCAL	0.01746589	0.6552529532056931
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.01740912	0.6531231613569246
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6468309526397245
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6468309526397245
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6468309526397245
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.6468309526397245
PALMOMENTAL REFLEX	0.0172414	0.6468309526397245
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6468309526397245
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6468309526397245
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.6468309526397245
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.6468309526397245
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.6468309526397245
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6468309526397245
ALCOHOL DEPENDENCE	0.0172414	0.6468309526397245
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.6468309526397245
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.6468309526397245
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6468309526397245
MYOPATHY, CONGENITAL	0.0172414	0.6468309526397245
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6468309526397245
CARDIAC ARRHYTHMIA	0.0172414	0.6468309526397245
CERVICAL RIB	0.0172414	0.6468309526397245
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6468309526397245
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6468309526397245
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6468309526397245
TRANSSEXUALITY	0.0172414	0.6468309526397245
DIASTEMATOMYELIA	0.0172414	0.6468309526397245
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.6468309526397245
269800 SENILE PLAQUE FORMATION	0.0172414	0.6468309526397245
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6468309526397245
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.6468309526397245
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.6468309526397245
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6468309526397245
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6468309526397245
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6468309526397245
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.6468309526397245
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6468309526397245
SICKLE CELL ANEMIA	0.0172414	0.6468309526397245
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6468309526397245
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.6468309526397245
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6468309526397245
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6468309526397245
RHEUMATOID ARTHRITIS	0.0172414	0.6468309526397245
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.6468309526397245
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6468309526397245
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6468309526397245
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.6468309526397245
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6468309526397245
MOTION SICKNESS	0.0172414	0.6468309526397245
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6468309526397245
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6468309526397245
AYME-GRIPP SYNDROME; AYGRP	0.017118239	0.6422104260607888
MOSAIC TRISOMY 1	0.01700279	0.6378792240324557
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.01675656	0.6286416223604059
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.016349089999999997	0.6133549166246702
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.6115698981965498
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.016301509999999998	0.6115698981965498
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.016301509999999998	0.6115698981965498
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.6115698981965498
NIEMANN-PICK DISEASE TYPE B	0.016130219999999997	0.6051437568230152
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.016130219999999997	0.6051437568230152
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.016130219999999997	0.6051437568230152
HAREL-YOON SYNDROME; HAYOS	0.016130219999999997	0.6051437568230152
MARINESCO-SJOGREN SYNDROME; MSS	0.015493570000000002	0.5812590997767151
COCKAYNE SYNDROME	0.015462849	0.5801065661253849
WARBURG MICRO SYNDROME 3; WARBM3	0.015278559	0.573192714798812
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.01499808	0.5626702224974073
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.014996448999999999	0.562609033656376
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.014925399999999998	0.5599435486984202
MYOCLONIC-ATONIC EPILEPSY	0.014925399999999998	0.5599435486984202
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.014925399999999998	0.5599435486984202
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.014925399999999998	0.5599435486984202
MENTAL RETARDATION, X-LINKED 41	0.014925399999999998	0.5599435486984202
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.014925399999999998	0.5599435486984202
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.5599435486984202
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.014925399999999998	0.5599435486984202
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.014918959999999998	0.559701944690915
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.014903419999999999	0.5591189437162829
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.014878519	0.558184754059313
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.014830169	0.5563708481955125
CORNELIA DE LANGE SYNDROME 1	0.014697769	0.5514037099045674
BRANCHIOOCULOFACIAL SYNDROME	0.014697769	0.5514037099045674
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.014455029999999999	0.5422970771129836
19P13.3 MICRODUPLICATION SYNDROME	0.014455029999999999	0.5422970771129836
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.014455029999999999	0.5422970771129836
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.014455029999999999	0.5422970771129836
614262 ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY; APUG	0.0143371	0.5378727975159205
FETAL AKINESIA DEFORMATION SEQUENCE 4; FADS4	0.0143371	0.5378727975159205
NATIVE AMERICAN MYOPATHY	0.0143371	0.5378727975159205
MOEBIUS SYNDROME; MBS	0.0143371	0.5378727975159205
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.01428875	0.5360588916521201
PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 2; PPKCA2	0.01424165	0.5342918809761116
W SYNDROME	0.01418511	0.532170717841897
SENGERS SYNDROME	0.01418488	0.5321620891273432
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.013996969	0.5251123918207738
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.013956049000000002	0.52357723095321
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.013863020000000002	0.5200871410131169
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.013698599999999998	0.5139187355916879
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.5139187355916879
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.013698599999999998	0.5139187355916879
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.013698599999999998	0.5139187355916879
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.013698599999999998	0.5139187355916879
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.013698599999999998	0.5139187355916879
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.5139187355916879
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.5139187355916879
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.013698599999999998	0.5139187355916879
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.013698599999999998	0.5139187355916879
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.5139187355916879
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.5139187355916879
WARBURG MICRO SYNDROME 2; WARBM2	0.01353232	0.5076805501308245
SECKEL SYNDROME 1; SCKL1	0.013492949	0.5062035017799724
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.013492949	0.5062035017799724
DESMOSTEROLOSIS	0.01345555	0.5048004352773815
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.01345555	0.5048004352773815
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.013414630000000002	0.5032652744098175
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.013414630000000002	0.5032652744098175
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	0.013399920000000001	0.5027134118398794
GAUCHER DISEASE TYPE 2	0.01335762	0.5011264786849928
COFS SYNDROME	0.013299779000000001	0.49895650703932415
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.013299779000000001	0.49895650703932415
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.013199619000000001	0.4951988894319143
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.012951530000000001	0.48589154523658
ATYPICAL WERNER SYNDROME	0.01285862	0.4824059197183647
SCALP-EAR-NIPPLE SYNDROME; SENS	0.01285862	0.4824059197183647
ALPORT SYNDROME, X-LINKED; ATS	0.01285862	0.4824059197183647
GAUCHER DISEASE TYPE 3	0.01280536	0.4804078095569166
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.01275836	0.4786445504959316
MARDEN-WALKER SYNDROME	0.01275836	0.4786445504959316
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.01269912	0.47642209375608574
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.01269912	0.47642209375608574
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.012658200000000001	0.47488693288852185
ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH	0.012658200000000001	0.47488693288852185
TIBIAL HEMIMELIA	0.012658200000000001	0.47488693288852185
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.012658200000000001	0.47488693288852185
MYOPATHY, MYOFIBRILLAR, 6; MFM6	0.012658200000000001	0.47488693288852185
CONGENITAL PATELLA DISLOCATION	0.012658200000000001	0.47488693288852185
KYPHOSCOLIOSIS-LATERAL TONGUE ATROPHY-HEREDITARY SPASTIC PARAPLEGIA SYNDROME	0.012658200000000001	0.47488693288852185
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4	0.012658200000000001	0.47488693288852185
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.012658200000000001	0.47488693288852185
ECTODERMAL DYSPLASIA AND NEUROSENSORY DEAFNESS	0.012658200000000001	0.47488693288852185
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.012658200000000001	0.47488693288852185
MYOPATHY, DISTAL 3	0.012658200000000001	0.47488693288852185
OTOONYCHOPERONEAL SYNDROME	0.012658200000000001	0.47488693288852185
FINNISH UPPER LIMB-ONSET DISTAL MYOPATHY	0.012658200000000001	0.47488693288852185
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 62	0.012658200000000001	0.47488693288852185
HALLERMANN-STREIFF SYNDROME; HSS	0.01242816	0.46625671768875604
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.01225073	0.45960022715278637
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.01225073	0.45960022715278637
RING CHROMOSOME 14 SYNDROME	0.01225073	0.45960022715278637
BETA-UREIDOPROPIONASE DEFICIENCY	0.01225073	0.45960022715278637
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.01225073	0.45960022715278637
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.01225073	0.45960022715278637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.01225073	0.45960022715278637
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.01225073	0.45960022715278637
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.01225073	0.45960022715278637
FUMARASE DEFICIENCY; FMRD	0.01225073	0.45960022715278637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.01225073	0.45960022715278637
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.01225073	0.45960022715278637
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.01225073	0.45960022715278637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.01225073	0.45960022715278637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.01225073	0.45960022715278637
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.0121951	0.4575132037152843
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.0121951	0.4575132037152843
ACRORENAL-MANDIBULAR SYNDROME	0.0121951	0.4575132037152843
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.0121951	0.4575132037152843
PELVISCAPULAR DYSPLASIA	0.0121951	0.4575132037152843
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.0121951	0.4575132037152843
RUIJS-AALFS SYNDROME; RJALS	0.0121951	0.4575132037152843
RARE CIRCULATORY SYSTEM DISEASE	0.0121951	0.4575132037152843
HYPERPROLINEMIA, TYPE I	0.012035718999999999	0.4515338421748832
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.012001930000000001	0.450266208974636
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.012001930000000001	0.450266208974636
GERMAN SYNDROME	0.012001930000000001	0.450266208974636
MOSAIC TRISOMY 8	0.012001930000000001	0.450266208974636
CONGENITAL CONTRACTURAL ARACHNODACTYLY	0.012001930000000001	0.450266208974636
VICI SYNDROME; VICIS	0.011936629	0.4478163668482236
CROME SYNDROME	0.011936628999999999	0.4478163668482235
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.011865369	0.4451429659825684
MYHRE SYNDROME	0.011865369	0.4451429659825684
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.011494299999999999	0.4312218856314908
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.011494299999999999	0.4312218856314908
WRINKLY SKIN SYNDROME	0.011494299999999999	0.4312218856314908
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.011494299999999999	0.4312218856314908
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.011494299999999999	0.4312218856314908
PEHO-LIKE SYNDROME; PEHOL	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.011494299999999999	0.4312218856314908
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.011494299999999999	0.4312218856314908
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.011494299999999999	0.4312218856314908
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.4312218856314908
PERLMAN SYNDROME	0.011494299999999999	0.4312218856314908
PYRIDOXINE-DEPENDENT EPILEPSY	0.011494299999999999	0.4312218856314908
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.011494299999999999	0.4312218856314908
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.011494299999999999	0.4312218856314908
HALLERMANN-STREIFF SYNDROME	0.011395210000000001	0.42750441030483105
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.01139521	0.42750441030483105
ROTHMUND-THOMSON SYNDROME	0.01137533	0.42675858923818466
METATROPIC DYSPLASIA	0.0112926	0.4236548781293487
NEMALINE MYOPATHY 2; NEM2	0.0112926	0.4236548781293487
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.01124122	0.4217272983303399
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.01124122	0.4217272983303399
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.011180199	0.4194380253269279
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.011180199	0.4194380253269279
KNOBLOCH SYNDROME 1; KNO1	0.011180199	0.4194380253269279
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.010731809	0.4026161587236285
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.010731809	0.4026161587236285
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.010731809	0.4026161587236285
ADAMS-OLIVER SYNDROME 2; AOS2	0.010731809	0.4026161587236285
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.01063878	0.39912606878353546
CATARACT 17, MULTIPLE TYPES	0.01063878	0.39912606878353546
PEROXISOME BIOGENESIS DISORDER 14B	0.01063878	0.39912606878353546
CATARACT 2, MULTIPLE TYPES; CTRCT2	0.01063878	0.39912606878353546
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.01063878	0.39912606878353546
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.01063878	0.39912606878353546
CATARACT 9, MULTIPLE TYPES; CTRCT9	0.01063878	0.39912606878353546
NANCE-HORAN SYNDROME	0.01063878	0.39912606878353546
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.010557109	0.39606208727779696
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.01046691	0.3926781680428653
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.01046408	0.39257199733770387
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.01019039	0.3823042021802361
WARBURG MICRO SYNDROME 1	0.01019039	0.3823042021802361
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.01019039	0.3823042021802361
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.01019039	0.3823042021802361
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.01019039	0.3823042021802361
OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS	0.01019039	0.3823042021802361
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.01001569	0.3757501307344045
XQ12-Q13.3 DUPLICATION SYNDROME	0.01001569	0.3757501307344045
PAINE SYNDROME	0.01001569	0.3757501307344045
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.01001569	0.3757501307344045
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.01001569	0.3757501307344045
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.01001569	0.3757501307344045
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.01001569	0.3757501307344045
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.009975379	0.37423781720233285
PHACE ASSOCIATION	0.009975379	0.37423781720233285
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.009975379	0.37423781720233285
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.009975379	0.37423781720233285
CODAS SYNDROME	0.009975379	0.37423781720233285
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.009975379	0.37423781720233285
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.009975379	0.37423781720233285
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.009800679	0.3676837457565013
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.009800679	0.3676837457565013
19P13.12 MICRODELETION SYNDROME	0.009696909	0.3637906948467478
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.009696909	0.3637906948467478
HENNEKAM-BEEMER SYNDROME	0.009651639	0.36209233872566715
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.009645529	0.36186311504773905
DUANE RETRACTION SYNDROME	0.009645529	0.36186311504773905
CATARACT, AUTOSOMAL DOMINANT, MULTIPLE TYPES 1	0.00943396	0.3539258606589404
CATARACT-HYPERTRICHOSIS-INTELLECTUAL DISABILITY SYNDROME	0.00943396	0.3539258606589404
CATARACT 7; CTRCT7	0.00943396	0.3539258606589404
49,XYYYY SYNDROME	0.00943396	0.3539258606589404
EDICT SYNDROME	0.00943396	0.3539258606589404
CATARACT-DEAFNESS-HYPOGONADISM SYNDROME	0.00943396	0.3539258606589404
CATARACT, CRYSTALLINE ACULEIFORM	0.00943396	0.3539258606589404
CATARACT 22, MULTIPLE TYPES; CTRCT22	0.00943396	0.3539258606589404
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.00943396	0.3539258606589404
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.00943396	0.3539258606589404
CATARACT 15, MULTIPLE TYPES; CTRCT15	0.00943396	0.3539258606589404
%115665 CATARACT, CONGENITAL, VOLKMANN TYPE; CCV	0.00943396	0.3539258606589404
CATARACT, NUCLEAR TOTAL	0.00943396	0.3539258606589404
CATARACT 1, MULTIPLE TYPES	0.00943396	0.3539258606589404
CATARACT, POSTERIOR POLAR, 1 CTPA CATARACT, CONGENITAL TOTAL, INCLUDED	0.00943396	0.3539258606589404
CATARACT 13 WITH ADULT I PHENOTYPE	0.00943396	0.3539258606589404
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 25	0.00943396	0.3539258606589404
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.00943396	0.3539258606589404
CATARACT, CONGENITAL OR JUVENILECATARACT, JUVENILE, HUTTERITE TYPE, INCLUDED	0.00943396	0.3539258606589404
INSULINOMATOSIS AND DIABETES MELLITUS; INSDM	0.00943396	0.3539258606589404
FECHTNER SYNDROME	0.00943396	0.3539258606589404
%614422 CATARACT, CONGENITAL, CERULEAN TYPE, 5; CCA5	0.00943396	0.3539258606589404
PHEOCHROMOCYTOMA	0.00943396	0.3539258606589404
SPASTIC ATAXIA-CORNEAL DYSTROPHY SYNDROME	0.00943396	0.3539258606589404
HEC SYNDROME	0.00943396	0.3539258606589404
PUPILLARY MEMBRANE, PERSISTENCE OF	0.00943396	0.3539258606589404
SUPERNUMERARY NOSTRIL	0.00943396	0.3539258606589404
CATARACT 3, MULTIPLE TYPES; CTRCT3	0.00943396	0.3539258606589404
RETINAL DYSTROPHY AND IRIS COLOBOMA WITH OR WITHOUT CONGENITAL CATARACT	0.00943396	0.3539258606589404
HYDROCEPHALUS, ENDOCARDIAL FIBROELASTOSIS, AND CATARACTS	0.00943396	0.3539258606589404
MUSCULAR HYPERTROPHY-HEPATOMEGALY-POLYHYDRAMNIOS SYNDROME	0.00943396	0.3539258606589404
CATARACT 44; CTRCT44	0.00943396	0.3539258606589404
CONGENITAL FIBRINOGEN DEFICIENCY	0.00943396	0.3539258606589404
SPINOCEREBELLAR DEGENERATION WITH MACULAR CORNEAL DYSTROPHY, CONGENITALCATARACTS, AND MYOPIA	0.00943396	0.3539258606589404
CATARACT 45	0.00943396	0.3539258606589404
LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT	0.00943396	0.3539258606589404
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.00943396	0.3539258606589404
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.00925926	0.34737178921310885
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.00925926	0.34737178921310885
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.00925926	0.34737178921310885
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.00925926	0.34737178921310885
HYDROXYLYSINURIA	0.00925926	0.34737178921310885
KRABBE DISEASE	0.00925926	0.34737178921310885
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.34737178921310885
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.34737178921310885
MERRF	0.00925926	0.34737178921310885
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00925926	0.34737178921310885
CARNOSINEMIA	0.00925926	0.34737178921310885
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.00925926	0.34737178921310885
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.00925926	0.34737178921310885
CARNOSINASE DEFICIENCY	0.00925926	0.34737178921310885
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00925926	0.34737178921310885
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.00925926	0.34737178921310885
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.00925926	0.34737178921310885
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00925926	0.34737178921310885
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00925926	0.34737178921310885
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.00925926	0.34737178921310885
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.00925926	0.34737178921310885
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.34737178921310885
GLYCINE ENCEPHALOPATHY	0.00925926	0.34737178921310885
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.34737178921310885
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.00925926	0.34737178921310885
BIOTINIDASE DEFICIENCY	0.00925926	0.34737178921310885
ROIFMAN-CHITAYAT SYNDROME	0.00925926	0.34737178921310885
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.0090035	0.33777665862933165
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.008940479	0.33541235332545216
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.008940479	0.33541235332545216
CONGENITAL MYASTHENIC SYNDROME	0.008940479	0.33541235332545216
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.008889099	0.3334847735264434
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.008889099	0.3334847735264434
GAUCHER DISEASE, PERINATAL LETHAL	0.008492089	0.31859048672215273
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.008492089	0.31859048672215273
RETT SYNDROME	0.008492089	0.31859048672215273
RFT1-CDG	0.008492089	0.31859048672215273
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.008492089	0.31859048672215273
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.008492089	0.31859048672215273
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.008440709	0.316662906923144
GLASS SYNDROME	0.008440709	0.316662906923144
21Q22.11Q22.12 MICRODELETION SYNDROME	0.008440709	0.316662906923144
BOHRING-OPITZ SYNDROME	0.008440709	0.316662906923144
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.008440709	0.316662906923144
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.00840089	0.3151690513369874
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.00839906	0.3151003967820597
HURLER SYNDROME	0.00823235	0.3088460793765956
LYNCH SYNDROME	0.008185879	0.30710266635908423
FAMILIAL COLORECTAL CANCER TYPE X	0.008185879	0.30710266635908423
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.00795067	0.2982785301787603
LISSENCEPHALY TYPE 3-METACARPAL BONE DYSPLASIA SYNDROME	0.00795067	0.2982785301787603
RAINE SYNDROME	0.00795067	0.2982785301787603
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.00795067	0.2982785301787603
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.00795067	0.2982785301787603
MECKEL SYNDROME 12; MKS12	0.00795067	0.2982785301787603
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.00795067	0.2982785301787603
NEU-LAXOVA SYNDROME	0.00795067	0.2982785301787603
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.00795067	0.2982785301787603
ADDUCTED THUMBS SYNDROME	0.00795067	0.2982785301787603
GERODERMA OSTEODYSPLASTICUM; GO	0.00789929	0.29635095037975157
OROFACIODIGITAL SYNDROME IX; OFD9	0.00789929	0.29635095037975157
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00789929	0.29635095037975157
CEREBROFACIOARTICULAR SYNDROME	0.00789929	0.29635095037975157
TEEBI-SHALTOUT SYNDROME; TBSH	0.00789929	0.29635095037975157
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.00789929	0.29635095037975157
MEIER-GORLIN SYNDROME 2; MGORS2	0.00789929	0.29635095037975157
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.00779868	0.29257645050473663
1Q44 MICRODELETION SYNDROME	0.00779868	0.29257645050473663
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00779868	0.29257645050473663
AMISH LETHAL MICROCEPHALY	0.00779868	0.29257645050473663
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.00779868	0.29257645050473663
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.00779868	0.29257645050473663
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.00779868	0.29257645050473663
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.007735659000000001	0.29021214520085714
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.007735659000000001	0.29021214520085714
FETAL GAUCHER DISEASE	0.007735659000000001	0.29021214520085714
1Q21.1 MICRODUPLICATION SYNDROME	0.007735659000000001	0.29021214520085714
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.0076842790000000005	0.28828456540184844
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.0076842790000000005	0.28828456540184844
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.0076842790000000005	0.28828456540184844
CATEL-MANZKE SYNDROME; CATMANS	0.0076842790000000005	0.28828456540184844
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.0076842790000000005	0.28828456540184844
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.0076842790000000005	0.28828456540184844
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.0076842790000000005	0.28828456540184844
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.0076842790000000005	0.28828456540184844
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.28451006552683344
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.28451006552683344
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.00752302	0.2822347485313083
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.00752302	0.2822347485313083
WILLIAMS-BEUREN SYNDROME; WBS	0.00752302	0.2822347485313083
ARTERIAL TORTUOSITY SYNDROME	0.00752302	0.2822347485313083
CONGENITAL ADRENAL HYPERPLASIA DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	0.00752302	0.2822347485313083
BUSCHKE-OLLENDORFF SYNDROME	0.00752302	0.2822347485313083
FABRY DISEASE	0.007512178999999999	0.28182803594662453
TSH-SECRETING PITUITARY ADENOMA	0.007512178999999999	0.28182803594662453
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.007310359	0.27425652650645443
MICROPHTHALMIA, LENZ TYPE	0.007310359	0.27425652650645443
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.007310359	0.27425652650645443
15Q24 MICRODELETION SYNDROME	0.007310359	0.27425652650645443
MOWAT-WILSON SYNDROME	0.007310359	0.27425652650645443
1P36 DELETION SYNDROME	0.007310358999999999	0.2742565265064544
POLYMICROGYRIA, PERISYLVIAN, WITH CEREBELLAR HYPOPLASIA AND ARTHROGRYPOSIS; PMGYCHA	0.00719424	0.2699001886574647
BRUCK SYNDROME	0.00719424	0.2699001886574647
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00719424	0.2699001886574647
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00719424	0.2699001886574647
ANTENATAL MULTIMINICORE DISEASE WITH ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.00719424	0.2699001886574647
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.00719424	0.2699001886574647
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.00719424	0.2699001886574647
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.00719424	0.2699001886574647
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.00719424	0.2699001886574647
NEMALINE MYOPATHY 10	0.00719424	0.2699001886574647
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.00719424	0.2699001886574647
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00719424	0.2699001886574647
ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.00719424	0.2699001886574647
INTERMEDIATE NEMALINE MYOPATHY	0.00719424	0.2699001886574647
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.00719424	0.2699001886574647
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.00719424	0.2699001886574647
TYPICAL NEMALINE MYOPATHY	0.00719424	0.2699001886574647
LETHAL CONGENITAL CONTRACTURE SYNDROME 8	0.00719424	0.2699001886574647
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.00719424	0.2699001886574647
LETHAL CONGENITAL CONTRACTURE SYNDROME 2	0.00719424	0.2699001886574647
NEMALINE MYOPATHY 3; NEM3	0.00719424	0.2699001886574647
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.00719424	0.2699001886574647
ARTHROGRYPOSIS - HYPERKERATOSIS, LETHAL FORM	0.00719424	0.2699001886574647
NOONAN SYNDROME 2; NS2	0.00719424	0.2699001886574647
MOEBIUS SYNDROME	0.00719424	0.2699001886574647
CONTRACTURES, CONGENITAL, TORTICOLLIS, AND MALIGNANT HYPERTHERMIA	0.00719424	0.2699001886574647
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.00719424	0.2699001886574647
MULTIMINICORE MYOPATHY	0.00719424	0.2699001886574647
INIENCEPHALY	0.00719424	0.2699001886574647
PELVIC DYSPLASIA - ARTHROGRYPOSIS OF LOWER LIMBS	0.00719424	0.2699001886574647
SPONDYLOSPINAL THORACIC DYSOSTOSIS	0.00719424	0.2699001886574647
NAKAJO-NISHIMURA SYNDROME	0.00719424	0.2699001886574647
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.00719424	0.2699001886574647
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.00719424	0.2699001886574647
NEUROPATHY, CONGENITAL, WITH ARTHROGRYPOSIS MULTIPLEX	0.00719424	0.2699001886574647
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.00719424	0.2699001886574647
GERMAN SYNDROME	0.00719424	0.2699001886574647
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.00719424	0.2699001886574647
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.00719424	0.2699001886574647
GLYCOGEN STORAGE DISEASE IV	0.00719424	0.2699001886574647
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.00719424	0.2699001886574647
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.00714286	0.2679726088584559
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.00714286	0.2679726088584559
COHEN-GIBSON SYNDROME; COGIS	0.00714286	0.2679726088584559
LOEYS-DIETZ SYNDROME 3; LDS3	0.00714286	0.2679726088584559
RAHMAN SYNDROME	0.00714286	0.2679726088584559
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.00714286	0.2679726088584559
WAHAB SYNDROME	0.00714286	0.2679726088584559
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00714286	0.2679726088584559
20Q11.2 MICRODELETION SYNDROME	0.00714286	0.2679726088584559
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.00714286	0.2679726088584559
BRITTLE CORNEA SYNDROME	0.00714286	0.2679726088584559
NORMOSMIC CONGENITAL HYPOGONADOTROPIC HYPOGONADISM	0.00714286	0.2679726088584559
PSEUDODIASTROPHIC DYSPLASIA	0.00714286	0.2679726088584559
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00714286	0.2679726088584559
BRACHYDACTYLY-SYNDACTYLY SYNDROME	0.00714286	0.2679726088584559
SILLENCE SYNDROME	0.00714286	0.2679726088584559
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.00714286	0.2679726088584559
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.00714286	0.2679726088584559
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.00714286	0.2679726088584559
ARTHROGRYPOSIS, DISTAL, TYPE 2B2; DA2B2	0.00714286	0.2679726088584559
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.00714286	0.2679726088584559
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.00714286	0.2679726088584559
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.00714286	0.2679726088584559
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.00714286	0.2679726088584559
CAMPTOSYNPOLYDACTYLY, COMPLEX	0.00714286	0.2679726088584559
MEESTER-LOEYS SYNDROME; MRLS	0.00714286	0.2679726088584559
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.00714286	0.2679726088584559
13Q12.3 MICRODELETION SYNDROME	0.00714286	0.2679726088584559
H SYNDROME	0.00714286	0.2679726088584559
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.00714286	0.2679726088584559
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.00714286	0.2679726088584559
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.00714286	0.2679726088584559
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.00704225	0.264198108983441
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00704225	0.264198108983441
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.00704225	0.264198108983441
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.00704225	0.264198108983441
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.264198108983441
SARCOSINEMIA	0.00704225	0.264198108983441
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.264198108983441
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.264198108983441
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.00704225	0.264198108983441
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.00704225	0.264198108983441
OROFACIODIGITAL SYNDROME TYPE 2	0.00704225	0.264198108983441
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.00704225	0.264198108983441
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.264198108983441
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.264198108983441
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.264198108983441
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00704225	0.264198108983441
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.00704225	0.264198108983441
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00704225	0.264198108983441
PELGER-HUET ANOMALY; PHA	0.00704225	0.264198108983441
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.00704225	0.264198108983441
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00704225	0.264198108983441
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.264198108983441
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.264198108983441
X SMALL RINGS	0.00704225	0.264198108983441
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00704225	0.264198108983441
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.264198108983441
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.00704225	0.264198108983441
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00704225	0.264198108983441
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.264198108983441
AL AMYLOIDOSIS	0.0069707599999999995	0.261516079403232
LIDDLE SYNDROME	0.0069707599999999995	0.261516079403232
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.0069707599999999995	0.261516079403232
CUSHING SYNDROME	0.0069707599999999995	0.261516079403232
HEMORRHAGIC FEVER-RENAL SYNDROME	0.0069707599999999995	0.261516079403232
PERIPARTUM CARDIOMYOPATHY	0.0069707599999999995	0.261516079403232
SOMATOMAMMOTROPINOMA	0.0069707599999999995	0.261516079403232
PITUITARY APOPLEXY	0.0069707599999999995	0.261516079403232
ALPORT SYNDROME	0.0069707599999999995	0.261516079403232
PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE	0.0069707599999999995	0.261516079403232
CUSHING SYNDROME DUE TO MACRONODULAR ADRENAL HYPERPLASIA	0.0069707599999999995	0.261516079403232
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.0069707599999999995	0.261516079403232
CLASSICAL EHLERS-DANLOS SYNDROME	0.0069707599999999995	0.261516079403232
POLYCYTHEMIA VERA	0.0069707599999999995	0.261516079403232
GENERALIZED GLUCOCORTICOID RESISTANCE SYNDROME	0.0069707599999999995	0.261516079403232
CUSHING DISEASE	0.0069707599999999995	0.261516079403232
CARNEY TRIAD	0.0069707599999999995	0.261516079403232
ARTERIAL TORTUOSITY SYNDROME	0.0069707599999999995	0.261516079403232
ACTH-INDEPENDENT CUSHING SYNDROME	0.0069707599999999995	0.261516079403232
ACTH-DEPENDENT CUSHING SYNDROME	0.0069707599999999995	0.261516079403232
ACROMEGALY	0.0069707599999999995	0.261516079403232
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.0069707599999999995	0.261516079403232
POSTORGASMIC ILLNESS SYNDROME	0.0069707599999999995	0.261516079403232
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	0.0069707599999999995	0.261516079403232
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.006601029	0.24764519566116716
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.006601029	0.24764519566116716
16P13.2 MICRODELETION SYNDROME	0.006601029	0.24764519566116716
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.006601029	0.24764519566116716
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.006601029	0.24764519566116716
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.006601029	0.24764519566116716
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.006601029	0.24764519566116716
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.006601029	0.24764519566116716
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.006553929	0.24587818498515876
GM1 GANGLIOSIDOSIS	0.006553929	0.24587818498515876
OCULODENTODIGITAL DYSPLASIA	0.006553929	0.24587818498515876
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.006105539	0.2290563183818594
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.006105539	0.2290563183818594
6Q25 MICRODELETION SYNDROME	0.006105539	0.2290563183818594
2Q31.1 MICRODELETION SYNDROME	0.006105539	0.2290563183818594
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.006105539	0.2290563183818594
ATYPICAL RETT SYNDROME	0.006105539	0.2290563183818594
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.006105539	0.2290563183818594
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.006105539	0.2290563183818594
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.006105539	0.2290563183818594
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.006105539	0.2290563183818594
GALLOWAY-MOWAT SYNDROME	0.006105539	0.2290563183818594
BOHRING-OPITZ SYNDROME	0.006105539	0.2290563183818594
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.006105539	0.2290563183818594
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.006105539	0.2290563183818594
HEART AND BRAIN MALFORMATION SYNDROME	0.006105539	0.2290563183818594
COG5-CDG	0.006105539	0.2290563183818594
MACDERMOT-WINTER SYNDROME	0.006105539	0.2290563183818594
DISTAL TRISOMY 15Q	0.006105539	0.2290563183818594
BOWEN-CONRADI SYNDROME	0.006105539	0.2290563183818594
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.00605961	0.22733323911777467
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.00605961	0.22733323911777467
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.00605961	0.22733323911777467
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00605961	0.22733323911777467
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.0060125099999999996	0.2255662284417663
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.005927329	0.22237056524870752
COCKAYNE SYNDROME A; CSA	0.005927329	0.22237056524870752
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.005844599	0.2192668541398715
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.005844599	0.2192668541398715
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.005844599	0.2192668541398715
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.005844599	0.2192668541398715
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.005844599	0.2192668541398715
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.005844599	0.2192668541398715
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.005844599	0.2192668541398715
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.005844599	0.2192668541398715
2P15P16.1 MICRODELETION SYNDROME	0.00556412	0.2087443618384669
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 2	0.00556412	0.2087443618384669
8Q22.1 MICRODELETION SYNDROME	0.00556412	0.2087443618384669
PENTASOMY X	0.00556412	0.2087443618384669
SHPRINTZEN-GOLDBERG SYNDROME	0.00556412	0.2087443618384669
2P15-16.1 MICRODELETION SYNDROME	0.00556412	0.2087443618384669
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.00556412	0.2087443618384669
WAARDENBURG SYNDROME TYPE 3	0.00556412	0.2087443618384669
TRISOMY 4P	0.00556412	0.2087443618384669
EAR-PATELLA-SHORT STATURE SYNDROME	0.00556412	0.2087443618384669
MOSAIC TRISOMY 9	0.00556412	0.2087443618384669
CRANIOFRONTONASAL DYSPLASIA	0.00556412	0.2087443618384669
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00556412	0.2087443618384669
OROFACIODIGITAL SYNDROME TYPE 4	0.00556412	0.2087443618384669
FAMILIAL VISCERAL MYOPATHY	0.00556412	0.2087443618384669
VENTRICULAR EXTRASYSTOLES WITH SYNCOPAL EPISODES-PERODACTYLY-ROBIN SEQUENCE SYNDROME	0.00556412	0.2087443618384669
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.00556412	0.2087443618384669
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00556412	0.2087443618384669
TRISOMY 18	0.00556412	0.2087443618384669
APHALANGY-SYNDACTYLY-MICROCEPHALY SYNDROME	0.00556412	0.2087443618384669
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.005396209	0.2024449875365721
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.005396209	0.2024449875365721
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.005396209	0.2024449875365721
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.005396209	0.2024449875365721
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.005396209	0.2024449875365721
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.005396209	0.2024449875365721
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.005396209	0.2024449875365721
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.005396209	0.2024449875365721
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.005396209	0.2024449875365721
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.005396209	0.2024449875365721
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.005396209	0.2024449875365721
KEPPEN-LUBINSKY SYNDROME	0.005396209	0.2024449875365721
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.005396209	0.2024449875365721
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.005396209	0.2024449875365721
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.005396209	0.2024449875365721
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.005396209	0.2024449875365721
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.005396209	0.2024449875365721
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.005396209	0.2024449875365721
INCONTINENTIA PIGMENTI	0.0053491089999999995	0.2006779768605637
HENNEKAM SYNDROME	0.0053491089999999995	0.2006779768605637
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.0053491089999999995	0.2006779768605637
RECOMBINANT 8 SYNDROME	0.0053491089999999995	0.2006779768605637
ACROCARDIOFACIAL SYNDROME	0.0053491089999999995	0.2006779768605637
INTELLECTUAL DISABILITY, WOLFF TYPE	0.0053491089999999995	0.2006779768605637
MOSAIC TRISOMY 14	0.0053491089999999995	0.2006779768605637
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.0053491089999999995	0.2006779768605637
SIMPSON-GOLABI-BEHMEL SYNDROME	0.0053491089999999995	0.2006779768605637
2Q24 MICRODELETION SYNDROME	0.0053491089999999995	0.2006779768605637
CRISPONI SYNDROME	0.0053491089999999995	0.2006779768605637
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.0053491089999999995	0.2006779768605637
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.005303179999999999	0.19895489759647902
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.005303179999999999	0.19895489759647902
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.005303179999999999	0.19895489759647902
SPASTIC PARAPLEGIA 2, X-LINKED; SPG2	0.005303179999999999	0.19895489759647902
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.005303179999999999	0.19895489759647902
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.005303179999999999	0.19895489759647902
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.005303179999999999	0.19895489759647902
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.005303179999999999	0.19895489759647902
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.005303179999999999	0.19895489759647902
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.005303179999999999	0.19895489759647902
TETRASOMY 9P	0.005292339	0.19854818501179525
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.005292339	0.19854818501179525
CHOREOACANTHOCYTOSIS	0.005292339	0.19854818501179525
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.005292339	0.19854818501179525
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.005292339	0.19854818501179525
ALEXANDER DISEASE	0.005170899	0.19399222372741182
POTOCKI-SHAFFER SYNDROME	0.005170899	0.19399222372741182
COACH SYNDROME	0.005170899	0.19399222372741182
ALLAN-HERNDON-DUDLEY SYNDROME	0.0048547899999999995	0.18213303099317965
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.0048547899999999995	0.18213303099317965
JACOBSEN SYNDROME	0.0048547899999999995	0.18213303099317965
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.0048547899999999995	0.18213303099317965
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.0048547899999999995	0.18213303099317965
AICARDI-GOUTIERES SYNDROME 5	0.0048547899999999995	0.18213303099317965
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.0048547899999999995	0.18213303099317965
TRISOMY 17P	0.0048547899999999995	0.18213303099317965
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.0048547899999999995	0.18213303099317965
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.0048547899999999995	0.18213303099317965
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.0048547899999999995	0.18213303099317965
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.0048547899999999995	0.18213303099317965
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.0048547899999999995	0.18213303099317965
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.0048547899999999995	0.18213303099317965
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.0048547899999999995	0.18213303099317965
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.0048547899999999995	0.18213303099317965
PONTOCEREBELLAR HYPOPLASIA, TYPE 12; PCH12	0.0048547899999999995	0.18213303099317965
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.004843949	0.18172631840849585
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.004843949	0.18172631840849585
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.004843949	0.18172631840849585
XERODERMA PIGMENTOSUM	0.004843949	0.18172631840849585
MENKES DISEASE	0.004843949	0.18172631840849585
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.004843949	0.18172631840849585
FRONTONASAL DYSPLASIA	0.00480769	0.18036602031717128
COLOBOMA OF MACULA-BRACHYDACTYLY TYPE B SYNDROME	0.00480769	0.18036602031717128
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.00480769	0.18036602031717128
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.00480769	0.18036602031717128
FIBROCHONDROGENESIS	0.00480769	0.18036602031717128
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.00480769	0.18036602031717128
SPONDYLOCAMPTODACTYLY SYNDROME	0.00480769	0.18036602031717128
8Q21.11 MICRODELETION SYNDROME	0.00480769	0.18036602031717128
ENG-STROM SYNDROME	0.00480769	0.18036602031717128
MASA SYNDROME	0.00480769	0.18036602031717128
ACROPECTOROVERTEBRAL DYSPLASIA	0.00480769	0.18036602031717128
AARSKOG-SCOTT SYNDROME	0.00480769	0.18036602031717128
EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE	0.00480769	0.18036602031717128
FRANK-TER HAAR SYNDROME	0.00480769	0.18036602031717128
CATEL-MANZKE SYNDROME	0.00480769	0.18036602031717128
PELVIS-SHOULDER DYSPLASIA	0.00480769	0.18036602031717128
HEREDITARY ACROKERATOTIC POIKILODERMA	0.00480769	0.18036602031717128
PHAVER SYNDROME	0.00480769	0.18036602031717128
INFANTILE SYSTEMIC HYALINOSIS	0.00480769	0.18036602031717128
CAMPTOBRACHYDACTYLY	0.00480769	0.18036602031717128
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.00480769	0.18036602031717128
CAMPTODACTYLY-FIBROUS TISSUE HYPERPLASIA-SKELETAL DYSPLASIA SYNDROME	0.00480769	0.18036602031717128
OTOPALATODIGITAL SYNDROME TYPE 2	0.00480769	0.18036602031717128
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.00480769	0.18036602031717128
LOEYS-DIETZ SYNDROME	0.00480769	0.18036602031717128
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.00480769	0.18036602031717128
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.00480769	0.18036602031717128
ALLAN-HERNDON-DUDLEY SYNDROME	0.00480769	0.18036602031717128
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.00480769	0.18036602031717128
15Q26 OVERGROWTH SYNDROME	0.00480769	0.18036602031717128
MUCKLE-WELLS SYNDROME	0.00480769	0.18036602031717128
ABLEPHARON MACROSTOMIA SYNDROME	0.00480769	0.18036602031717128
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.00480769	0.18036602031717128
CRANIOFACIAL-DEAFNESS-HAND SYNDROME	0.00480769	0.18036602031717128
FLOATING-HARBOR SYNDROME	0.00480769	0.18036602031717128
DIGITAL EXTENSOR MUSCLE APLASIA-POLYNEUROPATHY	0.00480769	0.18036602031717128
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.00480769	0.18036602031717128
KINDLER SYNDROME	0.00480769	0.18036602031717128
SYNDACTYLY TYPE 2	0.00480769	0.18036602031717128
FOCAL DERMAL HYPOPLASIA	0.00480769	0.18036602031717128
SYNDACTYLY TYPE 3	0.00480769	0.18036602031717128
COOPER-JABS SYNDROME	0.00480769	0.18036602031717128
ULNAR-MAMMARY SYNDROME	0.00480769	0.18036602031717128
LERI PLEONOSTEOSIS	0.00480769	0.18036602031717128
SYNDACTYLY TYPE 4	0.00480769	0.18036602031717128
SYNDACTYLY TYPE 5	0.00480769	0.18036602031717128
CHOLESTASIS WITH GALLSTONE, ATAXIA, AND VISUAL DISTURBANCE	0.00480769	0.18036602031717128
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.00480769	0.18036602031717128
FREEMAN-SHELDON SYNDROME	0.00480769	0.18036602031717128
MICROPHTHALMIA-MICROTIA-FETAL AKINESIA SYNDROME	0.00480769	0.18036602031717128
DIASTROPHIC DWARFISM	0.00480769	0.18036602031717128
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.00480769	0.18036602031717128
MESOMELIC LIMB SHORTENING AND BOWING	0.00480769	0.18036602031717128
SPONDYLOCAMPTODACTYLY	0.00480769	0.18036602031717128
DIGITOTALAR DYSMORPHISM	0.00480769	0.18036602031717128
MESOMELIC DYSPLASIA, KANTAPUTRA TYPE	0.00480769	0.18036602031717128
FRONTOMETAPHYSEAL DYSPLASIA	0.00480769	0.18036602031717128
EXTENSOR TENDONS OF FINGER ANOMALIES	0.00480769	0.18036602031717128
CAMPTODACTYLY 1; CAMPD1	0.00480769	0.18036602031717128
NEUROGENIC ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.00480769	0.18036602031717128
GORDON SYNDROME	0.00480769	0.18036602031717128
OCULOMAXILLOFACIAL DYSOSTOSIS	0.00480769	0.18036602031717128
16P11.2P12.2 MICRODELETION SYNDROME	0.00480769	0.18036602031717128
HYPERTRYPTOPHANEMIA; HYPTRP	0.00480769	0.18036602031717128
ACROFRONTOFACIONASAL DYSOSTOSIS	0.00480769	0.18036602031717128
HYPOPLASTIC TIBIAE-POSTAXIAL POLYDACTYLY SYNDROME	0.00480769	0.18036602031717128
FRONTORHINY	0.00480769	0.18036602031717128
OPHTHALMOMANDIBULOMELIC DYSPLASIA	0.00480769	0.18036602031717128
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.00480769	0.18036602031717128
TRISOMY 1Q	0.00480769	0.18036602031717128
DISTAL SYMPHALANGISM	0.00480769	0.18036602031717128
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.00480769	0.18036602031717128
ANTLEY-BIXLER SYNDROME	0.00480769	0.18036602031717128
THORACO-ABDOMINAL ENTERIC DUPLICATION	0.00480769	0.18036602031717128
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.00480769	0.18036602031717128
DESBUQUOIS SYNDROME	0.00480769	0.18036602031717128
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.00480769	0.18036602031717128
TRISOMY 20P	0.00480769	0.18036602031717128
ECTRODACTYLY-POLYDACTYLY SYNDROME	0.00480769	0.18036602031717128
CAMPTODACTYLY-TALL STATURE-SCOLIOSIS-HEARING LOSS SYNDROME	0.00480769	0.18036602031717128
113450 BRACHYDACTYLY-DISTAL SYMPHALANGISM SYNDROME	0.00480769	0.18036602031717128
ABSENCE OF FINGERPRINTS-CONGENITAL MILIA SYNDROME	0.00480769	0.18036602031717128
WEAVER SYNDROME	0.00480769	0.18036602031717128
METATROPIC DYSPLASIA	0.00480769	0.18036602031717128
SUMMITT SYNDROME	0.00480769	0.18036602031717128
DIGITOTALAR DYSMORPHISM	0.00480769	0.18036602031717128
TRISOMY 8Q	0.00480769	0.18036602031717128
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.00480769	0.18036602031717128
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.00480769	0.18036602031717128
DISTAL TRISOMY 18Q	0.00480769	0.18036602031717128
MESOMELIC DWARFISM-CLEFT PALATE-CAMPTODACTYLY SYNDROME	0.00480769	0.18036602031717128
PROXIMAL SYMPHALANGISM	0.00480769	0.18036602031717128
ERDHEIM-CHESTER DISEASE	0.00475092	0.17823622846840276
GIANT CELL ARTERITIS	0.00475092	0.17823622846840276
HERMANSKY-PUDLAK SYNDROME	0.00475092	0.17823622846840276
ADAMS-OLIVER SYNDROME 1; AOS1	0.004722509	0.17717035712411244
OROFACIODIGITAL SYNDROME I; OFD1	0.004722509	0.17717035712411244
PRADER-WILLI-LIKE SYNDROME	0.004639779	0.1740666460152765
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.004639779	0.1740666460152765
MUCOPOLYSACCHARIDOSIS, TYPE II	0.004639779	0.1740666460152765
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.004639779	0.1740666460152765
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.004639779	0.1740666460152765
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.004639779	0.1740666460152765
KAGAMI-OGATA SYNDROME	0.004639779	0.1740666460152765
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.004639779	0.1740666460152765
PETTIGREW SYNDROME	0.004639779	0.1740666460152765
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.004639779	0.1740666460152765
CANAVAN DISEASE	0.004639779	0.1740666460152765
ZTTK SYNDROME; ZTTKS	0.004639779	0.1740666460152765
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.004639779	0.1740666460152765
GLUTAMINE DEFICIENCY, CONGENITAL	0.004639779	0.1740666460152765
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.004639779	0.1740666460152765
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.004639779	0.1740666460152765
PALLISTER-KILLIAN SYNDROME	0.004639779	0.1740666460152765
HUNTINGTON DISEASE-LIKE 3	0.004639779	0.1740666460152765
SIALIDOSIS TYPE 2	0.004639779	0.1740666460152765
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.004639779	0.1740666460152765
JOUBERT SYNDROME 14	0.00462948	0.17368026718401935
ISOLATED ECTOPIA LENTIS	0.00462948	0.17368026718401935
BARDET-BIEDL SYNDROME 1; BBS1	0.00462948	0.17368026718401935
ALSTROM SYNDROME; ALMS	0.00462948	0.17368026718401935
VON HIPPEL-LINDAU DISEASE	0.00462948	0.17368026718401935
BARDET-BIEDL SYNDROME	0.00462948	0.17368026718401935
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.00418109	0.15685840058071998
XFE PROGEROID SYNDROME; XFEPS	0.00418109	0.15685840058071998
MONOSOMY 18P	0.00418109	0.15685840058071998
SECKEL SYNDROME 10; SCKL10	0.00418109	0.15685840058071998
PEDIATRIC-ONSET GRAVES DISEASE	0.00418109	0.15685840058071998
MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	0.00409836	0.153754689471884
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A; LGMD2A	0.00409836	0.153754689471884
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.00409836	0.153754689471884
RESTRICTIVE DERMOPATHY, LETHAL	0.00409836	0.153754689471884
NEONATAL MARFAN SYNDROME	0.00409836	0.153754689471884
DRACUNCULIASIS	0.00409836	0.153754689471884
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2A	0.00409836	0.153754689471884
MYOPATHY, TUBULAR AGGREGATE, 2; TAM2	0.00409836	0.153754689471884
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.00409836	0.153754689471884
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00409836	0.153754689471884
HYPERMANGANESEMIA WITH DYSTONIA 2	0.00409836	0.153754689471884
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.00409836	0.153754689471884
MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE	0.00409836	0.153754689471884
MAJEED SYNDROME	0.00409836	0.153754689471884
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	0.00409836	0.153754689471884
NEMALINE MYOPATHY 1; NEM1	0.00409836	0.153754689471884
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.00409836	0.153754689471884
NEMALINE MYOPATHY 4	0.00409836	0.153754689471884
GROWTH FACTORS, COMBINED DEFECT OF	0.00409836	0.153754689471884
CZECH DYSPLASIA, METATARSAL TYPE	0.00409836	0.153754689471884
268650 RUDIGER SYNDROME	0.00409836	0.153754689471884
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.00409836	0.153754689471884
ANAUXETIC DYSPLASIA 2; ANXD2	0.00409836	0.153754689471884
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.00409836	0.153754689471884
CHRONIC GRAFT VERSUS HOST DISEASE	0.00409836	0.153754689471884
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.00409836	0.153754689471884
HYPERKALEMIC PERIODIC PARALYSIS	0.00409836	0.153754689471884
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.00409836	0.153754689471884
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.00409836	0.153754689471884
245160 KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS;;BURTON SYNDROME	0.00409836	0.153754689471884
ICHTHYOSIS HYSTRIX OF CURTH-MACKLIN	0.00409836	0.153754689471884
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.00409836	0.153754689471884
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.00409836	0.153754689471884
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.00409836	0.153754689471884
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.00409836	0.153754689471884
MAJEED SYNDROME	0.00409836	0.153754689471884
TEMPLE SYNDROME	0.00409836	0.153754689471884
MECKEL SYNDROME 13; MKS13	0.00409836	0.153754689471884
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1; ARCI1	0.00409836	0.153754689471884
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.00409836	0.153754689471884
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA	0.00409836	0.153754689471884
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.00409836	0.153754689471884
DUCHENNE MUSCULAR DYSTROPHY	0.00409836	0.153754689471884
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.00409836	0.153754689471884
CUTIS LAXA-MARFANOID SYNDROME	0.00409836	0.153754689471884
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1B	0.00409836	0.153754689471884
AASE-SMITH SYNDROME I	0.00409836	0.153754689471884
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.00409836	0.153754689471884
DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS	0.00409836	0.153754689471884
MYOPATHY, CONGENITAL, WITH FAST-TWITCH (TYPE II) FIBER ATROPHY; MYOFTA	0.00409836	0.153754689471884
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.00409836	0.153754689471884
MARFAN SYNDROME; MFS	0.00409836	0.153754689471884
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.00409836	0.153754689471884
MYOPATHY, CENTRONUCLEAR, AUTOSOMAL DOMINANT	0.00409836	0.153754689471884
HURLER SYNDROME	0.00409836	0.153754689471884
SALIH MYOPATHY; SALMY	0.00409836	0.153754689471884
CHST3-RELATED SKELETAL DYSPLASIA	0.00409836	0.153754689471884
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00409836	0.153754689471884
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.00409836	0.153754689471884
STIFF SKIN SYNDROME	0.00409836	0.153754689471884
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00409836	0.153754689471884
LIPODYSTROPHY DUE TO PEPTIDIC GROWTH FACTORS DEFICIENCY	0.00409836	0.153754689471884
ORAL SUBMUCOUS FIBROSIS	0.00409836	0.153754689471884
MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	0.00409836	0.153754689471884
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.00409836	0.153754689471884
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00409836	0.153754689471884
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.00409836	0.153754689471884
BUSCHKE-OLLENDORFF SYNDROME; BOS	0.00409836	0.153754689471884
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00409836	0.153754689471884
SLC39A13-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00409836	0.153754689471884
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00409836	0.153754689471884
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00409836	0.153754689471884
ADULT-ONSET NEMALINE MYOPATHY	0.00409836	0.153754689471884
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.00409836	0.153754689471884
RIGID SPINE MUSCULAR DYSTROPHY 1	0.00409836	0.153754689471884
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.00409836	0.153754689471884
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1E	0.00409836	0.153754689471884
BASAN SYNDROME	0.00409836	0.153754689471884
POTASSIUM-AGGRAVATED MYOTONIA	0.00409836	0.153754689471884
SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA; SMMD	0.00409836	0.153754689471884
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.0040875189999999995	0.1533479768872002
ATYPICAL JUVENILE PARKINSONISM	0.0040875189999999995	0.1533479768872002
ADDISON DISEASE	0.0040875189999999995	0.1533479768872002
SPONTANEOUS PERIODIC HYPOTHERMIA	0.0040875189999999995	0.1533479768872002
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.0040875189999999995	0.1533479768872002
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.0040875189999999995	0.1533479768872002
LASSA FEVER	0.0040875189999999995	0.1533479768872002
BENIGN FAMILIAL INFANTILE EPILEPSY	0.0040875189999999995	0.1533479768872002
NIPAH VIRUS DISEASE	0.0040875189999999995	0.1533479768872002
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.0040875189999999995	0.1533479768872002
WHIPPLE DISEASE	0.0040875189999999995	0.1533479768872002
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.0040875189999999995	0.1533479768872002
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.0040875189999999995	0.1533479768872002
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.0040875189999999995	0.1533479768872002
VIRAL HEMORRHAGIC FEVER	0.0040875189999999995	0.1533479768872002
BEHÇET DISEASE	0.0040875189999999995	0.1533479768872002
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.0040875189999999995	0.1533479768872002
GITELMAN SYNDROME	0.0040875189999999995	0.1533479768872002
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.0040875189999999995	0.1533479768872002
RIFT VALLEY FEVER	0.0040875189999999995	0.1533479768872002
EBOLA HEMORRHAGIC FEVER	0.0040875189999999995	0.1533479768872002
ACUTE ADRENAL INSUFFICIENCY	0.0040875189999999995	0.1533479768872002
ADIPOSIS DOLOROSA	0.0040875189999999995	0.1533479768872002
MALIGNANT ATROPHIC PAPULOSIS	0.0040875189999999995	0.1533479768872002
LYMPHANGIOLEIOMYOMATOSIS	0.0040875189999999995	0.1533479768872002
NON-FUNCTIONING PITUITARY ADENOMA	0.0040875189999999995	0.1533479768872002
INSULINOMA	0.0040875189999999995	0.1533479768872002
ACQUIRED METHEMOGLOBINEMIA	0.0040875189999999995	0.1533479768872002
SYSTEMIC SCLEROSIS	0.0040875189999999995	0.1533479768872002
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.0040875189999999995	0.1533479768872002
CRONKHITE-CANADA SYNDROME	0.0040875189999999995	0.1533479768872002
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.0040875189999999995	0.1533479768872002
TAKAYASU ARTERITIS	0.0040875189999999995	0.1533479768872002
PROLACTINOMA	0.0040875189999999995	0.1533479768872002
LUJO HEMORRHAGIC FEVER	0.0040875189999999995	0.1533479768872002
NOCARDIOSIS	0.0040875189999999995	0.1533479768872002
GLIOBLASTOMA	0.0040875189999999995	0.1533479768872002
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.0040875189999999995	0.1533479768872002
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.0040875189999999995	0.1533479768872002
MIXED CONNECTIVE TISSUE DISEASE	0.0040875189999999995	0.1533479768872002
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.0040875189999999995	0.1533479768872002
MERCURY POISONING	0.003966079	0.1487920156028168
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.003966079	0.1487920156028168
SNEDDON SYNDROME	0.003966079	0.1487920156028168
KEUTEL SYNDROME; KTLS	0.003966079	0.1487920156028168
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.003966079	0.1487920156028168
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.003966079	0.1487920156028168
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.003966079	0.1487920156028168
PRADER-WILLI SYNDROME	0.003966079	0.1487920156028168
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.003966079	0.1487920156028168
FAMILIAL DYSAUTONOMIA	0.003966079	0.1487920156028168
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.003966079	0.1487920156028168
NEUROFIBROMATOSIS, TYPE I	0.003966079	0.1487920156028168
CLASSIC HOMOCYSTINURIA	0.003966079	0.1487920156028168
OROFACIODIGITAL SYNDROME TYPE 1	0.003966079	0.1487920156028168
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.003966079	0.1487920156028168
NEUROFIBROMATOSIS TYPE 1	0.003966079	0.1487920156028168
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.003966079	0.1487920156028168
SNEDDON SYNDROME	0.003966079	0.1487920156028168
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.003966079	0.1487920156028168
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.003966079	0.1487920156028168
CADASIL	0.003966079	0.1487920156028168
PREECLAMPSIA/ECLAMPSIA 1	0.003966079	0.1487920156028168
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.003966079	0.1487920156028168
BETA-KETOTHIOLASE DEFICIENCY	0.003966079	0.1487920156028168
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.003966079	0.1487920156028168
AUTOIMMUNE HEMOLYTIC ANEMIA	0.0035461	0.13303602034380774
PONTIAC FEVER	0.0035461	0.13303602034380774
EISENMENGER SYNDROME	0.0035461	0.13303602034380774
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 37	0.0035461	0.13303602034380774
PRIMARY FAMILIAL POLYCYTHEMIA	0.0035461	0.13303602034380774
DUBIN-JOHNSON SYNDROME	0.0035461	0.13303602034380774
ALPHA-THALASSEMIA-MYELODYSPLASTIC SYNDROME	0.0035461	0.13303602034380774
DERMATOMYOSITIS	0.0035461	0.13303602034380774
THYMOMA	0.0035461	0.13303602034380774
RARE HEREDITARY HEMOCHROMATOSIS	0.0035461	0.13303602034380774
KAWASAKI DISEASE	0.0035461	0.13303602034380774
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.0035461	0.13303602034380774
HODGKIN LYMPHOMA	0.0035461	0.13303602034380774
MASTOCYTOSIS	0.0035461	0.13303602034380774
CRYPTOGENIC ORGANIZING PNEUMONIA	0.0035461	0.13303602034380774
LYME DISEASE	0.0035461	0.13303602034380774
TYPHOID	0.0035461	0.13303602034380774
BABESIOSIS	0.0035461	0.13303602034380774
RELAPSING FEVER	0.0035461	0.13303602034380774
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.0035461	0.13303602034380774
MARBURG HEMORRHAGIC FEVER	0.0035461	0.13303602034380774
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	0.0035461	0.13303602034380774
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.0035461	0.13303602034380774
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, MYOPATHIC FORM	0.0035461	0.13303602034380774
AUTOIMMUNE HEMOLYTIC ANEMIA, COLD TYPE	0.0035461	0.13303602034380774
BECKER MUSCULAR DYSTROPHY	0.0035461	0.13303602034380774
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.0035461	0.13303602034380774
ISOLATED AGAMMAGLOBULINEMIA	0.0035461	0.13303602034380774
REYNOLDS SYNDROME	0.0035461	0.13303602034380774
CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE III	0.0035461	0.13303602034380774
PERIPHERAL HYPOTHYROIDISM	0.0035461	0.13303602034380774
PANHYPOPITUITARISM	0.0035461	0.13303602034380774
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.0035461	0.13303602034380774
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.0035461	0.13303602034380774
FUNCTIONING GONADOTROPIC ADENOMA	0.0035461	0.13303602034380774
CREATINE PHOSPHOKINASE, ELEVATED SERUM	0.0035461	0.13303602034380774
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 1	0.0035461	0.13303602034380774
UNCLASSIFIED MYELODYSPLASTIC SYNDROME	0.0035461	0.13303602034380774
CENTRAL CONGENITAL HYPOTHYROIDISM	0.0035461	0.13303602034380774
AREGENERATIVE ANEMIA	0.0035461	0.13303602034380774
CLASSIC HODGKIN LYMPHOMA	0.0035461	0.13303602034380774
GAMMA-HEAVY CHAIN DISEASE	0.0035461	0.13303602034380774
PRIMARY SCLEROSING CHOLANGITIS	0.0035461	0.13303602034380774
WISKOTT-ALDRICH SYNDROME	0.0035461	0.13303602034380774
REFRACTORY ANEMIA	0.0035461	0.13303602034380774
ANISOCORIA	0.0035461	0.13303602034380774
%241150 HYPOKALEMIC ALKALOSIS, FAMILIAL, WITH SPECIFIC RENAL TUBULOPATHY;;HYPOKALEMIA, FAMILIAL;;GULLNER SYNDROME	0.0035461	0.13303602034380774
CYSTINOSIS	0.0035461	0.13303602034380774
CASTLEMAN DISEASE	0.0035461	0.13303602034380774
GENETIC HYPERFERRITINEMIA WITHOUT IRON OVERLOAD	0.0035461	0.13303602034380774
EVANS SYNDROME	0.0035461	0.13303602034380774
ADIPOSIS DOLOROSA	0.0035461	0.13303602034380774
IATROGENIC BOTULISM	0.0035461	0.13303602034380774
PARATHYROID CARCINOMA	0.0035461	0.13303602034380774
NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA	0.0035461	0.13303602034380774
SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA	0.0035461	0.13303602034380774
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.0035461	0.13303602034380774
INHALATIONAL BOTULISM	0.0035461	0.13303602034380774
THYROID HYPOPLASIA	0.0035461	0.13303602034380774
THYROID HEMIAGENESIS	0.0035461	0.13303602034380774
DRUG-INDUCED AUTOIMMUNE HEMOLYTIC ANEMIA	0.0035461	0.13303602034380774
ACUTE PANMYELOSIS WITH MYELOFIBROSIS	0.0035461	0.13303602034380774
FAMILIAL THYROID DYSHORMONOGENESIS	0.0035461	0.13303602034380774
ATHYREOSIS	0.0035461	0.13303602034380774
CUSHING SYNDROME DUE TO ECTOPIC ACTH SECRETION	0.0035461	0.13303602034380774
CINCA SYNDROME	0.0035461	0.13303602034380774
HUGHES-STOVIN SYNDROME	0.0035461	0.13303602034380774
ARACHNOIDITIS	0.0035461	0.13303602034380774
REFRACTORY ANEMIA WITH EXCESS BLASTS	0.0035461	0.13303602034380774
CONGENITAL ANALBUMINEMIA	0.0035461	0.13303602034380774
PITUICYTOMA	0.0035461	0.13303602034380774
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.0035461	0.13303602034380774
NEUROLEPTIC MALIGNANT SYNDROME	0.0035461	0.13303602034380774
HEPATOCELLULAR CARCINOMA	0.0035461	0.13303602034380774
NON-FUNCTIONING PARAGANGLIOMA	0.0035461	0.13303602034380774
POST-TRAUMATIC PITUITARY DEFICIENCY	0.0035461	0.13303602034380774
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.0035461	0.13303602034380774
AMYOTROPHIC LATERAL SCLEROSIS	0.0035461	0.13303602034380774
HYPOTONIA-CYSTINURIA SYNDROME	0.0035461	0.13303602034380774
MIXED-TYPE AUTOIMMUNE HEMOLYTIC ANEMIA	0.0035461	0.13303602034380774
PULMONARY ARTERIAL HYPERTENSION	0.0035461	0.13303602034380774
CRIMEAN-CONGO HEMORRHAGIC FEVER	0.0035461	0.13303602034380774
AUTOIMMUNE HEMOLYTIC ANEMIA, WARM TYPE	0.0035461	0.13303602034380774
BOTULISM	0.0035461	0.13303602034380774
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.0035461	0.13303602034380774
PRIMARY MYELOFIBROSIS	0.0035461	0.13303602034380774
JUVENILE DERMATOMYOSITIS	0.0035461	0.13303602034380774
ADULT-ONSET STILL DISEASE	0.0035461	0.13303602034380774
PRIMARY BILIARY CHOLANGITIS	0.0035461	0.13303602034380774
SYSTEMIC CAPILLARY LEAK SYNDROME	0.0035461	0.13303602034380774
EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY	0.0035461	0.13303602034380774
EBSTEIN MALFORMATION	0.0035461	0.13303602034380774
HELLP SYNDROME	0.0035461	0.13303602034380774
BLACKFAN-DIAMOND ANEMIA	0.0035461	0.13303602034380774
THYMIC CARCINOMA	0.0035461	0.13303602034380774
PRIMARY PARATHYROID HYPERPLASIA	0.0035461	0.13303602034380774
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.0035461	0.13303602034380774
KLATSKIN TUMOR	0.0035461	0.13303602034380774
PYOGENIC ARTHRITIS-PYODERMA GANGRENOSUM-ACNE SYNDROME	0.0035461	0.13303602034380774
MUCOLIPIDOSIS TYPE III	0.0035461	0.13303602034380774
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.0035461	0.13303602034380774
MANTLE CELL LYMPHOMA	0.0035461	0.13303602034380774
AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS	0.0035461	0.13303602034380774
POEMS SYNDROME	0.0035461	0.13303602034380774
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.0035461	0.13303602034380774
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.0035461	0.13303602034380774
MULTIPLE MYELOMA	0.0035461	0.13303602034380774
PEDIATRIC HEPATOCELLULAR CARCINOMA	0.0035461	0.13303602034380774
MACROPHAGIC MYOFASCIITIS	0.0035461	0.13303602034380774
EOSINOPHILIC FASCIITIS	0.0035461	0.13303602034380774
STEVENS-JOHNSON SYNDROME	0.0035461	0.13303602034380774
CHRONIC MYELOID LEUKEMIA	0.0035461	0.13303602034380774
ACUTE PROMYELOCYTIC LEUKEMIA	0.0035461	0.13303602034380774
LEGIONELLOSIS	0.0035461	0.13303602034380774
X-LINKED AGAMMAGLOBULINEMIA	0.0035461	0.13303602034380774
LIPOSARCOMA	0.0035461	0.13303602034380774
CHRONIC NONBACTERIAL OSTEOMYELITIS/CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.0035461	0.13303602034380774
CUTANEOUS MASTOCYTOSIS	0.0035461	0.13303602034380774
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.0035461	0.13303602034380774
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.0035461	0.13303602034380774
PLAGUE	0.0035461	0.13303602034380774
PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX	0.0035461	0.13303602034380774
WALDENSTRÖM MACROGLOBULINEMIA	0.0035461	0.13303602034380774
AUTOSOMAL AGAMMAGLOBULINEMIA	0.0035461	0.13303602034380774
MALT LYMPHOMA	0.0035461	0.13303602034380774
COLD AGGLUTININ DISEASE	0.0035461	0.13303602034380774
X-LINKED SIDEROBLASTIC ANEMIA	0.0035461	0.13303602034380774
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	0.0035461	0.13303602034380774
SATOYOSHI SYNDROME	0.0035461	0.13303602034380774
HEMOCHROMATOSIS, TYPE 3; HFE3	0.0035461	0.13303602034380774
RHEUMATIC FEVER	0.0035461	0.13303602034380774
KAPOSI SARCOMA	0.0035461	0.13303602034380774
CHOLANGIOCARCINOMA	0.0035461	0.13303602034380774
FAMILIAL COLD URTICARIA	0.0035461	0.13303602034380774
MAST CELL SARCOMA	0.0035461	0.13303602034380774
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.0035461	0.13303602034380774
TOXIC EPIDERMAL NECROLYSIS	0.0035461	0.13303602034380774
TUBERCULOSIS	0.0035461	0.13303602034380774
MYXEDEMA	0.0035461	0.13303602034380774
HEMOCHROMATOSIS, TYPE 4; HFE4	0.0035461	0.13303602034380774
BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS	0.0035461	0.13303602034380774
CYCLIC NEUTROPENIA	0.0035461	0.13303602034380774
IDIOPATHIC/HERITABLE PULMONARY ARTERIAL HYPERTENSION	0.0035461	0.13303602034380774
TREMOR, HEREDITARY ESSENTIAL, 2; ETM2	0.0035461	0.13303602034380774
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.0035461	0.13303602034380774
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.0035461	0.13303602034380774
265400 PULMONARY HYPERTENSION, PRIMARY, AUTOSOMAL RECESSIVE	0.0035461	0.13303602034380774
KIKUCHI-FUJIMOTO DISEASE	0.0035461	0.13303602034380774
LEISHMANIASIS	0.0035461	0.13303602034380774
THYMIC EPITHELIAL NEOPLASM	0.0035461	0.13303602034380774
SEVERE CONGENITAL HYPOCHROMIC ANEMIA WITH RINGED SIDEROBLASTS	0.0035461	0.13303602034380774
POLYMYOSITIS	0.0035461	0.13303602034380774
SCHNITZLER SYNDROME	0.0035461	0.13303602034380774
GASTROINTESTINAL STROMAL TUMOR	0.0035461	0.13303602034380774
FOLLICULAR LYMPHOMA	0.0035461	0.13303602034380774
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.0035461	0.13303602034380774
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.0035461	0.13303602034380774
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.0035461	0.13303602034380774
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	0.0035461	0.13303602034380774
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B; LGMD2B	0.0035461	0.13303602034380774
SYMPTOMATIC FORM OF HEMOCHROMATOSIS TYPE 1	0.0035461	0.13303602034380774
ACUTE MONOBLASTIC LEUKEMIA	0.0035461	0.13303602034380774
POSTPOLIOMYELITIS SYNDROME	0.0035461	0.13303602034380774
BARTH SYNDROME; BTHS	0.0035461	0.13303602034380774
SPINAL ARTERIOVENOUS METAMERIC SYNDROME	0.0035461	0.13303602034380774
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.00342466	0.12848005905942433
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.00342466	0.12848005905942433
HYPERALDOSTERONISM, FAMILIAL, TYPE II; HALD2	0.00342466	0.12848005905942433
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.00342466	0.12848005905942433
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.00342466	0.12848005905942433
PARAGANGLIOMAS 6	0.00342466	0.12848005905942433
APERT SYNDROME	0.00342466	0.12848005905942433
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.00342466	0.12848005905942433
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.00342466	0.12848005905942433
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.00342466	0.12848005905942433
FAMILIAL HYPERALDOSTERONISM TYPE III	0.00342466	0.12848005905942433
ABDOMINAL OBESITY-METABOLIC SYNDROME QUANTITATIVE TRAIT LOCUS 2	0.00342466	0.12848005905942433
ABDOMINAL OBESITY-METABOLIC SYNDROME 1	0.00342466	0.12848005905942433
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASEDEFICIENCY	0.00342466	0.12848005905942433
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.00342466	0.12848005905942433
POSTERIOR URETHRAL VALVE	0.00342466	0.12848005905942433
CATECHOLAMINE-PRODUCING TUMOR	0.00342466	0.12848005905942433
OBESITY DUE TO MELANOCORTIN 4 RECEPTOR DEFICIENCY	0.00342466	0.12848005905942433
MYH7-RELATED LATE-ONSET SCAPULOPERONEAL MUSCULAR DYSTROPHY	0.00342466	0.12848005905942433
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.00342466	0.12848005905942433
ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3	0.00342466	0.12848005905942433
APPARENT MINERALOCORTICOID EXCESS	0.00342466	0.12848005905942433
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.00342466	0.12848005905942433
PRIMARY UNILATERAL ADRENAL HYPERPLASIA	0.00342466	0.12848005905942433
FRASIER SYNDROME	0.00342466	0.12848005905942433
MONOSOMY X	0.00342466	0.12848005905942433
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.00342466	0.12848005905942433
GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 1; GFND1	0.00342466	0.12848005905942433
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.00342466	0.12848005905942433
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.00342466	0.12848005905942433
ECTOPIC ALDOSTERONE-PRODUCING TUMOR	0.00342466	0.12848005905942433
ADRENOCORTICAL CARCINOMA WITH PURE ALDOSTERONE HYPERSECRETION	0.00342466	0.12848005905942433
TRIMETHYLAMINURIA	0.00342466	0.12848005905942433
DENYS-DRASH SYNDROME	0.00342466	0.12848005905942433
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.00342466	0.12848005905942433
CAUDAL REGRESSION SEQUENCE	0.00342466	0.12848005905942433
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1	0.00342466	0.12848005905942433
NEPHROBLASTOMA	0.00342466	0.12848005905942433
MARSHALL-SMITH SYNDROME; MRSHSS	0.00342466	0.12848005905942433
LCAT DEFICIENCY	0.00342466	0.12848005905942433
%123550 CRYOGLOBULINEMIA, FAMILIAL MIXED;;MELTZER SYNDROME	0.00342466	0.12848005905942433
POLYCYSTIC KIDNEY DISEASE 2	0.00342466	0.12848005905942433
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.00342466	0.12848005905942433
MOSAIC MONOSOMY X	0.00342466	0.12848005905942433
WERNER SYNDROME	0.00342466	0.12848005905942433
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	0.00342466	0.12848005905942433
ALKAPTONURIA	0.00342466	0.12848005905942433
TURNER SYNDROME	0.00342466	0.12848005905942433
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.00342466	0.12848005905942433
CONGENITAL HYPOTHYROIDISM	0.00342466	0.12848005905942433
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.00342466	0.12848005905942433
CIRRHOSIS, FAMILIAL	0.00342466	0.12848005905942433
LONG QT SYNDROME 13; LQT13	0.00342466	0.12848005905942433
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2; FSGS2	0.00342466	0.12848005905942433
SICKLE CELL ANEMIA	0.00342466	0.12848005905942433
ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS; ACDMPV	0.00342466	0.12848005905942433
PSEUDOHYPOALDOSTERONISM, TYPE II	0.00342466	0.12848005905942433
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.00342466	0.12848005905942433
SECONDARY POLYCYTHEMIA	0.00342466	0.12848005905942433
RHABDOID TUMOR	0.00342466	0.12848005905942433
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.00342466	0.12848005905942433
FAMILIAL PSEUDOHYPERKALEMIA	0.00342466	0.12848005905942433
PRIMARY LIPODYSTROPHY	0.00342466	0.12848005905942433
AMYLOIDOSIS, FAMILIAL VISCERAL	0.00342466	0.12848005905942433
TETANUS	0.00342466	0.12848005905942433
LIDDLE SYNDROME 2; LIDLS2	0.00342466	0.12848005905942433
LIDDLE SYNDROME 3; LIDLS3	0.00342466	0.12848005905942433
NAIL-PATELLA-LIKE RENAL DISEASE	0.00342466	0.12848005905942433
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.00342466	0.12848005905942433
NELSON SYNDROME	0.00342466	0.12848005905942433
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.00342466	0.12848005905942433
NEPHRONOPHTHISIS 1	0.00342466	0.12848005905942433
STIFF-PERSON SYNDROME; SPS	0.00342466	0.12848005905942433
ATRIOVENTRICULAR SEPTAL DEFECT 3; AVSD3	0.00342466	0.12848005905942433
PSEUDOHYPOALDOSTERONISM, TYPE IIC	0.00342466	0.12848005905942433
CARDIOMYOPATHY-CATARACT-HIP SPINE DISEASE SYNDROME	0.00342466	0.12848005905942433
IGA NEPHROPATHY, SUSCEPTIBILITY TO, 3	0.00342466	0.12848005905942433
MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME	0.00342466	0.12848005905942433
PSEUDOHYPOALDOSTERONISM, TYPE IIE; PHA2E	0.00342466	0.12848005905942433
MOYAMOYA DISEASE WITH EARLY-ONSET ACHALASIA	0.00342466	0.12848005905942433
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.00342466	0.12848005905942433
INTRACRANIAL HYPERTENSION, IDIOPATHIC	0.00342466	0.12848005905942433
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.00342466	0.12848005905942433
FAMILIAL BICUSPID AORTIC VALVE	0.00342466	0.12848005905942433
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2	0.00342466	0.12848005905942433
PSEUDOXANTHOMA ELASTICUM	0.00342466	0.12848005905942433
PSEUDOHYPOALDOSTERONISM TYPE 2	0.00342466	0.12848005905942433
%613944 IGA NEPHROPATHY, SUSCEPTIBILITY TO, 2; IGAN2	0.00342466	0.12848005905942433
AORTA COARCTATION	0.00342466	0.12848005905942433
ALAGILLE SYNDROME	0.00342466	0.12848005905942433
MELORHEOSTOSIS WITH OSTEOPOIKILOSIS	0.00342466	0.12848005905942433
MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME; MCTO	0.00342466	0.12848005905942433
OSTEOCHONDRODYSPLASIA, RHIZOMELIC, WITH CALLOSAL AGENESIS, THROMBOCYTOPENIA,HYDROCEPHALUS, AND HYPERTENSION	0.00342466	0.12848005905942433
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.00342466	0.12848005905942433
PPARG-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.00342466	0.12848005905942433
ALAGILLE SYNDROME 2	0.00342466	0.12848005905942433
CONGENITAL PULMONARY VEINS ATRESIA OR STENOSIS	0.00342466	0.12848005905942433
FAMILIAL PARTIAL LIPODYSTROPHY, KÖBBERLING TYPE	0.00342466	0.12848005905942433
IGA NEPHROPATHY, SUSCEPTIBILITY TO, 1; IGAN1	0.00342466	0.12848005905942433
ACQUIRED GENERALIZED LIPODYSTROPHY	0.00342466	0.12848005905942433
GRANGE SYNDROME	0.00342466	0.12848005905942433
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.00342466	0.12848005905942433
NAIL-PATELLA SYNDROME	0.00342466	0.12848005905942433
POLYARTERITIS NODOSA	0.00342466	0.12848005905942433
%161900 RENAL FAILURE, PROGRESSIVE, WITH HYPERTENSION; RFH1;;NEPHROPATHY, FAMILIAL;;NEPHRITIS, FAMILIAL, WITHOUT DEAFNESS OR OCULAR DEFECT;;RENAL FAILURE, ADULT-ONSET; AORF	0.00342466	0.12848005905942433
POLYCYSTIC KIDNEYS	0.00342466	0.12848005905942433
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00342466	0.12848005905942433
MEDULLARY CYSTIC KIDNEY DISEASE 1; MCKD1	0.00342466	0.12848005905942433
OCHOA SYNDROME	0.00342466	0.12848005905942433
LIDDLE SYNDROME 1; LIDLS1	0.00342466	0.12848005905942433
PRIMARY PROGRESSIVE FREEZING GAIT	0.00342466	0.12848005905942433
CONGENITAL ADRENAL HYPERPLASIA DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.00342466	0.12848005905942433
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.00342466	0.12848005905942433
RENAL AGENESIS	0.00342466	0.12848005905942433
POLYCYSTIC KIDNEY DISEASE 6 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD6	0.00342466	0.12848005905942433
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.00342466	0.12848005905942433
POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4	0.00342466	0.12848005905942433
GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM	0.00342466	0.12848005905942433
CYSTIC HAMARTOMA OF LUNG AND KIDNEY	0.00342466	0.12848005905942433
FIBRONECTIN GLOMERULOPATHY	0.00342466	0.12848005905942433
LMNA-RELATED CARDIOCUTANEOUS PROGERIA SYNDROME	0.00342466	0.12848005905942433
HYPERALDOSTERONISM, FAMILIAL, TYPE IV	0.00342466	0.12848005905942433
CONGENITAL ADRENAL HYPERPLASIA	0.00342466	0.12848005905942433
GLYCOGEN STORAGE DISEASE IC; GSD1C	0.00342466	0.12848005905942433
PLIN1-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.00342466	0.12848005905942433
GLYCOGEN STORAGE DISEASE IB	0.00342466	0.12848005905942433
GLYCOGEN STORAGE DISEASE IA	0.00342466	0.12848005905942433
GAUCHER DISEASE, TYPE I	0.00342466	0.12848005905942433
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.00342466	0.12848005905942433
PITUITARY ADENOMA, GROWTH HORMONE-SECRETING, 1	0.00342466	0.12848005905942433
POPOV-CHANG SYNDROME; POPCHAS	0.00342466	0.12848005905942433
PRIMARY MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS	0.00342466	0.12848005905942433
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.00342466	0.12848005905942433
JUVENILE PAGET DISEASE	0.00342466	0.12848005905942433
FAMILIAL HYPERALDOSTERONISM TYPE II	0.00342466	0.12848005905942433
SENIOR-LOKEN SYNDROME	0.00342466	0.12848005905942433
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00342466	0.12848005905942433
PREECLAMPSIA	0.00342466	0.12848005905942433
X-LINKED HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00342466	0.12848005905942433
GANGLIONEUROMA	0.00342466	0.12848005905942433
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00342466	0.12848005905942433
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1; ADCAD1	0.00342466	0.12848005905942433
ADRENOCORTICAL CARCINOMA	0.00342466	0.12848005905942433
INFANT BOTULISM	0.00342466	0.12848005905942433
BRACHYDACTYLY-ARTERIAL HYPERTENSION SYNDROME	0.00342466	0.12848005905942433
FAMILIAL HYPERALDOSTERONISM TYPE I	0.00342466	0.12848005905942433
STIFF SKIN SYNDROME	0.00342466	0.12848005905942433
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.00342466	0.12848005905942433
POLYCYSTIC KIDNEY DISEASE 3	0.00342466	0.12848005905942433
SCALP-EAR-NIPPLE SYNDROME	0.00342466	0.12848005905942433
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.002502669	0.09389050618928314
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.002502669	0.09389050618928314
NORRIE DISEASE	0.002502669	0.09389050618928314
COHEN SYNDROME	0.002502669	0.09389050618928314
PELIZAEUS-MERZBACHER DISEASE	0.002502669	0.09389050618928314
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.002502669	0.09389050618928314
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.002502669	0.09389050618928314
COFFIN-SIRIS SYNDROME 1; CSS1	0.002502669	0.09389050618928314
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.002502669	0.09389050618928314
CORNELIA DE LANGE SYNDROME	0.002502669	0.09389050618928314
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.002502669	0.09389050618928314
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.002502669	0.09389050618928314
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.002502669	0.09389050618928314
CHROMOSOME 18Q DELETION SYNDROME	0.002502669	0.09389050618928314
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.002502669	0.09389050618928314
WITTEVEEN-KOLK SYNDROME	0.002502669	0.09389050618928314
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.002502669	0.09389050618928314
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.002502669	0.09389050618928314
CHROMOSOME 19P13.13 DELETION SYNDROME	0.002502669	0.09389050618928314
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.002502669	0.09389050618928314
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.002502669	0.09389050618928314
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.002502669	0.09389050618928314
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.002502669	0.09389050618928314
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.002502669	0.09389050618928314
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.002502669	0.09389050618928314
COFFIN-SIRIS SYNDROME	0.002502669	0.09389050618928314
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.002502669	0.09389050618928314
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.002502669	0.09389050618928314
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.002502669	0.09389050618928314
MONOSOMY 9P	0.002502669	0.09389050618928314
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.002502669	0.09389050618928314
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.002502669	0.09389050618928314
8P11.2 DELETION SYNDROME	0.002502669	0.09389050618928314
TYROSINEMIA TYPE 2	0.002502669	0.09389050618928314
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.002502669	0.09389050618928314
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.002502669	0.09389050618928314
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.002502669	0.09389050618928314
CONGENITAL TOXOPLASMOSIS	0.002502669	0.09389050618928314
20Q11.2 MICRODUPLICATION SYNDROME	0.002502669	0.09389050618928314
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.002502669	0.09389050618928314
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.002502669	0.09389050618928314
MEHMO SYNDROME	0.002502669	0.09389050618928314
ADENYLOSUCCINASE DEFICIENCY	0.002502669	0.09389050618928314
PETERS-PLUS SYNDROME; PTRPLS	0.002502669	0.09389050618928314
SMITH-LEMLI-OPITZ SYNDROME	0.002502669	0.09389050618928314
WOLF-HIRSCHHORN SYNDROME	0.002502669	0.09389050618928314
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.002502669	0.09389050618928314
CONGENITAL RUBELLA SYNDROME	0.002502669	0.09389050618928314
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.002502669	0.09389050618928314
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.002502669	0.09389050618928314
KABUKI SYNDROME	0.002502669	0.09389050618928314
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.002502669	0.09389050618928314
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.002502669	0.09389050618928314
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.002502669	0.09389050618928314
PRIMARY CUTIS VERTICIS GYRATA	0.002502669	0.09389050618928314
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.002502669	0.09389050618928314
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.002502669	0.09389050618928314
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.002502669	0.09389050618928314
HSD10 DISEASE	0.002502669	0.09389050618928314
DUBOWITZ SYNDROME	0.002502669	0.09389050618928314
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.002502669	0.09389050618928314
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.002502669	0.09389050618928314
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.002502669	0.09389050618928314
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.002502669	0.09389050618928314
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.002502669	0.09389050618928314
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.002502669	0.09389050618928314
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.002502669	0.09389050618928314
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.002502669	0.09389050618928314
PELIZAEUS-MERZBACHER DISEASE	0.002502669	0.09389050618928314
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.002502669	0.09389050618928314
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.00196125	0.07357854964589067
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.00196125	0.07357854964589067
LOWRY-WOOD SYNDROME	0.00196125	0.07357854964589067
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.00196125	0.07357854964589067
MIETENS SYNDROME	0.00196125	0.07357854964589067
ATAXIA-PANCYTOPENIA SYNDROME	0.00196125	0.07357854964589067
ERMINE PHENOTYPE	0.00196125	0.07357854964589067
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.00196125	0.07357854964589067
ISOLATED COMPLEX I DEFICIENCY	0.00196125	0.07357854964589067
CHARGE SYNDROME	0.00196125	0.07357854964589067
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00196125	0.07357854964589067
MENTAL RETARDATION, X-LINKED 106; MRX106	0.00196125	0.07357854964589067
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00196125	0.07357854964589067
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.00196125	0.07357854964589067
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.00196125	0.07357854964589067
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.00196125	0.07357854964589067
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00196125	0.07357854964589067
FANCONI ANEMIA	0.00196125	0.07357854964589067
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.00196125	0.07357854964589067
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.00196125	0.07357854964589067
MEVALONIC ACIDURIA; MEVA	0.00196125	0.07357854964589067
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.00196125	0.07357854964589067
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00196125	0.07357854964589067
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.00196125	0.07357854964589067
MUCOLIPIDOSIS TYPE IV	0.00196125	0.07357854964589067
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.00196125	0.07357854964589067
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.00196125	0.07357854964589067
PETERS PLUS SYNDROME	0.00196125	0.07357854964589067
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.00196125	0.07357854964589067
MARINESCO-SJÖGREN SYNDROME	0.00196125	0.07357854964589067
6Q16 MICRODELETION SYNDROME	0.00196125	0.07357854964589067
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00196125	0.07357854964589067
FOCAL DERMAL HYPOPLASIA; FDH	0.00196125	0.07357854964589067
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.00196125	0.07357854964589067
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.00196125	0.07357854964589067
WAGR SYNDROME	0.00196125	0.07357854964589067
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.00196125	0.07357854964589067
AICARDI-GOUTIERES SYNDROME 6	0.00196125	0.07357854964589067
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.001746239	0.06551216466798751
ATAXIA-TELANGIECTASIA	0.001746239	0.06551216466798751
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.001746239	0.06551216466798751
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.001746239	0.06551216466798751
CHÉDIAK-HIGASHI SYNDROME	0.001746239	0.06551216466798751
WOLFRAM SYNDROME	0.001746239	0.06551216466798751
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.001746239	0.06551216466798751
OCULOCEREBROCUTANEOUS SYNDROME	0.001746239	0.06551216466798751
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.001746239	0.06551216466798751
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.001746239	0.06551216466798751
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.001746239	0.06551216466798751
OCULOCEREBROCUTANEOUS SYNDROME	0.001746239	0.06551216466798751
48,XXYY SYNDROME	0.001746239	0.06551216466798751
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.001746239	0.06551216466798751
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.001746239	0.06551216466798751
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.001746239	0.06551216466798751
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.001746239	0.06551216466798751
EPISODIC ATAXIA, TYPE 6	0.001746239	0.06551216466798751
SPINOCEREBELLAR ATAXIA TYPE 13	0.001746239	0.06551216466798751
INFANTILE NEUROAXONAL DYSTROPHY	0.001746239	0.06551216466798751
KNOBLOCH SYNDROME	0.001746239	0.06551216466798751
OCULOECTODERMAL SYNDROME; OES	0.001746239	0.06551216466798751
SCHINDLER DISEASE, TYPE I	0.001746239	0.06551216466798751
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.001746239	0.06551216466798751
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.001746239	0.06551216466798751
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.001746239	0.06551216466798751
SRD5A3-CDG	0.001746239	0.06551216466798751
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.001746239	0.06551216466798751
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.001746239	0.06551216466798751
SECONDARY SYRINGOMYELIA	0.001746239	0.06551216466798751
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.001746239	0.06551216466798751
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.001746239	0.06551216466798751
JOUBERT SYNDROME	0.001746239	0.06551216466798751
HUNTINGTON DISEASE-LIKE 1	0.001746239	0.06551216466798751
KALLMANN SYNDROME	0.001746239	0.06551216466798751
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.001746239	0.06551216466798751
MALAN OVERGROWTH SYNDROME	0.001746239	0.06551216466798751
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001746239	0.06551216466798751
19P13.13 MICRODELETION SYNDROME	0.001746239	0.06551216466798751
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.001746239	0.06551216466798751
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.001746239	0.06551216466798751
NEONATAL ADRENOLEUKODYSTROPHY	0.001746239	0.06551216466798751
VICI SYNDROME	0.001746239	0.06551216466798751
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.001746239	0.06551216466798751
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.001746239	0.06551216466798751
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001746239	0.06551216466798751
SALLA DISEASE	0.001746239	0.06551216466798751
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.001746239	0.06551216466798751
ANGELMAN SYNDROME	0.001746239	0.06551216466798751
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.001746239	0.06551216466798751
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.001746239	0.06551216466798751
GRISCELLI SYNDROME	0.001746239	0.06551216466798751
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.001746239	0.06551216466798751
SIALIDOSIS TYPE 1	0.001746239	0.06551216466798751
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.001746239	0.06551216466798751
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.001746239	0.06551216466798751
ELEJALDE DISEASE	0.001746239	0.06551216466798751
NARP SYNDROME	0.001746239	0.06551216466798751
ALSTRÖM SYNDROME	0.001746239	0.06551216466798751
LISSENCEPHALY, X-LINKED, 1; LISX1	0.001746239	0.06551216466798751
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.001746239	0.06551216466798751
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.001746239	0.06551216466798751
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.001746239	0.06551216466798751
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.001746239	0.06551216466798751
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.001746239	0.06551216466798751
6Q TERMINAL DELETION SYNDROME	0.001746239	0.06551216466798751
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.001746239	0.06551216466798751
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.001746239	0.06551216466798751
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.001746239	0.06551216466798751
JOUBERT SYNDROME WITH RENAL DEFECT	0.001746239	0.06551216466798751
JOUBERT SYNDROME WITH OCULAR DEFECT	0.001746239	0.06551216466798751
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.001746239	0.06551216466798751
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.001746239	0.06551216466798751
NEURAMINIDASE DEFICIENCY	0.001746239	0.06551216466798751
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.001746239	0.06551216466798751
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.001746239	0.06551216466798751
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.001746239	0.06551216466798751
OROFACIODIGITAL SYNDROME TYPE 6	0.001746239	0.06551216466798751
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.001746239	0.06551216466798751
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.001746239	0.06551216466798751
LEBER CONGENITAL AMAUROSIS	0.001746239	0.06551216466798751
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.001746239	0.06551216466798751
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.001746239	0.06551216466798751
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.001746239	0.06551216466798751
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.001746239	0.06551216466798751
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.001746239	0.06551216466798751
INFANTILE SIALIC ACID STORAGE DISEASE	0.001746239	0.06551216466798751
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.001746239	0.06551216466798751
GAPO SYNDROME; GAPOS	0.001746239	0.06551216466798751
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.001746239	0.06551216466798751
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.001746239	0.06551216466798751
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.001746239	0.06551216466798751
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.001746239	0.06551216466798751
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.001746239	0.06551216466798751
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.001746239	0.06551216466798751
MOMO SYNDROME	0.001746239	0.06551216466798751
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001746239	0.06551216466798751
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.001746239	0.06551216466798751
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.001746239	0.06551216466798751
FREE SIALIC ACID STORAGE DISEASE	0.001746239	0.06551216466798751
PERRAULT SYNDROME 5; PRLTS5	0.001746239	0.06551216466798751
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.001746239	0.06551216466798751
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.001746239	0.06551216466798751
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.001746239	0.06551216466798751
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.001746239	0.06551216466798751
GRISCELLI SYNDROME TYPE 1	0.001746239	0.06551216466798751
HARTNUP DISEASE	0.001746239	0.06551216466798751
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.001746239	0.06551216466798751
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.001746239	0.06551216466798751
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.001746239	0.06551216466798751
MENTAL RETARDATION, X-LINKED 104; MRX104	0.001746239	0.06551216466798751
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.001746239	0.06551216466798751
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.001746239	0.06551216466798751
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.001746239	0.06551216466798751
EPISODIC ATAXIA TYPE 3	0.001746239	0.06551216466798751
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.001746239	0.06551216466798751
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.001746239	0.06551216466798751
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.001746239	0.06551216466798751
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.001746239	0.06551216466798751
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.001746239	0.06551216466798751
METACHROMATIC LEUKODYSTROPHY	0.001746239	0.06551216466798751
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.001746239	0.06551216466798751
INFANTILE REFSUM DISEASE	0.001746239	0.06551216466798751
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001746239	0.06551216466798751
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.001746239	0.06551216466798751
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.001746239	0.06551216466798751
LEIGH SYNDROME	0.001746239	0.06551216466798751
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.001746239	0.06551216466798751
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.001746239	0.06551216466798751
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001746239	0.06551216466798751
ACROCALLOSAL SYNDROME; ACLS	0.001746239	0.06551216466798751
OCULOCEREBRORENAL SYNDROME OF LOWE	0.001746239	0.06551216466798751
KRABBE DISEASE	0.001746239	0.06551216466798751
PONTINE TEGMENTAL CAP DYSPLASIA	0.001746239	0.06551216466798751
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.001746239	0.06551216466798751
ALG2-CDG	0.001746239	0.06551216466798751
16Q24.3 MICRODELETION SYNDROME	0.001746239	0.06551216466798751
LEIGH SYNDROME; LS	0.001746239	0.06551216466798751
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.001746239	0.06551216466798751
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.001746239	0.06551216466798751
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.001746239	0.06551216466798751
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.001746239	0.06551216466798751
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.001746239	0.06551216466798751
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.001746239	0.06551216466798751
OPTIC PATHWAY GLIOMA	0.001746239	0.06551216466798751
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.001297849	0.048690298064688116
ALG1-CDG	0.001297849	0.048690298064688116
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.001297849	0.048690298064688116
ALG11-CDG	0.001297849	0.048690298064688116
MICROFORM HOLOPROSENCEPHALY	0.001297849	0.048690298064688116
ALG3-CDG	0.001297849	0.048690298064688116
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.001297849	0.048690298064688116
TEMPLE-BARAITSER SYNDROME	0.001297849	0.048690298064688116
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.001297849	0.048690298064688116
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.001297849	0.048690298064688116
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.001297849	0.048690298064688116
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001297849	0.048690298064688116
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.001297849	0.048690298064688116
PHACE SYNDROME	0.001297849	0.048690298064688116
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.001297849	0.048690298064688116
RUBINSTEIN-TAYBI SYNDROME	0.001297849	0.048690298064688116
CK SYNDROME	0.001297849	0.048690298064688116
KLEEFSTRA SYNDROME	0.001297849	0.048690298064688116
14Q12 MICRODELETION SYNDROME	0.001297849	0.048690298064688116
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001297849	0.048690298064688116
SMITH-MAGENIS SYNDROME	0.001297849	0.048690298064688116
PYRUVATE DEHYDROGENASE DEFICIENCY	0.001297849	0.048690298064688116
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.001297849	0.048690298064688116
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.001297849	0.048690298064688116
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.001297849	0.048690298064688116
DISTAL MONOSOMY 1Q	0.001297849	0.048690298064688116
RING CHROMOSOME 22 SYNDROME	0.001297849	0.048690298064688116
SJÖGREN-LARSSON SYNDROME	0.001297849	0.048690298064688116
STT3A-CDG	0.001297849	0.048690298064688116
CLASSIC PHENYLKETONURIA	0.001297849	0.048690298064688116
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.001297849	0.048690298064688116
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001297849	0.048690298064688116
MOYNAHAN SYNDROME	0.001297849	0.048690298064688116
ADNP SYNDROME	0.001297849	0.048690298064688116
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.001297849	0.048690298064688116
DPM1-CDG	0.001297849	0.048690298064688116
CAMOS SYNDROME	0.001297849	0.048690298064688116
SSR4-CDG	0.001297849	0.048690298064688116
DISTAL MONOSOMY 15Q	0.001297849	0.048690298064688116
10Q22.3Q23.3 MICRODELETION SYNDROME	0.001297849	0.048690298064688116
15Q14 MICRODELETION SYNDROME	0.001297849	0.048690298064688116
STT3B-CDG	0.001297849	0.048690298064688116
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.001297849	0.048690298064688116
DPAGT1-CDG	0.001297849	0.048690298064688116
TETRASOMY 18P	0.001297849	0.048690298064688116
20P13 MICRODELETION SYNDROME	0.001297849	0.048690298064688116
FILIPPI SYNDROME	0.001297849	0.048690298064688116
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.001297849	0.048690298064688116
HALL-RIGGS SYNDROME	0.001297849	0.048690298064688116
RUVALCABA SYNDROME	0.001297849	0.048690298064688116
DUPLICATION/INVERSION 15Q11	0.001297849	0.048690298064688116
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.001297849	0.048690298064688116
HARROD SYNDROME	0.001297849	0.048690298064688116
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.001297849	0.048690298064688116
HOLOPROSENCEPHALY	0.001297849	0.048690298064688116
LATHOSTEROLOSIS	0.001297849	0.048690298064688116
22Q11.2 MICRODUPLICATION SYNDROME	0.001297849	0.048690298064688116
22Q11.2 DELETION SYNDROME	0.001297849	0.048690298064688116
MATERNAL PHENYLKETONURIA	0.001297849	0.048690298064688116
ADENYLOSUCCINATE LYASE DEFICIENCY	0.001297849	0.048690298064688116
MULTIPLE SULFATASE DEFICIENCY	0.001297849	0.048690298064688116
KOOLEN-DE VRIES SYNDROME	0.001297849	0.048690298064688116
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.001297849	0.048690298064688116
3-HYDROXYISOBUTYRIC ACIDURIA	0.001297849	0.048690298064688116
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.001297849	0.048690298064688116
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.001297849	0.048690298064688116
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.001297849	0.048690298064688116
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.001297849	0.048690298064688116
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.001297849	0.048690298064688116
COFFIN-LOWRY SYNDROME	0.001297849	0.048690298064688116
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.001297849	0.048690298064688116
9Q33.3Q34.11 MICRODELETION SYNDROME	0.001297849	0.048690298064688116
WIEDEMANN-STEINER SYNDROME	0.001297849	0.048690298064688116
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.001297849	0.048690298064688116
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.001297849	0.048690298064688116
RENPENNING SYNDROME	0.001297849	0.048690298064688116
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.001297849	0.048690298064688116
DISTAL MONOSOMY 10Q	0.001297849	0.048690298064688116
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.001297849	0.048690298064688116
RENIER-GABREELS-JASPER SYNDROME	0.001297849	0.048690298064688116
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.001297849	0.048690298064688116
HEREDITARY METHEMOGLOBINEMIA	0.001297849	0.048690298064688116
MONOSOMY 18Q	0.001297849	0.048690298064688116
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.001297849	0.048690298064688116
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.001297849	0.048690298064688116
LOWRY-MACLEAN SYNDROME	0.001297849	0.048690298064688116
GALACTOSEMIA	0.001297849	0.048690298064688116
WALKER-WARBURG SYNDROME	0.001297849	0.048690298064688116
MEVALONIC ACIDURIA	0.001297849	0.048690298064688116
PITT-HOPKINS SYNDROME	0.001297849	0.048690298064688116
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.001297849	0.048690298064688116
TRIPLE A SYNDROME	0.001297849	0.048690298064688116
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.001297849	0.048690298064688116
DISTAL MONOSOMY 7Q36	0.001297849	0.048690298064688116
1Q21.1 MICRODELETION SYNDROME	0.001297849	0.048690298064688116
MICRO SYNDROME	0.001297849	0.048690298064688116
DISTAL MONOSOMY 3P	0.001297849	0.048690298064688116
8P23.1 MICRODELETION SYNDROME	0.001297849	0.048690298064688116
ANGELMAN SYNDROME	0.001297849	0.048690298064688116
XP22.13P22.2 DUPLICATION SYNDROME	0.001297849	0.048690298064688116
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.001297849	0.048690298064688116
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.001297849	0.048690298064688116
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.001297849	0.048690298064688116
KBG SYNDROME	0.001297849	0.048690298064688116
2Q23.1 MICRODELETION SYNDROME	0.001297849	0.048690298064688116
NEVUS COMEDONICUS SYNDROME	0.001297849	0.048690298064688116
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.001297849	0.048690298064688116
5Q35 MICRODUPLICATION SYNDROME	0.001297849	0.048690298064688116
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.001297849	0.048690298064688116
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.001297849	0.048690298064688116
LEUKOCYTE ADHESION DEFICIENCY	0.001297849	0.048690298064688116
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.001297849	0.048690298064688116
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.001297849	0.048690298064688116
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.001297849	0.048690298064688116
CEDNIK SYNDROME	0.001297849	0.048690298064688116
WOLCOTT-RALLISON SYNDROME	0.001297849	0.048690298064688116
WORSTER-DROUGHT SYNDROME	0.001297849	0.048690298064688116
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.001297849	0.048690298064688116
SANJAD-SAKATI SYNDROME	0.001297849	0.048690298064688116
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.001297849	0.048690298064688116
WOLF-HIRSCHHORN SYNDROME	0.001297849	0.048690298064688116
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.001297849	0.048690298064688116
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.001297849	0.048690298064688116
BARAITSER-WINTER SYNDROME 1; BRWS1	0.001297849	0.048690298064688116
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001297849	0.048690298064688116
EMANUEL SYNDROME	0.001297849	0.048690298064688116
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.001297849	0.048690298064688116
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.001297849	0.048690298064688116
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.001297849	0.048690298064688116
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001297849	0.048690298064688116
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.001297849	0.048690298064688116
JABERI-ELAHI SYNDROME; JABELS	0.001297849	0.048690298064688116
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.001297849	0.048690298064688116
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.001297849	0.048690298064688116
CHROMOSOME 1P35 DELETION SYNDROME	0.001297849	0.048690298064688116
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001297849	0.048690298064688116
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.001297849	0.048690298064688116
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.001297849	0.048690298064688116
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.001297849	0.048690298064688116
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.001297849	0.048690298064688116
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.001297849	0.048690298064688116
KLEEFSTRA SYNDROME 2; KLEFS2	0.001297849	0.048690298064688116
CHROMOSOME 10Q26 DELETION SYNDROME	0.001297849	0.048690298064688116
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001297849	0.048690298064688116
KLEEFSTRA SYNDROME	0.001297849	0.048690298064688116
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.001297849	0.048690298064688116
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.001297849	0.048690298064688116
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.001297849	0.048690298064688116
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.001297849	0.048690298064688116
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.001297849	0.048690298064688116
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.001297849	0.048690298064688116
AL KAISSI SYNDROME; ALKAS	0.001297849	0.048690298064688116
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.001297849	0.048690298064688116
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001297849	0.048690298064688116
AICARDI-GOUTIERES SYNDROME 7	0.001297849	0.048690298064688116
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.001297849	0.048690298064688116
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.001297849	0.048690298064688116
SUPRABULBAR PARESIS, CONGENITAL	0.001297849	0.048690298064688116
COFFIN-SIRIS SYNDROME 3; CSS3	0.001297849	0.048690298064688116
FILIPPI SYNDROME; FLPIS	0.001297849	0.048690298064688116
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.001297849	0.048690298064688116
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.001297849	0.048690298064688116
XYLOSIDASE DEFICIENCY	0.001297849	0.048690298064688116
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.001297849	0.048690298064688116
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.001297849	0.048690298064688116
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.001297849	0.048690298064688116
MEHMO SYNDROME; MEHMO	0.001297849	0.048690298064688116
PIERPONT SYNDROME	0.001297849	0.048690298064688116
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001297849	0.048690298064688116
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.001297849	0.048690298064688116
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.001297849	0.048690298064688116
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.001297849	0.048690298064688116
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001297849	0.048690298064688116
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.001297849	0.048690298064688116
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.001297849	0.048690298064688116
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.001297849	0.048690298064688116
SECKEL SYNDROME 7; SCKL7	0.001297849	0.048690298064688116
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001297849	0.048690298064688116
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.001297849	0.048690298064688116
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.001297849	0.048690298064688116
KABUKI SYNDROME 1	0.001297849	0.048690298064688116
KBG SYNDROME	0.001297849	0.048690298064688116
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.001297849	0.048690298064688116
HOLOPROSENCEPHALY 2; HPE2	0.001297849	0.048690298064688116
LATHOSTEROLOSIS	0.001297849	0.048690298064688116
COFFIN-SIRIS SYNDROME 4; CSS4	0.001297849	0.048690298064688116
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.001297849	0.048690298064688116
PHELAN-MCDERMID SYNDROME	0.001297849	0.048690298064688116
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001297849	0.048690298064688116
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.001297849	0.048690298064688116
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.001297849	0.048690298064688116
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.001297849	0.048690298064688116
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001297849	0.048690298064688116
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.001297849	0.048690298064688116
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.001297849	0.048690298064688116
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.001297849	0.048690298064688116
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.001297849	0.048690298064688116
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.001297849	0.048690298064688116
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.001297849	0.048690298064688116
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001297849	0.048690298064688116
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.001297849	0.048690298064688116
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.001297849	0.048690298064688116
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.001297849	0.048690298064688116
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.001297849	0.048690298064688116
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.001297849	0.048690298064688116
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.001297849	0.048690298064688116
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.001297849	0.048690298064688116
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.001297849	0.048690298064688116
PERRAULT SYNDROME 3	0.001297849	0.048690298064688116
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.001297849	0.048690298064688116
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.001297849	0.048690298064688116
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.001297849	0.048690298064688116
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.001297849	0.048690298064688116
C SYNDROME	0.001297849	0.048690298064688116
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.001297849	0.048690298064688116
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.001297849	0.048690298064688116
COFFIN-SIRIS SYNDROME 5	0.001297849	0.048690298064688116
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.001297849	0.048690298064688116
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.001297849	0.048690298064688116
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.001297849	0.048690298064688116
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.001297849	0.048690298064688116
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.001297849	0.048690298064688116
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001297849	0.048690298064688116
LISSENCEPHALY 4	0.001297849	0.048690298064688116
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.001297849	0.048690298064688116
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.001297849	0.048690298064688116
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.001297849	0.048690298064688116
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001297849	0.048690298064688116
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.001297849	0.048690298064688116
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001297849	0.048690298064688116
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001297849	0.048690298064688116
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001297849	0.048690298064688116
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001297849	0.048690298064688116
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.001297849	0.048690298064688116
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001297849	0.048690298064688116
COHEN SYNDROME	0.001297849	0.048690298064688116
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.001297849	0.048690298064688116
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.001297849	0.048690298064688116
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.001297849	0.048690298064688116
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.001297849	0.048690298064688116
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.001297849	0.048690298064688116
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.001297849	0.048690298064688116
LISSENCEPHALY 8; LIS8	0.001297849	0.048690298064688116
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.001297849	0.048690298064688116
LISSENCEPHALY 3; LIS3	0.001297849	0.048690298064688116
PITT-HOPKINS SYNDROME	0.001297849	0.048690298064688116
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001297849	0.048690298064688116
PSEUDO-TORCH SYNDROME 2	0.001297849	0.048690298064688116
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001297849	0.048690298064688116
POTOCKI-LUPSKI SYNDROME	0.001297849	0.048690298064688116
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001297849	0.048690298064688116
CHROMOSOME 16P13.3 DELETION SYNDROME	0.001297849	0.048690298064688116
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.001297849	0.048690298064688116
PHENYLKETONURIA	0.001297849	0.048690298064688116
KOOLEN-DE VRIES SYNDROME; KDVS	0.001297849	0.048690298064688116
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001297849	0.048690298064688116
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.001297849	0.048690298064688116
BANGSTAD SYNDROME	0.001297849	0.048690298064688116
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.001297849	0.048690298064688116
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.001297849	0.048690298064688116
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.001297849	0.048690298064688116
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.001297849	0.048690298064688116
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.001297849	0.048690298064688116
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001297849	0.048690298064688116
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001297849	0.048690298064688116
ASPARTYLGLUCOSAMINURIA; AGU	0.001297849	0.048690298064688116
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.001297849	0.048690298064688116
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.001297849	0.048690298064688116
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.001297849	0.048690298064688116
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.001297849	0.048690298064688116
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.001297849	0.048690298064688116
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.001297849	0.048690298064688116
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001297849	0.048690298064688116
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.001297849	0.048690298064688116
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001297849	0.048690298064688116
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001297849	0.048690298064688116
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.001297849	0.048690298064688116
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.001297849	0.048690298064688116
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.001297849	0.048690298064688116
INCONTINENTIA PIGMENTI; IP	0.001297849	0.048690298064688116
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.001297849	0.048690298064688116
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.001297849	0.048690298064688116
INFANTILE LIVER FAILURE SYNDROME 1	0.001297849	0.048690298064688116
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.001297849	0.048690298064688116
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.001297849	0.048690298064688116
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.001297849	0.048690298064688116
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.001297849	0.048690298064688116
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.001297849	0.048690298064688116
CYCLIC VOMITING SYNDROME	0.001297849	0.048690298064688116
KEARNS-SAYRE SYNDROME; KSS	0.001297849	0.048690298064688116
2Q37 MICRODELETION SYNDROME	0.001297849	0.048690298064688116
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.001297849	0.048690298064688116
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.001297849	0.048690298064688116
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.001297849	0.048690298064688116
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.001297849	0.048690298064688116
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.001297849	0.048690298064688116
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.001297849	0.048690298064688116
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.001297849	0.048690298064688116
COFFIN-LOWRY SYNDROME; CLS	0.001297849	0.048690298064688116
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.001297849	0.048690298064688116
ISOLATED CEREBELLAR AGENESIS	0.001297849	0.048690298064688116
MENTAL RETARDATION, X-LINKED 102	0.001297849	0.048690298064688116
17Q11.2 MICRODUPLICATION SYNDROME	0.001297849	0.048690298064688116
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.001297849	0.048690298064688116
MOWAT-WILSON SYNDROME; MOWS	0.001297849	0.048690298064688116
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001297849	0.048690298064688116
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.001297849	0.048690298064688116
ANGELMAN SYNDROME (TYPE 1)	0.001297849	0.048690298064688116
XQ28 (MECP2) DUPLICATION	0.001297849	0.048690298064688116
ANGELMAN SYNDROME (TYPE 2)	0.001297849	0.048690298064688116
SYMMETRICAL THALAMIC CALCIFICATIONS	0.001297849	0.048690298064688116
C SYNDROME	0.001297849	0.048690298064688116
HOLOPROSENCEPHALY 1; HPE1	0.001297849	0.048690298064688116
BRANCHIOSKELETOGENITAL SYNDROME	0.001297849	0.048690298064688116
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001297849	0.048690298064688116
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.001297849	0.048690298064688116
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001297849	0.048690298064688116
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.001297849	0.048690298064688116
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001297849	0.048690298064688116
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.001297849	0.048690298064688116
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.001297849	0.048690298064688116
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.001297849	0.048690298064688116
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.001297849	0.048690298064688116
ÅLAND ISLANDS EYE DISEASE	0.00120482	0.04520020812459503
GILLESPIE SYNDROME; GLSP	0.00120482	0.04520020812459503
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00120482	0.04520020812459503
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.00120482	0.04520020812459503
RETINAL DEGENERATION-NANOPHTHALMOS-GLAUCOMA SYNDROME	0.00120482	0.04520020812459503
RICHARDS-RUNDLE SYNDROME; RRNS	0.00120482	0.04520020812459503
AMYOTROPHIC DYSTONIC PARAPLEGIA	0.00120482	0.04520020812459503
CONE-ROD DYSTROPHY 20; CORD20	0.00120482	0.04520020812459503
PETERS ANOMALY	0.00120482	0.04520020812459503
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00120482	0.04520020812459503
BALLER-GEROLD SYNDROME	0.00120482	0.04520020812459503
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00120482	0.04520020812459503
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.00120482	0.04520020812459503
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA 38; SCA38	0.00120482	0.04520020812459503
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00120482	0.04520020812459503
CONE-ROD DYSTROPHY AND HEARING LOSS; CRDHL	0.00120482	0.04520020812459503
ARIMA SYNDROME	0.00120482	0.04520020812459503
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.00120482	0.04520020812459503
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.00120482	0.04520020812459503
BLUE CONE MONOCHROMACY; BCM	0.00120482	0.04520020812459503
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00120482	0.04520020812459503
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4	0.00120482	0.04520020812459503
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.00120482	0.04520020812459503
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.00120482	0.04520020812459503
OSTEOPETROSIS AND RELATED DISORDERS	0.00120482	0.04520020812459503
CHIARI MALFORMATION TYPE II	0.00120482	0.04520020812459503
OSTEOPOROSIS-OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME	0.00120482	0.04520020812459503
AUTOSOMAL RECESSIVE SPASTIC ATAXIA-OPTIC ATROPHY-DYSARTHRIA SYNDROME	0.00120482	0.04520020812459503
MESANGIAL SCLEROSIS, DIFFUSE RENAL, WITH OCULAR ABNORMALITIES	0.00120482	0.04520020812459503
JOUBERT SYNDROME 27	0.00120482	0.04520020812459503
ENDOSTEAL HYPEROSTOSIS, WORTH TYPE	0.00120482	0.04520020812459503
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00120482	0.04520020812459503
JOUBERT SYNDROME 28	0.00120482	0.04520020812459503
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.00120482	0.04520020812459503
OCULOCUTANEOUS ALBINISM TYPE 4	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 24; SCAR24	0.00120482	0.04520020812459503
PAPILLARY TUMOR OF THE PINEAL REGION	0.00120482	0.04520020812459503
PINEOCYTOMA	0.00120482	0.04520020812459503
SPASMUS NUTANS	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA 37; SCA37	0.00120482	0.04520020812459503
REFSUM DISEASE	0.00120482	0.04520020812459503
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.00120482	0.04520020812459503
EARLY-ONSET CEREBELLAR ATAXIA WITH RETAINED TENDON REFLEXES	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA 34; SCA34	0.00120482	0.04520020812459503
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00120482	0.04520020812459503
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.00120482	0.04520020812459503
X-LINKED PROGRESSIVE CEREBELLAR ATAXIA	0.00120482	0.04520020812459503
PROGRESSIVE BIFOCAL CHORIORETINAL ATROPHY	0.00120482	0.04520020812459503
LEBER CONGENITAL AMAUROSIS 12; LCA12	0.00120482	0.04520020812459503
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.00120482	0.04520020812459503
OCULOCUTANEOUS ALBINISM TYPE 1B	0.00120482	0.04520020812459503
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.00120482	0.04520020812459503
DYSOSTEOSCLEROSIS	0.00120482	0.04520020812459503
ANIRIDIA	0.00120482	0.04520020812459503
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.00120482	0.04520020812459503
VITREORETINOCHOROIDOPATHY; VRCP	0.00120482	0.04520020812459503
LAURENCE-MOON SYNDROME	0.00120482	0.04520020812459503
SPONDYLO-OCULAR SYNDROME	0.00120482	0.04520020812459503
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.00120482	0.04520020812459503
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.00120482	0.04520020812459503
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.00120482	0.04520020812459503
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00120482	0.04520020812459503
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.00120482	0.04520020812459503
CRANIOFRONTONASAL SYNDROME; CFNS	0.00120482	0.04520020812459503
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00120482	0.04520020812459503
ISOLATED ANIRIDIA	0.00120482	0.04520020812459503
BENIGN PAROXYSMAL TONIC UPGAZE OF CHILDHOOD WITH ATAXIA	0.00120482	0.04520020812459503
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00120482	0.04520020812459503
CATARACT 19, MULTIPLE TYPES; CTRCT19	0.00120482	0.04520020812459503
MORNING GLORY DISC ANOMALY	0.00120482	0.04520020812459503
MELKERSSON-ROSENTHAL SYNDROME	0.00120482	0.04520020812459503
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.00120482	0.04520020812459503
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.00120482	0.04520020812459503
ALBINISM, OCULOCUTANEOUS, TYPE III	0.00120482	0.04520020812459503
JOUBERT SYNDROME 7	0.00120482	0.04520020812459503
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.00120482	0.04520020812459503
NAVAJO NEUROHEPATOPATHY	0.00120482	0.04520020812459503
MARSHALL SYNDROME	0.00120482	0.04520020812459503
ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2	0.00120482	0.04520020812459503
PEROXISOME BIOGENESIS DISORDER 10B	0.00120482	0.04520020812459503
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.00120482	0.04520020812459503
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.00120482	0.04520020812459503
JALILI SYNDROME	0.00120482	0.04520020812459503
HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5	0.00120482	0.04520020812459503
ACHROMATOPSIA 7; ACHM7	0.00120482	0.04520020812459503
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.00120482	0.04520020812459503
YEMENITE DEAF-BLIND HYPOPIGMENTATION SYNDROME	0.00120482	0.04520020812459503
HEREDITARY MUCOEPITHELIAL DYSPLASIA	0.00120482	0.04520020812459503
CENANI-LENZ SYNDROME	0.00120482	0.04520020812459503
CATARACT-MICROCORNEA SYNDROME	0.00120482	0.04520020812459503
DANDY-WALKER SYNDROME	0.00120482	0.04520020812459503
SENIOR-LOKEN SYNDROME 9	0.00120482	0.04520020812459503
CODAS SYNDROME	0.00120482	0.04520020812459503
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.00120482	0.04520020812459503
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6	0.00120482	0.04520020812459503
JOUBERT SYNDROME 24	0.00120482	0.04520020812459503
X-LINKED RETINAL DYSPLASIA	0.00120482	0.04520020812459503
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA TYPE 21	0.00120482	0.04520020812459503
DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY	0.00120482	0.04520020812459503
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.00120482	0.04520020812459503
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.00120482	0.04520020812459503
RETINITIS PIGMENTOSA 20	0.00120482	0.04520020812459503
COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE	0.00120482	0.04520020812459503
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.00120482	0.04520020812459503
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00120482	0.04520020812459503
RICHARDS-RUNDLE SYNDROME	0.00120482	0.04520020812459503
PEROXISOME BIOGENESIS DISORDER 5B	0.00120482	0.04520020812459503
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.00120482	0.04520020812459503
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.00120482	0.04520020812459503
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.00120482	0.04520020812459503
USHER SYNDROME	0.00120482	0.04520020812459503
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.00120482	0.04520020812459503
ARNOLD-CHIARI MALFORMATION TYPE I	0.00120482	0.04520020812459503
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.00120482	0.04520020812459503
CATARACT-INTELLECTUAL DISABILITY-ANAL ATRESIA-URINARY DEFECTS SYNDROME	0.00120482	0.04520020812459503
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.00120482	0.04520020812459503
CRANIOECTODERMAL DYSPLASIA 1	0.00120482	0.04520020812459503
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.00120482	0.04520020812459503
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.00120482	0.04520020812459503
LEBER CONGENITAL AMAUROSIS 11; LCA11	0.00120482	0.04520020812459503
HERMANSKY-PUDLAK SYNDROME 3; HPS3	0.00120482	0.04520020812459503
X-LINKED RECESSIVE OCULAR ALBINISM	0.00120482	0.04520020812459503
245800 LAURENCE-MOON SYNDROME	0.00120482	0.04520020812459503
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.00120482	0.04520020812459503
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.00120482	0.04520020812459503
OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES	0.00120482	0.04520020812459503
DISTAL LIMB DEFICIENCIES-MICROGNATHIA SYNDROME	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA TYPE 19/22	0.00120482	0.04520020812459503
OCULOCUTANEOUS ALBINISM	0.00120482	0.04520020812459503
EPISODIC ATAXIA, TYPE 8	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA TYPE 18	0.00120482	0.04520020812459503
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.00120482	0.04520020812459503
OCULOCUTANEOUS ALBINISM TYPE 3	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.00120482	0.04520020812459503
X-LINKED IMMUNONEUROLOGIC DISORDER	0.00120482	0.04520020812459503
CRANIOECTODERMAL DYSPLASIA	0.00120482	0.04520020812459503
SPONDYLOMETAPHYSEAL DYSPLASIA-CONE-ROD DYSTROPHY SYNDROME	0.00120482	0.04520020812459503
CRANIOFACIAL DYSSYNOSTOSIS	0.00120482	0.04520020812459503
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA 43; SCA43	0.00120482	0.04520020812459503
CONE-ROD DYSTROPHY 6; CORD6	0.00120482	0.04520020812459503
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.00120482	0.04520020812459503
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1	0.00120482	0.04520020812459503
CONE DYSTROPHY 4	0.00120482	0.04520020812459503
RETINITIS PIGMENTOSA	0.00120482	0.04520020812459503
SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	0.00120482	0.04520020812459503
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00120482	0.04520020812459503
LEBER CONGENITAL AMAUROSIS 16	0.00120482	0.04520020812459503
CARDIOFACIOCUTANEOUS SYNDROME	0.00120482	0.04520020812459503
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00120482	0.04520020812459503
OCULOCUTANEOUS ALBINISM TYPE 1A	0.00120482	0.04520020812459503
CONGENITAL CATARACT-HYPERTROPHIC CARDIOMYOPATHY-MITOCHONDRIAL MYOPATHY SYNDROME	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.00120482	0.04520020812459503
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.00120482	0.04520020812459503
JOUBERT SYNDROME 26	0.00120482	0.04520020812459503
CEREBELLAR HYPOPLASIA	0.00120482	0.04520020812459503
RENAL COLOBOMA SYNDROME	0.00120482	0.04520020812459503
ATAXIA-OCULOMOTOR APRAXIA 3; AOA3	0.00120482	0.04520020812459503
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.00120482	0.04520020812459503
OCULOCUTANEOUS ALBINISM TYPE 2	0.00120482	0.04520020812459503
OPTIC DISC ANOMALIES WITH RETINAL AND/OR MACULAR DYSTROPHY; ODRMD	0.00120482	0.04520020812459503
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.00120482	0.04520020812459503
NEPHRONOPHTHISIS 11; NPHP11	0.00120482	0.04520020812459503
FARBER DISEASE	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.00120482	0.04520020812459503
CORNEAL DYSTROPHY-PERCEPTIVE DEAFNESS SYNDROME	0.00120482	0.04520020812459503
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.00120482	0.04520020812459503
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.00120482	0.04520020812459503
PARAPLEGIA-INTELLECTUAL DISABILITY-HYPERKERATOSIS SYNDROME	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA 18	0.00120482	0.04520020812459503
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.00120482	0.04520020812459503
NYSTAGMUS, VOLUNTARY	0.00120482	0.04520020812459503
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.00120482	0.04520020812459503
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.00120482	0.04520020812459503
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.00120482	0.04520020812459503
EPISODIC ATAXIA TYPE 7	0.00120482	0.04520020812459503
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA TYPE 2	0.00120482	0.04520020812459503
GORLIN-CHAUDHRY-MOSS SYNDROME	0.00120482	0.04520020812459503
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.00120482	0.04520020812459503
COLOBOMA, OCULAR	0.00120482	0.04520020812459503
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00120482	0.04520020812459503
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.00120482	0.04520020812459503
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA TYPE 29	0.00120482	0.04520020812459503
TERATOMA, PINEAL	0.00120482	0.04520020812459503
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.00120482	0.04520020812459503
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.00120482	0.04520020812459503
ATAXIA WITH VITAMIN E DEFICIENCY	0.00120482	0.04520020812459503
ACRO-RENAL-OCULAR SYNDROME	0.00120482	0.04520020812459503
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 60	0.00120482	0.04520020812459503
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.00120482	0.04520020812459503
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA 20	0.00120482	0.04520020812459503
EPISODIC ATAXIA WITH SLURRED SPEECH	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA TYPE 31	0.00120482	0.04520020812459503
PETERS ANOMALY	0.00120482	0.04520020812459503
OCULOCUTANEOUS ALBINISM TYPE 5	0.00120482	0.04520020812459503
JOUBERT SYNDROME 3; JBTS3	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.00120482	0.04520020812459503
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.00120482	0.04520020812459503
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.00120482	0.04520020812459503
SPASTIC PARAPLEGIA TYPE 7	0.00120482	0.04520020812459503
SCLEROSTEOSIS 1; SOST1	0.00120482	0.04520020812459503
CONGENITAL STATIONARY NIGHT BLINDNESS	0.00120482	0.04520020812459503
OPHTHALMOPLEGIA, FAMILIAL STATIC	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA 1	0.00120482	0.04520020812459503
JOUBERT SYNDROME 2	0.00120482	0.04520020812459503
MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM	0.00120482	0.04520020812459503
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.00120482	0.04520020812459503
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00120482	0.04520020812459503
GAPO SYNDROME	0.00120482	0.04520020812459503
CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA 14	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA 13	0.00120482	0.04520020812459503
FAMILIAL PAROXYSMAL ATAXIA	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA TYPE 1	0.00120482	0.04520020812459503
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.00120482	0.04520020812459503
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00120482	0.04520020812459503
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.00120482	0.04520020812459503
CONE-ROD DYSTROPHY, X-LINKED, 3	0.00120482	0.04520020812459503
BAKER-GORDON SYNDROME; BAGOS	0.00120482	0.04520020812459503
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00120482	0.04520020812459503
DISTAL TRISOMY 6P	0.00120482	0.04520020812459503
X-LINKED ENDOTHELIAL CORNEAL DYSTROPHY	0.00120482	0.04520020812459503
NOONAN SYNDROME	0.00120482	0.04520020812459503
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00120482	0.04520020812459503
LEBER CONGENITAL AMAUROSIS 5; LCA5	0.00120482	0.04520020812459503
SOTOS SYNDROME 2	0.00120482	0.04520020812459503
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00120482	0.04520020812459503
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.00120482	0.04520020812459503
WAARDENBURG-SHAH SYNDROME	0.00120482	0.04520020812459503
PEROXISOME BIOGENESIS DISORDER 6B	0.00120482	0.04520020812459503
LENTIGINES	0.00120482	0.04520020812459503
SPONDYLOOCULAR SYNDROME; SOS	0.00120482	0.04520020812459503
LEBER CONGENITAL AMAUROSIS 19; LCA19	0.00120482	0.04520020812459503
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.00120482	0.04520020812459503
MICROPHTHALMIA, ISOLATED, WITH CATARACT 1	0.00120482	0.04520020812459503
RETINITIS PIGMENTOSA 12; RP12	0.00120482	0.04520020812459503
SENIOR-LOKEN SYNDROME 3	0.00120482	0.04520020812459503
RETINITIS PIGMENTOSA 14	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA TYPE 38	0.00120482	0.04520020812459503
OLIVER-MCFARLANE SYNDROME	0.00120482	0.04520020812459503
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.00120482	0.04520020812459503
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.00120482	0.04520020812459503
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.00120482	0.04520020812459503
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.00120482	0.04520020812459503
LARYNGEAL ABDUCTOR PARALYSIS WITH CEREBELLAR ATAXIA AND MOTOR NEUROPATHY	0.00120482	0.04520020812459503
CHANARIN-DORFMAN SYNDROME	0.00120482	0.04520020812459503
OROFACIODIGITAL SYNDROME VI	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.00120482	0.04520020812459503
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.00120482	0.04520020812459503
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.00120482	0.04520020812459503
REFSUM DISEASE	0.00120482	0.04520020812459503
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.00120482	0.04520020812459503
SYRINGOMYELIA, ISOLATED	0.00120482	0.04520020812459503
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA TYPE 26	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA TYPE 25	0.00120482	0.04520020812459503
AUTOSOMAL RECESSIVE SPINOCEREBELLAR ATAXIA-BLINDNESS-DEAFNESS SYNDROME	0.00120482	0.04520020812459503
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO WWOX DEFICIENCY	0.00120482	0.04520020812459503
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.00120482	0.04520020812459503
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.00120482	0.04520020812459503
NYSTAGMUS, MYOCLONIC	0.00120482	0.04520020812459503
JOUBERT SYNDROME 32; JBTS32	0.00120482	0.04520020812459503
JOUBERT SYNDROME 31; JBTS31	0.00120482	0.04520020812459503
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA TYPE 28	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA 45; SCA45	0.00120482	0.04520020812459503
JOUBERT SYNDROME 4	0.00120482	0.04520020812459503
%615312 ALBINISM, OCULOCUTANEOUS, TYPE V; OCA5	0.00120482	0.04520020812459503
ANTERIOR SEGMENT DYSGENESIS 2; ASGD2	0.00120482	0.04520020812459503
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00120482	0.04520020812459503
AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA	0.00120482	0.04520020812459503
USHER SYNDROME TYPE 2	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26	0.00120482	0.04520020812459503
JOUBERT SYNDROME 5	0.00120482	0.04520020812459503
FETAL IODINE SYNDROME	0.00120482	0.04520020812459503
TREMOR, NYSTAGMUS, AND DUODENAL ULCER	0.00120482	0.04520020812459503
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.00120482	0.04520020812459503
ALAND ISLAND EYE DISEASE	0.00120482	0.04520020812459503
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.00120482	0.04520020812459503
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.00120482	0.04520020812459503
%108650 SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7;;SPASTIC ATAXIA WITH CONGENITAL MIOSIS;;MIOSIS, CONGENITAL, WITH SPASTIC ATAXIA	0.00120482	0.04520020812459503
RED SKIN PIGMENT ANOMALY OF NEW GUINEA	0.00120482	0.04520020812459503
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00120482	0.04520020812459503
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00120482	0.04520020812459503
AMAUROSIS-HYPERTRICHOSIS SYNDROME	0.00120482	0.04520020812459503
SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA 26	0.00120482	0.04520020812459503
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.00120482	0.04520020812459503
FOVEAL HYPOPLASIA-PRESENILE CATARACT SYNDROME	0.00120482	0.04520020812459503
ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6	0.00120482	0.04520020812459503
%300589 NYSTAGMUS 5, CONGENITAL, X-LINKED; NYS5	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA TYPE 7	0.00120482	0.04520020812459503
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA TYPE 3	0.00120482	0.04520020812459503
FRIEDREICH ATAXIA	0.00120482	0.04520020812459503
X-LINKED SPASTIC PARAPLEGIA TYPE 16	0.00120482	0.04520020812459503
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.00120482	0.04520020812459503
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00120482	0.04520020812459503
REVESZ SYNDROME	0.00120482	0.04520020812459503
SPASTIC PARAPLEGIA TYPE 2	0.00120482	0.04520020812459503
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 59	0.00120482	0.04520020812459503
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA TYPE 8	0.00120482	0.04520020812459503
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH HYPERCALCIURIA AND NEPHROCALCINOSIS WITH SEVERE OCULAR INVOLVEMENT	0.00120482	0.04520020812459503
EXUDATIVE VITREORETINOPATHY 7; EVR7	0.00120482	0.04520020812459503
CHIARI MALFORMATION TYPE I	0.00120482	0.04520020812459503
DIENCEPHALIC SYNDROME	0.00120482	0.04520020812459503
CEREBELLAR ATAXIA, CAYMAN TYPE	0.00120482	0.04520020812459503
NANCE-HORAN SYNDROME	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA 46; SCA46	0.00120482	0.04520020812459503
FOVEAL HYPOPLASIA 2; FVH2	0.00120482	0.04520020812459503
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.00120482	0.04520020812459503
CEREBELLAR HYPOPLASIA-TAPETORETINAL DEGENERATION SYNDROME	0.00120482	0.04520020812459503
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.00120482	0.04520020812459503
183800 SPLIT-HAND WITH CONGENITAL NYSTAGMUS, FUNDAL CHANGES, AND CATARACTS;;NYSTAGMUS-SPLIT HAND SYNDROME;;KARSCH-NEUGEBAUER SYNDROME; KNS	0.00120482	0.04520020812459503
OCULOCUTANEOUS ALBINISM TYPE 6	0.00120482	0.04520020812459503
BRANCHIAL MYOCLONUS WITH SPASTIC PARAPARESIS AND CEREBELLAR ATAXIA	0.00120482	0.04520020812459503
OCULAR ALBINISM	0.00120482	0.04520020812459503
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.00075643	0.028378341521295647
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00075643	0.028378341521295647
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.00075643	0.028378341521295647
RHIZOMELIC SYNDROME, URBACH TYPE	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00075643	0.028378341521295647
HOLOPROSENCEPHALY-RADIAL HEART RENAL ANOMALIES SYNDROME	0.00075643	0.028378341521295647
RENAL TUBULAR DYSGENESIS	0.00075643	0.028378341521295647
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00075643	0.028378341521295647
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.00075643	0.028378341521295647
ALAZAMI SYNDROME; ALAZS	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00075643	0.028378341521295647
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30	0.00075643	0.028378341521295647
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.028378341521295647
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.00075643	0.028378341521295647
STIMMLER SYNDROME	0.00075643	0.028378341521295647
HOLOPROSENCEPHALY 11	0.00075643	0.028378341521295647
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.00075643	0.028378341521295647
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00075643	0.028378341521295647
STROMME SYNDROME; STROMS	0.00075643	0.028378341521295647
ADAMS-OLIVER SYNDROME 3; AOS3	0.00075643	0.028378341521295647
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00075643	0.028378341521295647
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.00075643	0.028378341521295647
ERYTHROKERATODERMIA VARIABILIS	0.00075643	0.028378341521295647
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00075643	0.028378341521295647
FEINGOLD SYNDROME 2; FGLDS2	0.00075643	0.028378341521295647
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.00075643	0.028378341521295647
HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY	0.00075643	0.028378341521295647
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.00075643	0.028378341521295647
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.00075643	0.028378341521295647
JOHANSON-BLIZZARD SYNDROME; JBS	0.00075643	0.028378341521295647
SECKEL SYNDROME	0.00075643	0.028378341521295647
SATOYOSHI SYNDROME	0.00075643	0.028378341521295647
DISTAL 17P13.1 MICRODELETION SYNDROME	0.00075643	0.028378341521295647
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.00075643	0.028378341521295647
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.00075643	0.028378341521295647
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00075643	0.028378341521295647
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.00075643	0.028378341521295647
MENTAL RETARDATION, X-LINKED 63	0.00075643	0.028378341521295647
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.028378341521295647
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00075643	0.028378341521295647
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.00075643	0.028378341521295647
SCHISIS ASSOCIATION	0.00075643	0.028378341521295647
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.00075643	0.028378341521295647
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.00075643	0.028378341521295647
NIJMEGEN BREAKAGE SYNDROME	0.00075643	0.028378341521295647
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.00075643	0.028378341521295647
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.00075643	0.028378341521295647
DE SANCTIS-CACCHIONE SYNDROME	0.00075643	0.028378341521295647
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.00075643	0.028378341521295647
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.00075643	0.028378341521295647
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.00075643	0.028378341521295647
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.00075643	0.028378341521295647
OROFACIODIGITAL SYNDROME TYPE 14	0.00075643	0.028378341521295647
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.00075643	0.028378341521295647
LIG4 SYNDROME	0.00075643	0.028378341521295647
SECKEL SYNDROME 2; SCKL2	0.00075643	0.028378341521295647
RIDDLE SYNDROME	0.00075643	0.028378341521295647
SPINAL MUSCULAR ATROPHY WITH MICROCEPHALY AND MENTAL SUBNORMALITY	0.00075643	0.028378341521295647
SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION	0.00075643	0.028378341521295647
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.00075643	0.028378341521295647
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.00075643	0.028378341521295647
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.00075643	0.028378341521295647
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00075643	0.028378341521295647
RHIZOMELIC SYNDROME	0.00075643	0.028378341521295647
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00075643	0.028378341521295647
601453 TRICHODENTAL DYSPLASIA	0.00075643	0.028378341521295647
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.00075643	0.028378341521295647
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.00075643	0.028378341521295647
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00075643	0.028378341521295647
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.00075643	0.028378341521295647
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.00075643	0.028378341521295647
TONNE-KALSCHEUER SYNDROME; TOKAS	0.00075643	0.028378341521295647
BARATELA-SCOTT SYNDROME	0.00075643	0.028378341521295647
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.00075643	0.028378341521295647
OGDEN SYNDROME; OGDNS	0.00075643	0.028378341521295647
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00075643	0.028378341521295647
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.00075643	0.028378341521295647
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.00075643	0.028378341521295647
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.00075643	0.028378341521295647
MASA SYNDROME	0.00075643	0.028378341521295647
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.00075643	0.028378341521295647
LEPRECHAUNISM	0.00075643	0.028378341521295647
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.00075643	0.028378341521295647
%300712 CRANIOFACIOSKELETAL SYNDROME	0.00075643	0.028378341521295647
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.00075643	0.028378341521295647
KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY	0.00075643	0.028378341521295647
MECKEL SYNDROME	0.00075643	0.028378341521295647
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.00075643	0.028378341521295647
CHROMOSOME XP11.3 DELETION SYNDROME	0.00075643	0.028378341521295647
CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME	0.00075643	0.028378341521295647
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.00075643	0.028378341521295647
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00075643	0.028378341521295647
LOWRY-MACLEAN SYNDROME	0.00075643	0.028378341521295647
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00075643	0.028378341521295647
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.00075643	0.028378341521295647
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.00075643	0.028378341521295647
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00075643	0.028378341521295647
OCULOAURICULOFRONTONASAL SYNDROME	0.00075643	0.028378341521295647
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.00075643	0.028378341521295647
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.00075643	0.028378341521295647
MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE	0.00075643	0.028378341521295647
FACIOCARDIOMELIC SYNDROME	0.00075643	0.028378341521295647
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.00075643	0.028378341521295647
HADZISELIMOVIC SYNDROME	0.00075643	0.028378341521295647
WEAVER-WILLIAMS SYNDROME	0.00075643	0.028378341521295647
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00075643	0.028378341521295647
MMEP SYNDROME	0.00075643	0.028378341521295647
WARSAW BREAKAGE SYNDROME; WABS	0.00075643	0.028378341521295647
MECKEL SYNDROME, TYPE 1; MKS1	0.00075643	0.028378341521295647
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00075643	0.028378341521295647
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.00075643	0.028378341521295647
FRONTONASAL DYSPLASIA 2; FND2	0.00075643	0.028378341521295647
HOYERAAL-HREIDARSSON SYNDROME	0.00075643	0.028378341521295647
FORSYTHE-WAKELING SYNDROME; FWS	0.00075643	0.028378341521295647
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00075643	0.028378341521295647
TETRAPLOIDY	0.00075643	0.028378341521295647
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00075643	0.028378341521295647
SECKEL SYNDROME 4	0.00075643	0.028378341521295647
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.00075643	0.028378341521295647
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.00075643	0.028378341521295647
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO ZNF335 DEFICIENCY	0.00075643	0.028378341521295647
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.00075643	0.028378341521295647
HUMERO-RADIAL SYNOSTOSIS	0.00075643	0.028378341521295647
MEIER-GORLIN SYNDROME 3; MGORS3	0.00075643	0.028378341521295647
MEIER-GORLIN SYNDROME 5; MGORS5	0.00075643	0.028378341521295647
SECKEL SYNDROME 5; SCKL5	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.00075643	0.028378341521295647
LAMBOTTE SYNDROME	0.00075643	0.028378341521295647
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.00075643	0.028378341521295647
XK APROSENCEPHALY SYNDROME	0.00075643	0.028378341521295647
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00075643	0.028378341521295647
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00075643	0.028378341521295647
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.00075643	0.028378341521295647
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.00075643	0.028378341521295647
GOLDBERG-SHPRINTZEN SYNDROME	0.00075643	0.028378341521295647
HOLOPROSENCEPHALY 5; HPE5	0.00075643	0.028378341521295647
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.00075643	0.028378341521295647
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00075643	0.028378341521295647
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.00075643	0.028378341521295647
PSEUDOTRISOMY 13 SYNDROME	0.00075643	0.028378341521295647
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.00075643	0.028378341521295647
XYLT1-CDG	0.00075643	0.028378341521295647
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.00075643	0.028378341521295647
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.00075643	0.028378341521295647
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00075643	0.028378341521295647
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.00075643	0.028378341521295647
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.00075643	0.028378341521295647
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00075643	0.028378341521295647
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00075643	0.028378341521295647
3MC SYNDROME 1	0.00075643	0.028378341521295647
OCULOPALATOCEREBRAL SYNDROME	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.00075643	0.028378341521295647
MECKEL SYNDROME, TYPE 4; MKS4	0.00075643	0.028378341521295647
MUCOLIPIDOSIS IV; ML4	0.00075643	0.028378341521295647
NIJMEGEN BREAKAGE SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.00075643	0.028378341521295647
FONTAINE PROGEROID SYNDROME; FPS	0.00075643	0.028378341521295647
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.00075643	0.028378341521295647
MICROCEPHALY-CARDIOMYOPATHY	0.00075643	0.028378341521295647
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00075643	0.028378341521295647
CHROMOSOME 1Q21.1 DELETION SYNDROME, 1.35-MB	0.00075643	0.028378341521295647
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.00075643	0.028378341521295647
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.00075643	0.028378341521295647
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.00075643	0.028378341521295647
MEIER-GORLIN SYNDROME 8; MGORS8	0.00075643	0.028378341521295647
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.00075643	0.028378341521295647
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.00075643	0.028378341521295647
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.00075643	0.028378341521295647
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP U	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00075643	0.028378341521295647
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.00075643	0.028378341521295647
HEREDITARY BULLOUS DYSTROPHY, MACULAR TYPE	0.00075643	0.028378341521295647
SEVERE COMBINED IMMUNODEFICIENCY	0.00075643	0.028378341521295647
2Q32Q33 MICRODELETION SYNDROME	0.00075643	0.028378341521295647
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.00075643	0.028378341521295647
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00075643	0.028378341521295647
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.00075643	0.028378341521295647
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.00075643	0.028378341521295647
MICROCEPHALY-ALBINISM-DIGITAL ANOMALIES SYNDROME	0.00075643	0.028378341521295647
ACHALASIA-MICROCEPHALY SYNDROME	0.00075643	0.028378341521295647
DYSTONIA 28, CHILDHOOD-ONSET	0.00075643	0.028378341521295647
MÜLLERIAN DUCT ANOMALIES-LIMB ANOMALIES SYNDROME	0.00075643	0.028378341521295647
HYPO- AND HYPERMELANOTIC CUTANEOUS MACULES-RETARDED GROWTH-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.028378341521295647
TOLUENE EMBRYOPATHY	0.00075643	0.028378341521295647
PHENOBARBITAL EMBRYOPATHY	0.00075643	0.028378341521295647
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.00075643	0.028378341521295647
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00075643	0.028378341521295647
46,XX GONADAL DYSGENESIS	0.00075643	0.028378341521295647
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	0.00075643	0.028378341521295647
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.00075643	0.028378341521295647
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.00075643	0.028378341521295647
OPTIC ATROPHY 11; OPA11	0.00075643	0.028378341521295647
FETAL METHYLMERCURY SYNDROME	0.00075643	0.028378341521295647
FETAL ALCOHOL SYNDROME	0.00075643	0.028378341521295647
FETAL TRIMETHADIONE SYNDROME	0.00075643	0.028378341521295647
FETAL HYDANTOIN SYNDROME	0.00075643	0.028378341521295647
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00075643	0.028378341521295647
AUTOSOMAL DOMINANT PRIMARY MICROCEPHALY	0.00075643	0.028378341521295647
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.00075643	0.028378341521295647
DIABETIC EMBRYOPATHY	0.00075643	0.028378341521295647
MICROPHTHALMIA, SYNDROMIC 3	0.00075643	0.028378341521295647
FRASER SYNDROME	0.00075643	0.028378341521295647
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00075643	0.028378341521295647
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.00075643	0.028378341521295647
BLOOM SYNDROME	0.00075643	0.028378341521295647
WILLIAMS SYNDROME	0.00075643	0.028378341521295647
BOWEN-CONRADI SYNDROME	0.00075643	0.028378341521295647
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.00075643	0.028378341521295647
KLIPPEL-TRÉNAUNAY SYNDROME	0.00075643	0.028378341521295647
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.00075643	0.028378341521295647
CARDIAC LIPIDOSIS, FAMILIAL	0.00075643	0.028378341521295647
CRI-DU-CHAT SYNDROME	0.00075643	0.028378341521295647
MEIER-GORLIN SYNDROME 6; MGORS6	0.00075643	0.028378341521295647
MARTSOLF SYNDROME	0.00075643	0.028378341521295647
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00075643	0.028378341521295647
SECKEL SYNDROME 9; SCKL9	0.00075643	0.028378341521295647
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.00075643	0.028378341521295647
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.00075643	0.028378341521295647
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00075643	0.028378341521295647
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00075643	0.028378341521295647
207790 ARACHNOID CYSTS, INTRACRANIAL	0.00075643	0.028378341521295647
GROWTH HORMONE INSENSITIVITY SYNDROME	0.00075643	0.028378341521295647
TURNPENNY-FRY SYNDROME; TPFS	0.00075643	0.028378341521295647
ALAZAMI-YUAN SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00075643	0.028378341521295647
DYSOSTOSIS, STANESCU TYPE	0.00075643	0.028378341521295647
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.00075643	0.028378341521295647
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00075643	0.028378341521295647
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.028378341521295647
BARDET-BIEDL SYNDROME 20	0.00075643	0.028378341521295647
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATIONAND MICROCEPHALY	0.00075643	0.028378341521295647
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00075643	0.028378341521295647
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.00075643	0.028378341521295647
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.00075643	0.028378341521295647
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.00075643	0.028378341521295647
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.00075643	0.028378341521295647
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.00075643	0.028378341521295647
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00075643	0.028378341521295647
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00075643	0.028378341521295647
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00075643	0.028378341521295647
17Q21.31 MICRODUPLICATION SYNDROME	0.00075643	0.028378341521295647
19Q13.11 MICRODELETION SYNDROME	0.00075643	0.028378341521295647
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00075643	0.028378341521295647
RUVALCABA SYNDROME	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.00075643	0.028378341521295647
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.00075643	0.028378341521295647
SAY SYNDROME	0.00075643	0.028378341521295647
IMMUNODEFICIENCY 55; IMD55	0.00075643	0.028378341521295647
ACROCRANIOFACIAL DYSOSTOSIS	0.00075643	0.028378341521295647
FEINGOLD SYNDROME 1; FGLDS1	0.00075643	0.028378341521295647
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00075643	0.028378341521295647
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.00075643	0.028378341521295647
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.00075643	0.028378341521295647
FRYNS-SMEETS-THIRY SYNDROME	0.00075643	0.028378341521295647
GENITOPALATOCARDIAC SYNDROME	0.00075643	0.028378341521295647
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.00075643	0.028378341521295647
MONOSOMY 13Q34	0.00075643	0.028378341521295647
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00075643	0.028378341521295647
MICROCEPHALY, AUTOSOMAL DOMINANT	0.00075643	0.028378341521295647
GMS SYNDROME	0.00075643	0.028378341521295647
VERVERI-BRADY SYNDROME; VERBRAS	0.00075643	0.028378341521295647
RING CHROMOSOME 13 SYNDROME	0.00075643	0.028378341521295647
BRAIN-LUNG-THYROID SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE; MCPH23	0.00075643	0.028378341521295647
DISTAL TRISOMY 5Q	0.00075643	0.028378341521295647
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00075643	0.028378341521295647
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00075643	0.028378341521295647
LARYNGEAL ABDUCTOR PARALYSIS	0.00075643	0.028378341521295647
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.00075643	0.028378341521295647
HOLOPROSENCEPHALY 3; HPE3	0.00075643	0.028378341521295647
HYPERTRICHOSIS CUBITI	0.00075643	0.028378341521295647
JOHANSON-BLIZZARD SYNDROME	0.00075643	0.028378341521295647
JOHNSON NEUROECTODERMAL SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.00075643	0.028378341521295647
TRIGLYCERIDE STORAGE DISEASE, TYPE I	0.00075643	0.028378341521295647
JUBERG-HAYWARD SYNDROME	0.00075643	0.028378341521295647
JUNG SYNDROME	0.00075643	0.028378341521295647
HYPERREFLEXIA	0.00075643	0.028378341521295647
VELOCARDIOFACIAL SYNDROME	0.00075643	0.028378341521295647
KERATOSIS FOLLICULARIS-DWARFISM-CEREBRAL ATROPHY SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY 18, PRIMARY, AUTOSOMAL DOMINANT; MCPH18	0.00075643	0.028378341521295647
TRISOMY 9P	0.00075643	0.028378341521295647
LARYNGEAL ABDUCTOR PARALYSIS-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.028378341521295647
ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION	0.00075643	0.028378341521295647
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00075643	0.028378341521295647
ACHALASIA-MICROCEPHALY SYNDROME	0.00075643	0.028378341521295647
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.00075643	0.028378341521295647
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.00075643	0.028378341521295647
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00075643	0.028378341521295647
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.00075643	0.028378341521295647
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.00075643	0.028378341521295647
MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24	0.00075643	0.028378341521295647
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00075643	0.028378341521295647
PRIMARY PULMONARY HYPOPLASIA	0.00075643	0.028378341521295647
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.00075643	0.028378341521295647
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.00075643	0.028378341521295647
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.00075643	0.028378341521295647
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.00075643	0.028378341521295647
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00075643	0.028378341521295647
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00075643	0.028378341521295647
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.00075643	0.028378341521295647
HOLMES-GANG SYNDROME	0.00075643	0.028378341521295647
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.00075643	0.028378341521295647
TRISOMY 18P	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.00075643	0.028378341521295647
ENCEPHALOMALACIA, MULTILOCULAR	0.00075643	0.028378341521295647
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00075643	0.028378341521295647
BLOOM SYNDROME	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00075643	0.028378341521295647
FANCONI ANEMIA	0.00075643	0.028378341521295647
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00075643	0.028378341521295647
BONNEMANN-MEINECKE-REICH SYNDROME	0.00075643	0.028378341521295647
SECKEL SYNDROME 8; SCKL8	0.00075643	0.028378341521295647
RECURRENT 16P12.1 MICRODELETION (NEURODEVELOPMENTAL SUSCEPTIBILITY LOCUS)	0.00075643	0.028378341521295647
DESBUQUOIS DYSPLASIA 2; DBQD2	0.00075643	0.028378341521295647
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00075643	0.028378341521295647
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.00075643	0.028378341521295647
12Q14 MICRODELETION SYNDROME	0.00075643	0.028378341521295647
CRANIOTELENCEPHALIC DYSPLASIA	0.00075643	0.028378341521295647
FEINGOLD SYNDROME	0.00075643	0.028378341521295647
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00075643	0.028378341521295647
PIEBALDISM	0.00075643	0.028378341521295647
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.00075643	0.028378341521295647
BARTSOCAS-PAPAS SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE; MCPH12	0.00075643	0.028378341521295647
MONOSOMY 5P	0.00075643	0.028378341521295647
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.00075643	0.028378341521295647
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.00075643	0.028378341521295647
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.00075643	0.028378341521295647
CONGENITAL OSTEOGENESIS IMPERFECTA-MICROCEPHALY-CATARACTS SYNDROME	0.00075643	0.028378341521295647
NEU-LAXOVA SYNDROME 2; NLS2	0.00075643	0.028378341521295647
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.00075643	0.028378341521295647
DISTAL MONOSOMY 17Q	0.00075643	0.028378341521295647
DISTAL MONOSOMY 13Q	0.00075643	0.028378341521295647
MONOSOMY 13Q14	0.00075643	0.028378341521295647
LIG4 SYNDROME	0.00075643	0.028378341521295647
DISTAL MONOSOMY 10P	0.00075643	0.028378341521295647
OROFACIODIGITAL SYNDROME XIV; OFD14	0.00075643	0.028378341521295647
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00075643	0.028378341521295647
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.00075643	0.028378341521295647
DIAMOND-BLACKFAN ANEMIA 1	0.00075643	0.028378341521295647
1Q21.1 RECURRENT MICRODELETION (SUSCEPTIBILITY LOCUS FOR NEURODEVELOPMENTAL DISORDERS)	0.00075643	0.028378341521295647
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.00075643	0.028378341521295647
CAREY-FINEMAN-ZITER SYNDROME	0.00075643	0.028378341521295647
BRESEK SYNDROME	0.00075643	0.028378341521295647
CRI DU CHAT SYNDROME (5P DELETION)	0.00075643	0.028378341521295647
RING CHROMOSOME 1 SYNDROME	0.00075643	0.028378341521295647
CEREBROCOSTOMANDIBULAR SYNDROME	0.00075643	0.028378341521295647
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.00075643	0.028378341521295647
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.00075643	0.028378341521295647
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00075643	0.028378341521295647
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.00075643	0.028378341521295647
OTOMANDIBULAR SYNDROME	0.00075643	0.028378341521295647
ACROOTOOCULAR SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALIC OSTEODYSPLASTIC DYSPLASIA, SAUL-WILSON TYPE	0.00075643	0.028378341521295647
PSEUDOPROGERIA SYNDROME	0.00075643	0.028378341521295647
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.00075643	0.028378341521295647
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.00075643	0.028378341521295647
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 2; CEMCOX2	0.00075643	0.028378341521295647
RING CHROMOSOME 12 SYNDROME	0.00075643	0.028378341521295647
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.00075643	0.028378341521295647
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.00075643	0.028378341521295647
9Q SUBTELOMERIC DELETION SYNDROME	0.00075643	0.028378341521295647
MICROTRIPLICATION 11Q24.1	0.00075643	0.028378341521295647
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.00075643	0.028378341521295647
3Q29 MICRODELETION SYNDROME	0.00075643	0.028378341521295647
MILLER-DIEKER SYNDROME (MDS)	0.00075643	0.028378341521295647
RING CHROMOSOME 7 SYNDROME	0.00075643	0.028378341521295647
CONGENITAL VARICELLA SYNDROME	0.00075643	0.028378341521295647
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.00075643	0.028378341521295647
POLAND SYNDROME	0.00075643	0.028378341521295647
OROFACIODIGITAL SYNDROME TYPE 5	0.00075643	0.028378341521295647
HARTSFIELD SYNDROME; HRTFDS	0.00075643	0.028378341521295647
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.00075643	0.028378341521295647
RING CHROMOSOME 6 SYNDROME	0.00075643	0.028378341521295647
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00075643	0.028378341521295647
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00075643	0.028378341521295647
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.00075643	0.028378341521295647
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.00075643	0.028378341521295647
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00075643	0.028378341521295647
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.00075643	0.028378341521295647
CHARGE SYNDROME	0.00075643	0.028378341521295647
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.00075643	0.028378341521295647
LETHAL HEMOLYTIC ANEMIA-GENITAL ANOMALIES SYNDROME	0.00075643	0.028378341521295647
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.00075643	0.028378341521295647
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.00075643	0.028378341521295647
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.00075643	0.028378341521295647
DUBOWITZ SYNDROME	0.00075643	0.028378341521295647
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.028378341521295647
YUNIS-VARON SYNDROME	0.00075643	0.028378341521295647
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.00075643	0.028378341521295647
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.00075643	0.028378341521295647
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.00075643	0.028378341521295647
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00075643	0.028378341521295647
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00075643	0.028378341521295647
NON-DISTAL TRISOMY 13Q	0.00075643	0.028378341521295647
ISOLATED OSTEOPOIKILOSIS	0.00075643	0.028378341521295647
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.00075643	0.028378341521295647
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.00075643	0.028378341521295647
PAGOD SYNDROME	0.00075643	0.028378341521295647
NON-DISTAL TRISOMY 10Q	0.00075643	0.028378341521295647
OCULO-PALATO-CEREBRAL SYNDROME	0.00075643	0.028378341521295647
CRANIOSYNOSTOSIS 6; CRS6	0.00075643	0.028378341521295647
AL-RAQAD SYNDROME; ARS	0.00075643	0.028378341521295647
CEREBELLOFACIODENTAL SYNDROME	0.00075643	0.028378341521295647
TOWNES-BROCKS SYNDROME 1; TBS1	0.00075643	0.028378341521295647
COFFIN-SIRIS SYNDROME 10; CSS10	0.00075643	0.028378341521295647
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.00075643	0.028378341521295647
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00075643	0.028378341521295647
CERNUNNOS-XLF DEFICIENCY	0.00075643	0.028378341521295647
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.00075643	0.028378341521295647
17P11.2 MICRODUPLICATION SYNDROME	0.00075643	0.028378341521295647
ANONYCHIA-MICROCEPHALY SYNDROME	0.00075643	0.028378341521295647
OKAMOTO SYNDROME	0.00075643	0.028378341521295647
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00075643	0.028378341521295647
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.00075643	0.028378341521295647
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.00075643	0.028378341521295647
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.00075643	0.028378341521295647
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.00075643	0.028378341521295647
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.00075643	0.028378341521295647
49,XXXXY SYNDROME	0.000541419	0.020311956543392472
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.000541419	0.020311956543392472
48,XXXY SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 91; MRX91	0.000541419	0.020311956543392472
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.020311956543392472
DARIER-WHITE DISEASE; DAR	0.000541419	0.020311956543392472
MYASTHENIA GRAVIS	0.000541419	0.020311956543392472
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.020311956543392472
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000541419	0.020311956543392472
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000541419	0.020311956543392472
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.020311956543392472
ATYPICAL TERATOID RHABDOID TUMOR	0.000541419	0.020311956543392472
THYROCEREBRORETINAL SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 82	0.000541419	0.020311956543392472
9Q21.13 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
MUCOPOLYSACCHARIDOSIS TYPE 3	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 101; MRX101	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.020311956543392472
MUSCLE-EYE-BRAIN DISEASE	0.000541419	0.020311956543392472
1P36 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000541419	0.020311956543392472
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.020311956543392472
CROUZON SYNDROME	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.000541419	0.020311956543392472
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.020311956543392472
WYBURN-MASON SYNDROME	0.000541419	0.020311956543392472
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.000541419	0.020311956543392472
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.020311956543392472
ONDINE SYNDROME	0.000541419	0.020311956543392472
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000541419	0.020311956543392472
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.020311956543392472
HUNTINGTON DISEASE; HD	0.000541419	0.020311956543392472
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.020311956543392472
CLARK-BARAITSER SYNDROME	0.000541419	0.020311956543392472
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.020311956543392472
DERMOTRICHIC SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.020311956543392472
ADRENOLEUKODYSTROPHY	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.020311956543392472
NETHERTON SYNDROME	0.000541419	0.020311956543392472
RAYNAUD-CLAES SYNDROME; MRXSRC	0.000541419	0.020311956543392472
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 21	0.000541419	0.020311956543392472
HADDAD SYNDROME	0.000541419	0.020311956543392472
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 72	0.000541419	0.020311956543392472
FAMILIAL MULTIPLE NEVI FLAMMEI	0.000541419	0.020311956543392472
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.020311956543392472
FLYNN-AIRD SYNDROME	0.000541419	0.020311956543392472
ZIMMERMANN-LABAND SYNDROME 1	0.000541419	0.020311956543392472
CENTRONUCLEAR MYOPATHY	0.000541419	0.020311956543392472
NIEMANN-PICK DISEASE TYPE C	0.000541419	0.020311956543392472
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000541419	0.020311956543392472
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.020311956543392472
LHERMITTE-DUCLOS DISEASE	0.000541419	0.020311956543392472
X-LINKED CENTRONUCLEAR MYOPATHY	0.000541419	0.020311956543392472
CRANIOPHARYNGIOMA	0.000541419	0.020311956543392472
EPILEPSY, READING	0.000541419	0.020311956543392472
2Q33.1 DELETION SYNDROME	0.000541419	0.020311956543392472
ATKIN-FLAITZ SYNDROME	0.000541419	0.020311956543392472
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.020311956543392472
POSTENCEPHALITIC PARKINSONISM	0.000541419	0.020311956543392472
ADAMS-OLIVER SYNDROME	0.000541419	0.020311956543392472
ADRENOMYODYSTROPHY	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 88	0.000541419	0.020311956543392472
PALLISTER-HALL SYNDROME	0.000541419	0.020311956543392472
RECURRENT ACUTE PANCREATITIS	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 90	0.000541419	0.020311956543392472
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.020311956543392472
NEUROFIBROMATOSIS, TYPE II	0.000541419	0.020311956543392472
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.000541419	0.020311956543392472
PAPILLORENAL SYNDROME	0.000541419	0.020311956543392472
TAY-SACHS DISEASE	0.000541419	0.020311956543392472
THREONINEMIA	0.000541419	0.020311956543392472
LIPOID PROTEINOSIS	0.000541419	0.020311956543392472
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.000541419	0.020311956543392472
TEMTAMY SYNDROME; TEMTYS	0.000541419	0.020311956543392472
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000541419	0.020311956543392472
ECTODERMAL DYSPLASIA SYNDROME	0.000541419	0.020311956543392472
SAETHRE-CHOTZEN SYNDROME	0.000541419	0.020311956543392472
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.000541419	0.020311956543392472
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.000541419	0.020311956543392472
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.000541419	0.020311956543392472
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.000541419	0.020311956543392472
KIFAFA SEIZURE DISORDER	0.000541419	0.020311956543392472
KETOADIPICACIDURIA	0.000541419	0.020311956543392472
DIAMINOPENTANURIA	0.000541419	0.020311956543392472
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.000541419	0.020311956543392472
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.000541419	0.020311956543392472
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.000541419	0.020311956543392472
DYSOSTEOSCLEROSIS	0.000541419	0.020311956543392472
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.020311956543392472
MOGS-CDG	0.000541419	0.020311956543392472
ALG9-CDG	0.000541419	0.020311956543392472
LANDAU-KLEFFNER SYNDROME	0.000541419	0.020311956543392472
GRISCELLI SYNDROME, TYPE 1	0.000541419	0.020311956543392472
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.020311956543392472
ACUTE INTERMITTENT PORPHYRIA	0.000541419	0.020311956543392472
HEREDITARY FOLATE MALABSORPTION	0.000541419	0.020311956543392472
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.000541419	0.020311956543392472
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.000541419	0.020311956543392472
CEREBELLOPARENCHYMAL DISORDER II	0.000541419	0.020311956543392472
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.000541419	0.020311956543392472
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000541419	0.020311956543392472
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.000541419	0.020311956543392472
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.020311956543392472
ARGININEMIA	0.000541419	0.020311956543392472
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.000541419	0.020311956543392472
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000541419	0.020311956543392472
CITRULLINEMIA, CLASSIC	0.000541419	0.020311956543392472
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.000541419	0.020311956543392472
L-2-HYDROXYGLUTARIC ACIDURIA	0.000541419	0.020311956543392472
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.020311956543392472
MPDU1-CDG	0.000541419	0.020311956543392472
PORPHYRIA VARIEGATA	0.000541419	0.020311956543392472
EPILEPSY-TELANGIECTASIA	0.000541419	0.020311956543392472
DISTAL MONOSOMY 19P13.3	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.000541419	0.020311956543392472
HYPERPROLINEMIA, TYPE II	0.000541419	0.020311956543392472
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.020311956543392472
ISOLATED SPINA BIFIDA	0.000541419	0.020311956543392472
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.000541419	0.020311956543392472
GAUCHER DISEASE, TYPE IIIC	0.000541419	0.020311956543392472
HYPERLYSINEMIA, TYPE I	0.000541419	0.020311956543392472
KEUTEL SYNDROME	0.000541419	0.020311956543392472
HYPERLEUCINE-ISOLEUCINEMIA	0.000541419	0.020311956543392472
BERNARD-SOULIER SYNDROME	0.000541419	0.020311956543392472
HYPER-BETA-ALANINEMIA	0.000541419	0.020311956543392472
SCRUB TYPHUS	0.000541419	0.020311956543392472
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.020311956543392472
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392472
ENCEPHALITIS LETHARGICA	0.000541419	0.020311956543392472
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.000541419	0.020311956543392472
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.000541419	0.020311956543392472
GLUTARIC ACIDEMIA I; GA1	0.000541419	0.020311956543392472
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.000541419	0.020311956543392472
GAUCHER DISEASE, TYPE II	0.000541419	0.020311956543392472
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392472
SCHIZENCEPHALY	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.000541419	0.020311956543392472
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.020311956543392472
VISCERAL STEATOSIS, CONGENITAL	0.000541419	0.020311956543392472
GRISCELLI SYNDROME TYPE 2	0.000541419	0.020311956543392472
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.020311956543392472
FOLATE MALABSORPTION, HEREDITARY	0.000541419	0.020311956543392472
SANDHOFF DISEASE	0.000541419	0.020311956543392472
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.000541419	0.020311956543392472
HYPOADRENOCORTICISM, FAMILIAL	0.000541419	0.020311956543392472
47,XYY SYNDROME	0.000541419	0.020311956543392472
HYPOPHOSPHATASIA, INFANTILE	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.020311956543392472
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.000541419	0.020311956543392472
FOUNTAIN SYNDROME	0.000541419	0.020311956543392472
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000541419	0.020311956543392472
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.020311956543392472
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.020311956543392472
HEREDITARY COPROPORPHYRIA	0.000541419	0.020311956543392472
MAPLE SYRUP URINE DISEASE; MSUD	0.000541419	0.020311956543392472
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.020311956543392472
MEGALENCEPHALY WITH DYSMYELINATION	0.000541419	0.020311956543392472
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.020311956543392472
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.000541419	0.020311956543392472
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.000541419	0.020311956543392472
SMITH-FINEMAN-MYERS SYNDROME	0.000541419	0.020311956543392472
RAMON SYNDROME	0.000541419	0.020311956543392472
PYRUVATE CARBOXYLASE DEFICIENCY	0.000541419	0.020311956543392472
DIGEORGE SYNDROME; DGS	0.000541419	0.020311956543392472
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000541419	0.020311956543392472
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.020311956543392472
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.000541419	0.020311956543392472
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.000541419	0.020311956543392472
HARTNUP DISORDER	0.000541419	0.020311956543392472
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.020311956543392472
PROTEUS SYNDROME	0.000541419	0.020311956543392472
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000541419	0.020311956543392472
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.000541419	0.020311956543392472
PEHO SYNDROME; PEHO	0.000541419	0.020311956543392472
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.020311956543392472
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.000541419	0.020311956543392472
RAPID-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.020311956543392472
STURGE-WEBER SYNDROME	0.000541419	0.020311956543392472
FAMILIAL THROMBOCYTOSIS	0.000541419	0.020311956543392472
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.020311956543392472
7Q11.23 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392472
TAY-SACHS DISEASE; TSD	0.000541419	0.020311956543392472
GM2-GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.020311956543392472
SULFOCYSTEINURIA	0.000541419	0.020311956543392472
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000541419	0.020311956543392472
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.020311956543392472
PARIETAL FORAMINA	0.000541419	0.020311956543392472
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.000541419	0.020311956543392472
PARTINGTON SYNDROME	0.000541419	0.020311956543392472
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000541419	0.020311956543392472
PITUITARY STALK INTERRUPTION SYNDROME	0.000541419	0.020311956543392472
PRADER-WILLI SYNDROME; PWS	0.000541419	0.020311956543392472
COG8-CDG	0.000541419	0.020311956543392472
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.000541419	0.020311956543392472
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.000541419	0.020311956543392472
SMITH-MAGENIS SYNDROME; SMS	0.000541419	0.020311956543392472
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.020311956543392472
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000541419	0.020311956543392472
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.000541419	0.020311956543392472
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000541419	0.020311956543392472
ARGININOSUCCINIC ACIDURIA	0.000541419	0.020311956543392472
METACHROMATIC LEUKODYSTROPHY	0.000541419	0.020311956543392472
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.000541419	0.020311956543392472
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.020311956543392472
CEREBROTENDINOUS XANTHOMATOSIS	0.000541419	0.020311956543392472
FRAGILE X SYNDROME	0.000541419	0.020311956543392472
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.000541419	0.020311956543392472
AUTISM	0.000541419	0.020311956543392472
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.000541419	0.020311956543392472
METHYLMALONIC ACIDURIA, CBLA TYPE	0.000541419	0.020311956543392472
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.000541419	0.020311956543392472
OHDO SYNDROME	0.000541419	0.020311956543392472
DEND SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.020311956543392472
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.000541419	0.020311956543392472
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000541419	0.020311956543392472
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.000541419	0.020311956543392472
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.020311956543392472
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.020311956543392472
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.000541419	0.020311956543392472
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.020311956543392472
ASPARTYLGLUCOSAMINURIA	0.000541419	0.020311956543392472
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.020311956543392472
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000541419	0.020311956543392472
THANATOPHORIC DYSPLASIA TYPE 2	0.000541419	0.020311956543392472
PFEIFFER SYNDROME TYPE 3	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.020311956543392472
RABIES	0.000541419	0.020311956543392472
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.020311956543392472
PFEIFFER SYNDROME TYPE 2	0.000541419	0.020311956543392472
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.000541419	0.020311956543392472
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.000541419	0.020311956543392472
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000541419	0.020311956543392472
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000541419	0.020311956543392472
ALEXANDER DISEASE	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000541419	0.020311956543392472
MONOSOMY 9Q22.3	0.000541419	0.020311956543392472
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000541419	0.020311956543392472
MILLER-DIEKER SYNDROME	0.000541419	0.020311956543392472
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.000541419	0.020311956543392472
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.000541419	0.020311956543392472
IMMUNODEFICIENCY 49; IMD49	0.000541419	0.020311956543392472
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.020311956543392472
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.000541419	0.020311956543392472
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.000541419	0.020311956543392472
SHASHI-PENA SYNDROME; SHAPNS	0.000541419	0.020311956543392472
EPENDYMOMA	0.000541419	0.020311956543392472
SUBEPENDYMOMA	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.000541419	0.020311956543392472
PINEOBLASTOMA	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.000541419	0.020311956543392472
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.020311956543392472
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.000541419	0.020311956543392472
KAGAMI-OGATA SYNDROME	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000541419	0.020311956543392472
AICA-RIBOSIDURIA	0.000541419	0.020311956543392472
MICROSPORIDIOSIS	0.000541419	0.020311956543392472
MIRAGE SYNDROME; MIRAGE	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000541419	0.020311956543392472
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.000541419	0.020311956543392472
MOYAMOYA DISEASE	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000541419	0.020311956543392472
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.000541419	0.020311956543392472
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000541419	0.020311956543392472
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.020311956543392472
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.020311956543392472
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.000541419	0.020311956543392472
CHROMOSOME 16P13.2 DELETION SYNDROME	0.000541419	0.020311956543392472
1Q41Q42 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.000541419	0.020311956543392472
17Q24.2 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392472
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.000541419	0.020311956543392472
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.020311956543392472
5Q14.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.000541419	0.020311956543392472
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000541419	0.020311956543392472
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.000541419	0.020311956543392472
JACOBSEN SYNDROME	0.000541419	0.020311956543392472
JOUBERT SYNDROME 30; JBTS30	0.000541419	0.020311956543392472
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.000541419	0.020311956543392472
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.000541419	0.020311956543392472
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.000541419	0.020311956543392472
15Q11Q13 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392472
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392472
4Q21 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.000541419	0.020311956543392472
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.000541419	0.020311956543392472
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.000541419	0.020311956543392472
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
CENTRAL BILATERAL MACROGYRIA	0.000541419	0.020311956543392472
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.000541419	0.020311956543392472
CITRULLINEMIA TYPE I	0.000541419	0.020311956543392472
CITRULLINEMIA TYPE II	0.000541419	0.020311956543392472
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.000541419	0.020311956543392472
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.000541419	0.020311956543392472
NEUROCUTANEOUS MELANOCYTOSIS	0.000541419	0.020311956543392472
JUVENILE HUNTINGTON DISEASE	0.000541419	0.020311956543392472
LUSCAN-LUMISH SYNDROME; LLS	0.000541419	0.020311956543392472
LINEAR VERRUCOUS NEVUS SYNDROME	0.000541419	0.020311956543392472
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.000541419	0.020311956543392472
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.000541419	0.020311956543392472
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.020311956543392472
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.000541419	0.020311956543392472
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.000541419	0.020311956543392472
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.000541419	0.020311956543392472
NASU-HAKOLA DISEASE	0.000541419	0.020311956543392472
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392472
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.020311956543392472
ADAMS-OLIVER SYNDROME 5; AOS5	0.000541419	0.020311956543392472
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000541419	0.020311956543392472
WEBB-DATTANI SYNDROME; WEDAS	0.000541419	0.020311956543392472
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020311956543392472
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.000541419	0.020311956543392472
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
INHERITED CREUTZFELDT-JAKOB DISEASE	0.000541419	0.020311956543392472
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000541419	0.020311956543392472
HELSMOORTEL-VAN DER AA SYNDROME	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.000541419	0.020311956543392472
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.000541419	0.020311956543392472
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.020311956543392472
TARP SYNDROME	0.000541419	0.020311956543392472
CHROMOSOME 5Q12 DELETION SYNDROME	0.000541419	0.020311956543392472
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.000541419	0.020311956543392472
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.000541419	0.020311956543392472
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.020311956543392472
L1 SYNDROME	0.000541419	0.020311956543392472
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.020311956543392472
LINEAR NEVUS SEBACEUS SYNDROME	0.000541419	0.020311956543392472
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000541419	0.020311956543392472
DISTAL 16P11.2 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
17Q12 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392472
20P12.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
20Q13.33 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
DESANTO-SHINAWI SYNDROME	0.000541419	0.020311956543392472
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.000541419	0.020311956543392472
SMITH-KINGSMORE SYNDROME; SKS	0.000541419	0.020311956543392472
XP21 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.020311956543392472
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392472
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.020311956543392472
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.000541419	0.020311956543392472
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.000541419	0.020311956543392472
THANATOPHORIC DYSPLASIA	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.000541419	0.020311956543392472
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.000541419	0.020311956543392472
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.000541419	0.020311956543392472
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.000541419	0.020311956543392472
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.020311956543392472
TENORIO SYNDROME; TNORS	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000541419	0.020311956543392472
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.000541419	0.020311956543392472
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.000541419	0.020311956543392472
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.020311956543392472
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.000541419	0.020311956543392472
CHILDHOOD DISINTEGRATIVE DISORDER	0.000541419	0.020311956543392472
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.000541419	0.020311956543392472
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.020311956543392472
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392472
ABETA AMYLOIDOSIS, DUTCH TYPE	0.000541419	0.020311956543392472
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.000541419	0.020311956543392472
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.000541419	0.020311956543392472
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.000541419	0.020311956543392472
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.000541419	0.020311956543392472
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.000541419	0.020311956543392472
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.000541419	0.020311956543392472
DYSEQUILIBRIUM SYNDROME	0.000541419	0.020311956543392472
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.000541419	0.020311956543392472
CENTRAL DIABETES INSIPIDUS	0.000541419	0.020311956543392472
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.000541419	0.020311956543392472
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
COFFIN-SIRIS SYNDROME 8; CSS8	0.000541419	0.020311956543392472
ACROMELIC FRONTONASAL DYSPLASIA	0.000541419	0.020311956543392472
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000541419	0.020311956543392472
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.000541419	0.020311956543392472
THANATOPHORIC DYSPLASIA TYPE 1	0.000541419	0.020311956543392472
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392472
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.020311956543392472
EDINBURGH MALFORMATION SYNDROME	0.000541419	0.020311956543392472
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.020311956543392472
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392472
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.020311956543392472
ROMANO-WARD SYNDROME	0.000541419	0.020311956543392472
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.000541419	0.020311956543392472
RING CHROMOSOME 10 SYNDROME	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.000541419	0.020311956543392472
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.000541419	0.020311956543392472
HISTIOCYTOID CARDIOMYOPATHY	0.000541419	0.020311956543392472
CONGENITAL DISORDER OF GLYCOSYLATION	0.000541419	0.020311956543392472
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.020311956543392472
MULTIPLE CARBOXYLASE DEFICIENCY	0.000541419	0.020311956543392472
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.000541419	0.020311956543392472
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.020311956543392472
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.000541419	0.020311956543392472
CRYPTOCOCCOSIS	0.000541419	0.020311956543392472
FAMILIAL BENIGN COPPER DEFICIENCY	0.000541419	0.020311956543392472
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.000541419	0.020311956543392472
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.020311956543392472
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.000541419	0.020311956543392472
BETA-MANNOSIDOSIS	0.000541419	0.020311956543392472
ROSAÏ-DORFMAN DISEASE	0.000541419	0.020311956543392472
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.000541419	0.020311956543392472
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.000541419	0.020311956543392472
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.020311956543392472
2P21 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.020311956543392472
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.020311956543392472
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.000541419	0.020311956543392472
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.000541419	0.020311956543392472
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.000541419	0.020311956543392472
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.000541419	0.020311956543392472
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.000541419	0.020311956543392472
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.020311956543392472
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.000541419	0.020311956543392472
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.000541419	0.020311956543392472
EPISODIC ATAXIA TYPE 6	0.000541419	0.020311956543392472
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.000541419	0.020311956543392472
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.000541419	0.020311956543392472
CYSTATHIONINURIA	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.020311956543392472
SPINOCEREBELLAR ATAXIA 47; SCA47	0.000541419	0.020311956543392472
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.000541419	0.020311956543392472
DONNAI-BARROW SYNDROME	0.000541419	0.020311956543392472
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.020311956543392472
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.020311956543392472
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.020311956543392472
NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392472
FRONTAL ENCEPHALOCELE	0.000541419	0.020311956543392472
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.000541419	0.020311956543392472
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.020311956543392472
HYDRANENCEPHALY	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.000541419	0.020311956543392472
CONGENITAL HYDROCEPHALUS	0.000541419	0.020311956543392472
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.000541419	0.020311956543392472
SOTOS SYNDROME	0.000541419	0.020311956543392472
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.020311956543392472
PITT-HOPKINS-LIKE SYNDROME	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.000541419	0.020311956543392472
NEPHROGENIC DIABETES INSIPIDUS	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.020311956543392472
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.020311956543392472
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.000541419	0.020311956543392472
FRYNS SYNDROME	0.000541419	0.020311956543392472
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.000541419	0.020311956543392472
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000541419	0.020311956543392472
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.000541419	0.020311956543392472
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.020311956543392472
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.000541419	0.020311956543392472
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.000541419	0.020311956543392472
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.000541419	0.020311956543392472
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.000541419	0.020311956543392472
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.020311956543392472
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.000541419	0.020311956543392472
EAST SYNDROME	0.000541419	0.020311956543392472
ADULT-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.020311956543392472
COWDEN SYNDROME	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.000541419	0.020311956543392472
ENDOCARDIAL FIBROELASTOSIS	0.000541419	0.020311956543392472
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.020311956543392472
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.000541419	0.020311956543392472
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.020311956543392472
FLYNN-AIRD SYNDROME	0.000541419	0.020311956543392472
FOIX-CHAVANY-MARIE SYNDROME	0.000541419	0.020311956543392472
CRIGLER-NAJJAR SYNDROME	0.000541419	0.020311956543392472
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.000541419	0.020311956543392472
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.020311956543392472
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.000541419	0.020311956543392472
ISOLATED GLYCEROL KINASE DEFICIENCY	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.000541419	0.020311956543392472
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.020311956543392472
LISSENCEPHALY 1; LIS1	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.000541419	0.020311956543392472
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
DYSTONIA-APHONIA SYNDROME	0.000541419	0.020311956543392472
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000541419	0.020311956543392472
HYPERPROLINEMIA TYPE 1	0.000541419	0.020311956543392472
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000541419	0.020311956543392472
CONO-SPONDYLAR DYSPLASIA	0.000541419	0.020311956543392472
KUFOR-RAKEB SYNDROME	0.000541419	0.020311956543392472
PROPIONIC ACIDEMIA	0.000541419	0.020311956543392472
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.000541419	0.020311956543392472
GLYCINE ENCEPHALOPATHY; GCE	0.000541419	0.020311956543392472
HYPOPHOSPHATASIA	0.000541419	0.020311956543392472
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.000541419	0.020311956543392472
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
WIEDEMANN-STEINER SYNDROME; WDSTS	0.000541419	0.020311956543392472
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.020311956543392472
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.000541419	0.020311956543392472
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.020311956543392472
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.000541419	0.020311956543392472
CRANIOSYNOSTOSIS 2	0.000541419	0.020311956543392472
PGM3-CDG	0.000541419	0.020311956543392472
11Q22.2Q22.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.000541419	0.020311956543392472
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.000541419	0.020311956543392472
NIEMANN-PICK DISEASE, TYPE C2	0.000541419	0.020311956543392472
ALZHEIMER DISEASE 3; AD	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.000541419	0.020311956543392472
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.020311956543392472
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.000541419	0.020311956543392472
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.000541419	0.020311956543392472
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.000541419	0.020311956543392472
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.020311956543392472
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.000541419	0.020311956543392472
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.000541419	0.020311956543392472
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.000541419	0.020311956543392472
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.020311956543392472
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.000541419	0.020311956543392472
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.000541419	0.020311956543392472
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.000541419	0.020311956543392472
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.020311956543392472
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.000541419	0.020311956543392472
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.000541419	0.020311956543392472
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.000541419	0.020311956543392472
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.020311956543392472
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000541419	0.020311956543392472
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.020311956543392472
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.000541419	0.020311956543392472
MAN1B1-CDG	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000541419	0.020311956543392472
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.000541419	0.020311956543392472
MEND SYNDROME	0.000541419	0.020311956543392472
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.000541419	0.020311956543392472
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.020311956543392472
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.000541419	0.020311956543392472
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.000541419	0.020311956543392472
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000541419	0.020311956543392472
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.000541419	0.020311956543392472
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392472
MAPLE SYRUP URINE DISEASE	0.000541419	0.020311956543392472
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.000541419	0.020311956543392472
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.000541419	0.020311956543392472
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 9	0.000541419	0.020311956543392472
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 1	0.000541419	0.020311956543392472
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.020311956543392472
ICHTHYOSIS AND MALE HYPOGONADISM	0.000541419	0.020311956543392472
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.020311956543392472
GLYCEROL KINASE DEFICIENCY; GKD	0.000541419	0.020311956543392472
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.000541419	0.020311956543392472
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.000541419	0.020311956543392472
8Q24.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
ETHYLMALONIC ENCEPHALOPATHY	0.000541419	0.020311956543392472
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.020311956543392472
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.000541419	0.020311956543392472
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.000541419	0.020311956543392472
SHUKLA-VERNON SYNDROME; SHUVER	0.000541419	0.020311956543392472
XQ25 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 103	0.000541419	0.020311956543392472
XQ25 DUPLICATION SYNDROME	0.000541419	0.020311956543392472
IMMUNODEFICIENCY 47	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.000541419	0.020311956543392472
MEND SYNDROME; MEND	0.000541419	0.020311956543392472
ACUTE BILIRUBIN ENCEPHALOPATHY	0.000541419	0.020311956543392472
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.000541419	0.020311956543392472
WAISMAN SYNDROME; WSMN	0.000541419	0.020311956543392472
RETT SYNDROME; RTT	0.000541419	0.020311956543392472
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.000541419	0.020311956543392472
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.000541419	0.020311956543392472
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.000541419	0.020311956543392472
MUENKE SYNDROME	0.000541419	0.020311956543392472
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.000541419	0.020311956543392472
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000541419	0.020311956543392472
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000541419	0.020311956543392472
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.000541419	0.020311956543392472
GRACILE BONE DYSPLASIA; GCLEB	0.000541419	0.020311956543392472
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.020311956543392472
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.020311956543392472
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.000541419	0.020311956543392472
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.000541419	0.020311956543392472
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.000541419	0.020311956543392472
POTOCKI-SHAFFER SYNDROME	0.000541419	0.020311956543392472
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.020311956543392472
GURRIERI SYNDROME	0.000541419	0.020311956543392472
TIMOTHY SYNDROME; TS	0.000541419	0.020311956543392472
HEREDITARY FRUCTOSE INTOLERANCE	0.000541419	0.020311956543392472
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.000541419	0.020311956543392472
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.020311956543392472
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392472
CHROMOSOME 2Q37 DELETION SYNDROME	0.000541419	0.020311956543392472
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.020311956543392472
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000541419	0.020311956543392472
MONOSOMY 22Q13.3	0.000541419	0.020311956543392472
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.000541419	0.020311956543392472
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000541419	0.020311956543392472
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.000541419	0.020311956543392472
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.020311956543392472
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.000541419	0.020311956543392472
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.000541419	0.020311956543392472
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.000541419	0.020311956543392472
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.000541419	0.020311956543392472
COFFIN-SIRIS SYNDROME 2; CSS2	0.000541419	0.020311956543392472
BARAITSER-WINTER SYNDROME 2; BRWS2	0.000541419	0.020311956543392472
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000541419	0.020311956543392472
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000541419	0.020311956543392472
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.000541419	0.020311956543392472
SEVERE CANAVAN DISEASE	0.000541419	0.020311956543392472
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.020311956543392472
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.000541419	0.020311956543392472
SIALURIA	0.000541419	0.020311956543392472
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.000541419	0.020311956543392472
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000541419	0.020311956543392472
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.000541419	0.020311956543392472
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.000541419	0.020311956543392472
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.000541419	0.020311956543392472
HEREDITARY HYPEREKPLEXIA	0.000541419	0.020311956543392472
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.020311956543392472
MECKEL SYNDROME, TYPE 10; MKS10	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.000541419	0.020311956543392472
STURGE-WEBER SYNDROME	0.000541419	0.020311956543392472
FOUNTAIN SYNDROME	0.000541419	0.020311956543392472
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.020311956543392472
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.000541419	0.020311956543392472
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.020311956543392472
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.000541419	0.020311956543392472
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.000541419	0.020311956543392472
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000541419	0.020311956543392472
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.000541419	0.020311956543392472
PORENCEPHALY	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000541419	0.020311956543392472
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.020311956543392472
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000541419	0.020311956543392472
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000541419	0.020311956543392472
LISSENCEPHALY 5; LIS5	0.000541419	0.020311956543392472
11P15.4 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392472
DDOST-CDG	0.000541419	0.020311956543392472
COWDEN SYNDROME 6; CWS6	0.000541419	0.020311956543392472
QAZI-MARKOUIZOS SYNDROME	0.000541419	0.020311956543392472
RAMON SYNDROME	0.000541419	0.020311956543392472
COWDEN SYNDROME 5; CWS5	0.000541419	0.020311956543392472
ISOLATED BILIARY ATRESIA	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, 18	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.020311956543392472
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.000541419	0.020311956543392472
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.000541419	0.020311956543392472
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000541419	0.020311956543392472
HEMIDYSTONIA-HEMIATROPHY SYNDROME	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.000541419	0.020311956543392472
GM2 GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.000541419	0.020311956543392472
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.020311956543392472
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000541419	0.020311956543392472
CORNELIA DE LANGE SYNDROME 3	0.000541419	0.020311956543392472
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.000541419	0.020311956543392472
WILSON-TURNER SYNDROME	0.000541419	0.020311956543392472
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.000541419	0.020311956543392472
ZIMMERMANN-LABAND SYNDROME	0.000541419	0.020311956543392472
CHIME SYNDROME	0.000541419	0.020311956543392472
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392472
FUCOSIDOSIS	0.000541419	0.020311956543392472
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.000541419	0.020311956543392472
GALACTOSIALIDOSIS	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.000541419	0.020311956543392472
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000541419	0.020311956543392472
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.000541419	0.020311956543392472
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.000541419	0.020311956543392472
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.000541419	0.020311956543392472
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.020311956543392472
RETINITIS PIGMENTOSA 59; RP59	0.000541419	0.020311956543392472
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.000541419	0.020311956543392472
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.020311956543392472
TEMPLE-BARAITSER SYNDROME; TMBTS	0.000541419	0.020311956543392472
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.000541419	0.020311956543392472
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.000541419	0.020311956543392472
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000541419	0.020311956543392472
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.000541419	0.020311956543392472
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.000541419	0.020311956543392472
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.020311956543392472
HOLOPROSENCEPHALY 7	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.000541419	0.020311956543392472
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000541419	0.020311956543392472
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.000541419	0.020311956543392472
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.000541419	0.020311956543392472
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.020311956543392472
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.020311956543392472
ZLOTOGORA-OGUR SYNDROME	0.000541419	0.020311956543392472
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.000541419	0.020311956543392472
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.000541419	0.020311956543392472
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000541419	0.020311956543392472
NOONAN SYNDROME 7; NS7	0.000541419	0.020311956543392472
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.000541419	0.020311956543392472
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.000541419	0.020311956543392472
ISOVALERIC ACIDEMIA	0.000541419	0.020311956543392472
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.000541419	0.020311956543392472
TETRASOMY 5P	0.000541419	0.020311956543392472
THYROCEREBRORENAL SYNDROME	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.000541419	0.020311956543392472
RETT SYNDROME, CONGENITAL VARIANT	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000541419	0.020311956543392472
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.000541419	0.020311956543392472
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.020311956543392472
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.000541419	0.020311956543392472
TRISOMY X	0.000541419	0.020311956543392472
TRISOMY 13	0.000541419	0.020311956543392472
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.000541419	0.020311956543392472
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.000541419	0.020311956543392472
GABA-TRANSAMINASE DEFICIENCY	0.000541419	0.020311956543392472
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.020311956543392472
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000541419	0.020311956543392472
FAMILIAL MEDITERRANEAN FEVER	0.000541419	0.020311956543392472
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000541419	0.020311956543392472
